abstract_id,Session title,abstract Title,Ground Truth,indication
393216,Colorectal Cancer,"Surgical Quality For Patients (Pts) Treated With Neoadjuvant Chemotherapy Vs Chemoradiation For Locally Advanced Rectal Cancer (Larc): Prospect (Ncctg N1048, Alliance)",Locally Advanced;;Rectal Cancer,Locally Advanced Rectal Cancer
393219,Colorectal Cancer,"Effectiveness And Safety Of Rectal Arterial Infusion Chemotherapy Combined With Anti-Pd1 Antibody For Microsatellite Stable Locally Advanced Rectal Cancer: Early Outcome Report Of A Two-Stage, Single Armed, Phase II Study (Raic)",Microsatellite Stable;;Locally Advanced;;Rectal Cancer,Microsatellite Stable Locally Advanced Rectal Cancer
147461,Myeloma And Other Monoclonal Gammopathies - Clinical,Depth Of Response And Mrd Status In Ultra High-Risk Myeloma And Plasma Cell Leukemia Treated With Dara-Cvrd And Augmented Autologous Transplant: Results Of The Risk-Stratified Uk Optimum/Muknine Trial,Ultra High-Risk;;Myeloma;;Plasma Cell Leukemia,Ultra High-Risk Myeloma;;Plasma Cell Leukemia
147482,Myeloproliferative Neoplasms - Clinical,Overall And Progression-Free Survival In Patients Treated With Fedratinib As First-Line Myelofibrosis (Mf) Therapy And After Prior Ruxolitinib (Rux): Results From The Jakarta And Jakarta2 Trials,First-Line;;Myelofibrosis,First-Line Myelofibrosis
180260,"Clonal Hematopoiesis, Aging and Inflammation: Poster I",Genomic Landscape of RUNX1-Familial Platelet Disorder with Myeloid Malignancies Reveals Rising Clonal Hematopoiesis,RUNX1-Familial Platelet Disorder;;Myeloid Malignancies,RUNX1-Familial Platelet Disorder;;Myeloid Malignancy
147495,Sickle Cell Disease,The Burden Of Sickle Cell Disease (Scd) On Patients In Ghana And Nigeria Compared With Other Low-/Middle-Income And High-Income Countries: Results From The Sickle Cell World Assessment Survey (Sway),Sickle Cell Disease,Sickle Cell Disease
262190,Chronic lymphocytic leukemia and related disorders - Clinical,"Nemtabrutinib (Mk-1026), A Non-Covalent Inhibitor Of Wild-Type And C481S Mutated Bruton Tyrosine Kinase For B-Cell Malignancies: Efficacy And Safety Of The Phase 2 Dose-Expansion Bellwave-001 Study",B-Cell Malignancies,B-Cell Malignancy
327727,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",The Expression of mi-RNAs Involved in the Hematopoietic Niche Microenvironment in Newly Diagnosed AML Patients,Newly Diagnosed;;AML,Newly Diagnosed Acute Myeloid Leukemia
327732,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome,Adult;;AML,Adult Acute Myeloid Leukemia
147508,Stem Cell Transplantation - Clinical,Belumosudil For Chronic Graft-Versus Host Disease After 2 Or More Prior Lines Of Therapy: The Rockstar Study (Kd025-213),Chronic;;Graft-Versus Host Disease,Chronic Graft-Versus Host Disease
147511,Stem Cell Transplantation - Clinical,Narsoplimab (Oms721) Treatment Contributes To Improvements In Organ Function In Adult Patients With High-Risk Transplant-Associated Thrombotic Microangiopathy,,
213047,Geriatric Urological Society (GUS),Parkinson's Disease and the Impact on Urologic Health in Older Adults,Parkinson's Disease;;Older Adults,Elderly Parkinson's Disease
327741,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",Intensive Therapy for NPM1 Mutant AML Patients: Negative Impact of FLT3-ITDhighbut Not FLT3-ITDlow and FLT3-TKD and Role of Transplant in Patients over 60 Years of Age,NPM1;;Mutant;;AML,NPM1-Mutant Acute Myeloid Leukemia
180285,Bone Marrow Failure: Poster I,Predictors of Efficacy in Chinese Patients with Severe Aplastic Anemia Treated with Eltrombopag and Intensive Immunosupressive Therapy,Severe Aplastic Anemia,Severe Aplastic Anemia
294973,MSD - Navigating through the rapidly evolving treatment landscape for GI Cancers - A Clinical & Patient Centric Approach towards implementing Immunotherapy,Changing GEC Patient Care with IO plus Chemotherapy in First-Line,GI Cancers;;First-Line,First-Line Gastrointestinal Cancer
262206,Chronic myeloid leukemia - Clinical,Bosutinib Dose Optimization In The Second-Line Treatment Of Elderly Cml Patients: Extended 3-Year Follow-Up And Final Results Of The Best Study,Second-Line;;Elderly;;Cml,Second-Line Elderly Chronic Myeloid Leukemia
147521,Thrombosis And Vascular Biology - Biology & Translational Research,Thrombophilia As Risk Factor For Asparaginase Related Venous Thromboembolism In Pediatric And Young Adult Patients Affected By Acute Lymphoblastic Leukemia,Venous Thromboembolism;;Pediatric;;Young Adult,Pediatric Young Adult Venous Thromboembolism
393283,Developmental Therapeutics,"A Phase I Study Of Safety, Pharmacokinetics, And Pharmacodynamics Of Scr-6920, A Protein Arginine Methyltransferase 5(Prmt5) Inhibitor, In Patients With Advanced Malignant Tumors",Advanced;;Malignant Tumors,Advanced Malignant Tumor
262209,Chronic myeloid leukemia - Clinical,Real-Life Outcomes Of Ponatinib Treatment In Patients With Chronic Myeloid Leukemia (Cml) Or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+All): 5-Year-Data From A Belgian Registry,Chronic Myeloid Leukemia;;Philadelphia Chromosome-Positive;;Acute Lymphoblastic Leukemia,Chronic Myeloid Leukemia;;Ph Chromosome-Positive Acute Lymphoblastic Leukemia
180298,Bone Marrow Failure: Poster I,"Pozelimab, a Human Monoclonal Antibody Against Complement Factor C5, Provided Inhibition of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria",Paroxysmal Nocturnal Hemoglobinuria,Paroxysmal Nocturnal Hemoglobinuria
393291,Developmental Therapeutics,"Preclinical Evaluation Of Hlx42, A Novel Egfr-Targeting Adc, For Cetuximab Or Tki Resistant Cancer",Cancer,Cancer
180300,Bone Marrow Failure: Poster I,Clinical Presentation of Patients with Adult Late-Onset Telomere Biology Disorders - Results from the Aachen Telomeropathy Registry,Adult;;Late-Onset;;Telomere Biology Disorders,Adult Late-Onset Telomere Biology Disorder
327760,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",Clinical and Molecular Characterization of Newly Diagnosed IDH/TP53 Co-Mutated AML and Impact of Genomically Sensitive Treatment Strategies,Newly Diagnosed;;IDH;;TP53;;Co-Mutated;;AML,Newly Diagnosed IDH-Mutated TP53-Mutated Acute Myeloid Leukemia
311376,"Abstracts: RA - Diagnosis, Manifestations, and Outcomes I: Pre- and Early Disease",Sputum RA-Associated Autoantibodies Independently Associate with Future Development of Classified RA in an At-Risk Cohort of Individuals with Systemic Anti-CCP Positivity,RA ,Rheumatoid Arthritis
229467,Vaccines and Immunity against Bacteria and Parasites,"The novel adjuvant, ADA-1, restores age-associated defects in the adaptive immune response to Clostridioides difficile infection and vaccination in an aging mouse model",Clostridioides difficile infection,Clostridioides Difficile Infection
327778,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III",The LSC17 Score Correlates with the ELN 2022 Classification of AML and Is an Independent Predictor of Detectable Measurable Residual Disease after Induction Chemotherapy,AML,Acute Myeloid Leukemia
147554,Acute Lymphoblastic Leukemia - Clinical,Antibodies To Pegylated E. Coli Asparaginase Predict The Occurrence Of Hypersensitivity Reactions In High-Risk Patients Undergoing The Consolidation Phase Of The Aieop-Bfm All 2009 Protocol.,High-Risk;;Acute Lymphoblastic Leukemia,High-Risk Acute Lymphoblastic Leukemia
327789,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III","Multiomic Single-Cell Sequencing of Mixed Phenotypic Acute Leukemia (MPAL) Reveals Complex Immunophenotypic, Transcriptional, and Genetic Heterogeneity",Mixed Phenotypic Acute Leukemia,Mixed Phenotypic Acute Leukemia
213104,Quality Improvement Summit: Laying the Foundation for Primary Palliative Care in Urology,What Clinical Innovations and Other Interventions Are Needed?,,
393329,Developmental Therapeutics,A Phase 1 Study Of Bal0891 As Monotherapy And In Combination With Chemotherapy In Patients With Advanced Solid Tumors.,Advanced;;Solid Tumors,Advanced Solid Tumor
376946,Quality of life and palliative care,Automated Metrics From The Electronic Health Record Enable Evaluation Of Palliative Care In Patients With Acute Myeloid Leukaemia: A Data Science Approach,Acute Myeloid Leukaemia,Acute Myeloid Leukemia
262259,"Gene therapy, cellular immunotherapy and vaccination - Biology & Translational Research",Multiplex Deletion Of Myeloid Antigens Cd33 And Cll-1 By Crispr/Cas9 In Human Hematopoietic Stem Cells Highlights The Potential Of Next-Generation Transplants For Aml Treatment.,Aml,Acute Myeloid Leukemia
229493,Vaccination and immunotherapy against COVID-19,Pan-coronavirus neutralizing S2 human monoclonal antibodies and utility of direct respiratory administration as combination therapy with S1 antibodies against SARS-CoV-2,SARS-CoV-2,SARS-CoV-2 Infection
393337,Germ Cell (Testicular) Cancer And Penile Cancer,Efficacy And Safety Of High-Dose Chemotherapy As Second Or Subsequent Salvage Therapy In Relapsed Or Refractory Germ Cell Cancer Patients: A Multicentric Analysis,Relapsed;;Refractory;;Germ Cell Cancer,Relapsed or Refractory Germ Cell Cancer
376961,Acute myeloid leukemia - Clinical,Lifetime Clinical Outcomes Of Cpx-351 Versus 7+3 Modeled From The 5-Year Results Of A Randomized Phase 3 Trial For Older Adults With Newly Diagnosed High-Risk Or Secondary Acute Myeloid Leukaemia,Older Adults;;Newly Diagnosed;;High-Risk;;Secondary;;Acute Myeloid Leukaemia,Elderly Newly Diagnosed High-Risk Secondary Acute Myeloid Leukaemia
295042,Proffered Paper session: Policy and preventive strategies,Invited Discussant 1312O and 1313O,,
229509,Cells of the Innate Immune System,Osteoclast differentiation alters monocyte inflammatory responses to Staphylococcus aureus,Staphylococcus aureus,Staphylococcus Aureus Infection
180358,Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I,Targeting Metabolic Vulnerabilities in Primary Effusion Lymphoma Using the Novel Nucleoside Analog 6-Eti,Primary Effusion Lymphoma,Primary Effusion Lymphoma
327817,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I",Connecting Genetic Heterogeneity with Single-Cell Transcriptome Dysregulations in Pediatric Acute Myeloid Leukemia,Pediatric;;Acute Myeloid Leukemia,Pediatric Acute Myeloid Leukemia
311433,"Abstracts: SLE - Diagnosis, Manifestations, and Outcomes II: Complications",Overall and Post-vaccination Prevalence of Severe COVID-19-related Events Among Commercially Insured Patients with Systemic Lupus Erythematosus and the General U.S. Population,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus
327823,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I",Quantitative Impact of Mutated NPM1 MRD in Patients with AML Undergoing Allogeneic Stem Cell Transplantation,Mutated;;NPM1;;AML,NPM1-Mutated Acute Myeloid Leukemia
311447,Abstracts: SLE - Treatment,CAR T Cell Treatment of Refractory Systemic Lupus Erythematosus,Refractory;;Systemic Lupus Erythematosus,Refractory Systemic Lupus Erythematosus
311449,Abstracts: SLE - Treatment,Hydroxychloroquine Dosing Less Than 5 Mg/kg/day Leads to Increased Hospitalizations for Systemic Lupus Erythematosus Flares,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus
409754,Regulating the Regulator: Exploring the Therapeutic Landscape for Complement-Mediated Kidney Diseases,Audience Q&A,,
393371,Gynaecological Cancers,Ccne1 Amplification Defines A Good Prognostic Subgroup Among Brcawt/Hrdneg Advanced High-Grade Ovarian Cancer (Hgoc),Advanced;;High-Grade;;Ovarian Cancer,Advanced High-Grade Ovarian Cancer
262300,"Hematopoiesis, stem cells and microenvironment",Monoallelic And Biallelic Germline Mutations Affecting The Transcription Factor Helios Cause Pleiotropic Defects Of Immunity,,
393379,Gynaecological Cancers,Correlation Between Chemotherapy Response Score (Crs) And Germline Brca1/2 (Gbrca) Status In Women Diagnosed With Figo Stage Iiic/Iv High-Grade Serous Ovarian Cancer (Hgsoc),Stage Iiic/Iv;;High-Grade;;Serous Ovarian Cancer,Stage IIIc/IV High-Grade Serous Ovarian Cancer
213157,Society for the Study of Male Reproduction (SSMR),Society for the Study of Male Reproduction (SSMR),,
393382,Gynaecological Cancers,The Predictive Role Of Circulating Exosomal Pd-L1 In Cervical Cancer Immunotherapy,Cervical Cancer,Cervical Cancer
344232,Intercepting Molecular Residual Disease in the Clinic,Chair Introduction,,
180389,Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I,Safety and Efficacy of Isavuconazole in Patients Aged 65 Years or Older with Invasive Fungal Disease: A Post-Hoc Analysis from the VITAL and Secure Studies,Invasive Fungal Disease,Elderly Invasive Fungal Disease
180390,Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I,Clinical Characteristics Associated with Venous Thromboembolism in Patients with Non-APL Acute Myeloid Leukemia,Venous Thromboembolism;;Acute Myeloid Leukemia,Venous Thromboembolism;;Acute Myeloid Leukemia
262320,Hodgkin lymphoma - Clinical,"Brentuximab Vedotin, Etoposide, Solumedrol, High Dose Ara-C & Platinum Followed By Hdt & Apbsct For Refractory/Relapsed Hodgkin Lymphoma Patients: Long-Term Results Of The Geltamo Group Breshap Study",Refractory;;Relapsed;;Hodgkin Lymphoma,Refractory/Relapsed Hodgkin Lymphoma
180403,"Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I",Updated Results from a Phase II Study of Hyper-CVAD with Sequential Blinatumomab in Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia,Adults;;Newly Diagnosed;;Philadelphia Chromosome;;Negative;;B-Cell Acute Lymphoblastic Leukemia,Adult Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia
327859,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",Robust Validation of the UKALL High Hyperdiploid Risk Profile Using Individual Patient Data Collected By the Harmony Alliance,ALL,Acute Lymphoblastic Leukemia
393400,Gynaecological Cancers,Tumor-Informed Ctdna Detection As A Predictive Marker For Postoperative Residual Disease In Epithelial Ovarian Cancer: A Feasibility Study,Epithelial Ovarian Cancer,Epithelial Ovarian Cancer
327865,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III",Clinical Significance of IGH Clonality Analysis with RNA Sequencing in B-Cell Precursor Acute Lymphoblastic Leukemia,B-Cell Precursor Acute Lymphoblastic Leukemia,B-Cell Precursor Acute Lymphoblastic Leukemia
327866,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III",The Rise and Fall of Leukemia Clones in Longitudinal Samples from Diagnosis to Relapse in KMT2A-rearranged Infant and Childhood Leukemia,Relapse;;KMT2A;;rearranged;;Infant;;Childhood;;Leukemia,Relapsed KMT2A-Rearranged Infant Childhood Leukemia
262328,Indolent and mantle-cell non-Hodgkin lymphoma - Clinical,"Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) Btk Inhibitor In Previously Treated Mantle Cell Lymphoma: Updated Results From The Phase 1/2 Bruin Study",Previously Treated;;Mantle Cell Lymphoma,Previously Treated Mantle Cell Lymphoma
393407,Gynaecological Cancers,Mental And Socioeconomic Burden In Co-Parents And Children Of Patients With Endometrial And Cervical Cancer: A Swedish Population-Based Study,Children;;Endometrial;;Cervical Cancer,Childhood Endometrial Cancer;;Childhood Cervical Cancer
147649,Acute Myeloid Leukemia - Clinical,Phase 1 First-In-Human Study Of Irreversible Flt3 Inhibitor Ff-10101-01 In Relapsed Or Refractory Acute Myeloid Leukemia,Relapsed;;Refractory;;Acute Myeloid Leukemia,Relapsed/Refractory Acute Myeloid Leukemia
327877,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I",The Influence of Genetic Ancestry on Disease Biology in Pediatric T-Cell Acute Lymphoblastic Leukemia,Pediatric;;T-Cell Acute Lymphoblastic Leukemia,Pediatric T-Cell Acute Lymphoblastic Leukemia
311500,Abstracts: Vasculitis - ANCA-Associated,"A Randomized, Double-Blind, Phase II Study of Glucocorticoid Replacement by Vilobelimab, an Anti-C5a Monoclonal Antibody, in ANCA-Associated Vasculitis",ANCA-Associated;;Vasculitis,ANCA-Associated Vasculitis
180429,"Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I",Modified Intensive Induction Treatment for Elderly Acute Myeloid Leukemia Patients Based on Peripheral Blast Clearance Rate: A Phase II Single-Arm Study,Elderly;;Acute Myeloid Leukemia,Elderly Acute Myeloid Leukemia
311504,Abstracts: Vasculitis - ANCA-Associated,Recovery of Renal Function Among ANCA-Associated Vasculitis Patients with Baseline eGFR <=20 in the Avacopan ADVOCATE Trial,ANCA;;Associated;;Vasculitis,ANCA-Associated Vasculitis
229586,Neonatal and Fetal Mucosal Immunity,Microbiota drive concomitant expression of IL-17 and the inhibitory receptor PD-1 to regulate effector functions of gd17 cells in the intestine,,
180437,"Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I",Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial,Adult;;Newly Diagnosed;;AML,Adult Newly Diagnosed Acute Myeloid Leukemia
377049,Acute myeloid leukemia - Biology & Translational Research,"Therapeutic Potential And Strategies Of Pim447, A Pan-Pim Inhibitor, Targeting Refractory Myeloid Leukemia With Kit-Driven T(8/21)",Refractory;;Myeloid Leukemia,Refractory Myeloid Leukemia
180442,"Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I","Aspacytarabine (BST-236) As Monotherapy Is Safe, Well-Tolerated and Effective for the Treatment of Adults with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Therapy. Results of a Phase 2 Study",Adults;;Newly Diagnosed;;Acute Myeloid Leukemia,Adult Newly Diagnosed Acute Myeloid Leukemia
295132,"The three ""Ws"" of early breast cancer management","Neo-adjuvant therapy in luminal breast cancer: Who to treat, which regimen, and what duration?",luminal breast cancer,Luminal Breast Cancer
147677,Acute Myeloid Leukemia - Clinical,Validation And Clinical Application Of An Unsupervised Analysis Approach To Measurable Residual Disease Testing In Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia
180445,"Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I",Updated Survival and Response Analyses from a Phase 1 Study of Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation,Newly Diagnosed;;AML;;IDH1;;IDH2 Mutation,IDH1-Mutated IDH2-Mutated Newly Diagnosed Acute Myeloid Leukemia
327904,Lymphomas: Translational-Molecular and Genetic: Poster II,BCL6 Rearranged Indolent B-Cell Lymphomas Show Mutational Profile Similar to Marginal Zone Lymphomas,BCL6;;Rearranged;;Indolent B-Cell Lymphomas;;Marginal Zone Lymphomas,BCL6-Rearranged Indolent B-Cell Lymphoma;;Marginal Zone Lymphoma
409825,Winning Team: The Nephrology Workforce for the 21st Century,Advocacy and Policy: What Can Nephrologists and National Organizations Do?,,
147689,Acute Myeloid Leukemia - Clinical,Induced Systemic T-Cell Specific Responses To Multiple Tumor-Associated Antigens After Allogenic Leukemia-Derived Dendritic Cell Vaccine Dcp-001 In Aml Patients With Persistent Mrd,Aml,Acute Myeloid Leukemia
180465,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I",Integrated Transcriptomics and Proteomics Identifies Therapeutic Targets in Pediatric Acute Myeloid Leukemia,Pediatric;;Acute Myeloid Leukemia,Pediatric Acute Myeloid Leukemia
409842,Collagen IV Conundrums: Genetic Variants and Clinical Management,Do All Collagen Variants Cause Glomerular Disease?,,
164086,LBA01: Late-breaking Abstract I - Benign,Randomized control trial of ultrasonic propulsion to facilitate clearance of chronic residual fragments,,
327929,Lymphomas: Translational-Molecular and Genetic: Poster III,Genome-Wide Methylation and Haplotype-Resolved Aberrant Somatic Hypermutation Patterns in B-Cell Lymphomas,B-Cell Lymphomas,B-Cell Lymphoma
180473,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I",Evolution of Genomic Landscape in Acute Myeloid Leukemia after Decitabine and Venetoclax,Acute Myeloid Leukemia,Acute Myeloid Leukemia
180478,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I",Duplex-Sequencing Uncovers Low-Frequency Mutations in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia,KMT2A-Rearranged;;Infant;;Acute Lymphoblastic Leukemia,KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia
213248,Society of Benign Prostate Disease,"BPH Guidelines: Conflict and Contrast in the AUA, EAU, NICE BPH Guidelines",BPH,Benign Prostatic Hyperplasia
377088,Infections in hematology (incl. supportive care/therapy),Clinical Characteristics Of Patients With Prolonged Viral Shedding Of Omicron Variant In Haematological Disease,Haematological Disease,Haematological Disease
295167,Thermo Fisher Scientific - Connecting patients everywhere to precision oncology,Circulating tumour DNA for monitoring of response to neoadjuvant chemotherapy in patients with high grade serous ovarian carcinoma,high grade;;serous ovarian carcinoma,High Grade Serous Ovarian Carcinoma
164102,LBA02: Late-breaking Abstract II - Malignant,MRI-guided Focused Ultrasound (MRgFUS) Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results of a Phase IIb Multicenter Study,Intermediate-Risk;;Prostate Cancer,Intermediate-Risk Prostate Cancer
213255,Society of Benign Prostate Disease,Microbiome and BPH,Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia
311555,Adult Thieves Market Poster,Itchy Rash and Starry Eyed,,
213252,Society of Benign Prostate Disease,Rapid Fire,Benign;;Prostate Disease,Benign Prostate Disease
377096,Acute myeloid leukemia - Clinical,"Azacitidine, Venetoclax And Gilteritinib For Patients With Newly Diagnosed Flt3-Mutated Acute Myeloid Leukemia: A Subgroup Analysis From A Phase Ii Study",Newly Diagnosed;;Flt3-Mutated;;Acute Myeloid Leukemia,Newly Diagnosed Flt3-Mutated Acute Myeloid Leukemia
344332,"Clinical Trial Design in a Diverse World, Part 3: Biomarkers in Clinical Trials",Chair Introduction,,
393489,"Head and neck cancers, excl. thyroid",Efficacy Of Notch Inhibitors (Ni) Relative To Prior Systemic Therapy Or Observation In Patients (Pts) With Recurrent/Metastatic (R/M) Adenoid Cystic Carcinoma (Acc),Recurrent;;Metastatic;;Adenoid Cystic Carcinoma,Recurrent/Metastatic Adenoid Cystic Carcinoma
180497,Lymphomas: Translational-Molecular and Genetic: Poster I,A Prospective Study of Clonal Evolution in Follicular Lymphoma: Circulating Tumor DNA Correlates with Overall Tumor Burden and Fluctuates over Time without Therapy,Follicular Lymphoma,Follicular Lymphoma
180501,Lymphomas: Translational-Non-Genetic: Poster I,Differential Gene Expression in Circulating T-Cells in Long-Term Adolescent/Young Adult Hodgkin Lymphoma (AYAHL) Survivors and Their Unaffected Twins,Adolescent/;;oung;;Adult Hodgkin Lymphoma,Adolescent/Young Adult Hodgkin Lymphoma
262425,"Iron metabolism, deficiency and overload",Familial Erythrocytoses In The Czech Republic - Genetic Characterization And Hepcidin Regulation,Familial Erythrocytoses,Familial Erythrocytosis
213274,MP01: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I,"The ""Butterfly"" transurethral retraction device for BPH - over 1 year follow up",BPH,Benign Prostatic Hyperplasia
311577,Adult Thieves Market: Show Me Your Best Cases,Q&A,,
377120,"Gene therapy, cellular immunotherapy and vaccination - Clinical",Axicabtagene Ciloleucel Versus Tisagenlecleucel Car-T Cells In Relapsed Or Refractory Diffuse Large B Cell Lymphoma,Relapsed Or Refractory;;Diffuse Large B Cell Lymphoma,Relapsed/Refractory Diffuse Large B Cell Lymphoma
377121,Stem cell transplantation - Clinical,Single Nucleotide Polymorphisms In Patients With Endothelial Damage After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation,,
229667,Immuneregulation-Innate Immune Responses,The biological mechanisms of metformin effects on aging-associated inflammation in obesity,,
213291,MP01: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I,Minimally Invasive and Endoscopic Therapies for Benign Prostatic Hyperplasia: Head-to-Head Comparison of Short-Term Outcomes by Network Meta-Analysis,Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia
327983,Lymphomas: Translational-Non-Genetic: Poster II,Pharmacodynamic Biomarkers of Mosunetuzumab Efficacy and Safety in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: Results from a Phase I/II Study,Relapsed;;Refractory;;Non-Hodgkin Lymphoma,Relapsed/Refractory Non-Hodgkin Lymphoma
180529,"Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I",Treatment Regimens and Clinical Outcomes Among Follicular Lymphoma Patients Treated with Third-Line Therapy in the United States: A Real-World EHR Study,Third-Line;;Follicular Lymphoma,Third-Line Follicular Lymphoma
311607,Bacterial Autoimmune Sequellae: Common and Newly Recognized Clinical Syndromes,"UTI Biofilms, Amyloid, and Lupus Flares",,
377144,Clinical updates in ALL,A Chemotherapy-Free Combination Of Ponatinib And Blinatumomab For Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Subgroup Analysis From A Phase Ii Study,Newly Diagnosed;;Philadelphia Chromosome;;Positive;;Acute Lymphoblastic Leukemia,Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia
327998,Lymphomas: Translational-Non-Genetic: Poster III,"Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma",Second-Line;;Relapsed;;Refractory;;Classical Hodgkin Lymphoma,Second-Line Relapsed or Refractory Classical Hodgkin Lymphoma
409919,What's Complement Got to Do with It? ANCA Vasculitis and the Complement System,Audience Q&A,ANCA Vasculitis,ANCA Vasculitis
147776,Aggressive Non-Hodgkin Lymphoma - Clinical,"Discovery Of Hbw-3-20, The First Reversible Inhibitor Of Bruton'S Tyrosine Kinase (Btk) With High Brain Exposure",Aggressive;;Non-Hodgkin Lymphoma,Aggressive Non-Hodgkin Lymphoma
328003,Lymphomas: Translational-Non-Genetic: Poster III,Immune Profiling of Double and Triple Hit High Grade B Cell Lymphoma Patients Treated with DA-EPOCH Reveals Activation of T Cells and Reduced T Cell Exhaustion,High Grade;;B Cell Lymphoma,High Grade B Cell Lymphoma
262464,Lymphoma Biology & Translational Research,Potentiating Anti-Cd20 Monoclonal Antibody Therapy By Targeting Complement C3 Activation Fragments Covalently Deposited On Lymphoma Cells,Lymphoma ,Lymphoma 
213317,MP03: Bladder Cancer: Invasive I,How does the type of urinary diversion affect health related quality of life (HRQOL) in the course of four years after radical cystectomy? - A propensity score-matched analysis,Invasive;;Bladder Cancer,Invasive Bladder Cancer
147782,Bleeding Disorders (Congenital And Acquired),Investigation Of Preterm Intraventricular Hemorrhage-Induced Inflammatory Response And Microrna Levels In Human Choroid Plexus Epithelial Cells,Congenital;;Acquired;;Bleeding Disorder,Congenital Bleeding Disorder;;Acquired Bleeding Disorder
147785,Bleeding Disorders (Congenital And Acquired),"Haemophilia B Leyden, An Age-Related Mechanism For An Increase Of Factor Ix: Case Report And Literature Review",Haemophilia B Leyden,Haemophilia B Leyden
328014,Lymphomas: Translational-Non-Genetic: Poster I,Leveraging Pre-Clinical Animal Model of CTCL to Explore Therapeutic Potential of a Novel STAT3 Degrader,Lymphomas,Lymphoma
328016,Lymphomas: Translational-Non-Genetic: Poster I,A Novel Cryopreservation and Biobanking Strategy to Study Lymphoid Tissue Stromal Cells in Lymphoproliferative Disorders,Lymphoproliferative Disorder,Lymphoproliferative Disorder
213341,MP04: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II,Trends in holmium laser enucleation of the prostate for treatment of benign prostatic hyperplasia,benign prostatic hyperplasia,Benign Prostatic Hyperplasia
213344,MP04: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II,En-Bloc enucleation technique with early apical release and urinary sphincter preservation using Pulse modulation (Virtual Basket) vs En-Bloc HoLEP,Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia
295266,How to incorporate digital medicine in survivorship care after breast cancer,How to incorporate digital medicine in survivorship care after breast cancer,breast cancer,Breast Cancer
213348,MP04: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II,Thulium YAG vs Thulium Fiber Laser Enucleation of the Prostate (ThuLEP vs TFLEP): a Multi-institution Trial to Compare Intra and Early Postoperative Outcomes.,Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia
377189,Bone marrow failure syndromes incl. PNH - Clinical,Changings In Genetic Definition And Management Of Acquired Aplastic Anemia: A Single Center Experience,Acquired;;Aplastic Anemia,Acquired Aplastic Anemia
311657,Challenges in Psoriatic Disease: Divergent Skin and Joints,Challenges in Psoriatic Disease: When Skin and Joint Symptoms Are Divergent,Psoriatic Disease,Psoriatic Disease
377194,Myeloma and other monoclonal gammopathies - Biology & Translational Research,Arginine Deprivation Induces Acquisition Of A Senescent Phenotype And Favors Genomic Instability In Multiple Myeloma Plasma Cells,Multiple Myeloma,Multiple Myeloma
409966,Dyslipidemia in Pediatric CKD: Risk for Stiff Vessels?,Controversies in the Management of Dyslipidemia in Children with CKD,Dyslipidemia;;Children,Childhood Dyslipidemia
393583,Hepatocellular Carcinoma (Hcc),"Comparative Efficacy Of Systemic Sequential Regorafenib After Sorafenib Or Lenvatinib Treatment Failure For Advanced Hepatocellular Carcinoma: A Retrospective, Multi-Center, Real-World Study",Advanced;;Hepatocellular Carcinoma,Advanced Hepatocellular Carcinoma
262514,Myelodysplastic syndromes - Clinical,Clinical Significance Of Routine High-Resolution Strucural Variant Profiling In Myelodysplastic Syndromes,Myelodysplastic Syndromes,Myelodysplastic Syndrome
262522,Myelodysplastic syndromes - Clinical,Runx1 Variants With High Variant Allele Frequency In Myeloid Neoplasms. Germline Or Not?,Myeloid Neoplasms,Myeloid Neoplasm
164220,Society for Pediatric Urology (SPU),Panel Discussion,,
409981,Power of Large Biorepositories in Diabetic Kidney Disease,Power of the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Repositories,Diabetic Kidney Disease,Diabetic Kidney Disease
147837,Chronic Lymphocytic Leukemia And Related Disorders - Biology & Translational Research,Influence Of Inflammatory Cytokines On S100A Proteins Expression In Cll Patients,Cll,Chronic Lymphocytic Leukemia
262527,Myeloma and other monoclonal gammopathies - Biology & Translational Research,Characterization Of Multiple Myeloma Cell Lines With Acquired-Resistance To Proteasome Inhibitors Highlights A Link Between Resistance And Metabolic Deregulation,Multiple Myeloma,Multiple Myeloma
409986,A Rocky Course: Bones and Stones Through the Life Span,Novel Therapies in the Management of Genetic Stone Disease: Cystinuria and PH1,Cystinuria;;PH1;;Genetic Stone Disease,Cystinuria;;Primary Hyperoxaluria Type 1;;Genetic Stone Disease
311696,Development of Proposed Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis (CNO) and Chronic Recurrent Multifocal Osteomyelitis (CRMO),Proposed ACR/EULAR Classification Criteria for CNO,Pediatric;;Chronic Nonbacterial Osteomyelitis,Pediatric Chronic Nonbacterial Osteomyelitis
344465,Contributions of the Tumor Glycome to Immune Suppression and Immunotherapy Resistance and Opportunities for Therapeutic Intervention,Chairperson,,
344467,Contributions of the Tumor Glycome to Immune Suppression and Immunotherapy Resistance and Opportunities for Therapeutic Intervention,Reprogramming the tumor-immune microenvironment by targeting galectin-glycan interactions,,
295316,Sex and gender differences in oncology: From prevention to care,Gender differences in colorectal cancer screening,colorectal cancer,Colorectal Cancer
147864,Chronic Lymphocytic Leukemia And Related Disorders - Clinical,Effectiveness And Safety Of Ibrutinib In Chronic Lymphocytic Leukemia (Cll) And Mantle Cell Lymphoma (Mcl) In Belgian Routine Clinical Practice With A 3-Year Follow-Up,Chronic Lymphocytic Leukemia;;Mantle Cell Lymphoma,Chronic Lymphocytic Leukemia;;Mantle Cell Lymphoma
393627,Investigational Immunotherapy,Tertiary Lymphoid Structures Localization And Maturation Heterogeneities Correlate With Divergent Clinical Outcomes And Immune Responses Of Clear Cell Renal Cell Carcinoma,Clear Cell Renal Cell Carcinoma,Clear Cell Renal Cell Carcinoma
213405,"MP07: Bladder & Urethra: Anatomy, Physiology & Pharmacology",Medications mostly associated with haematuria: assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries,haematuria,Haematuria
164257,Society of Urologic Oncology (SUO),Controversies in the Management of High-Risk Prostate Cancer,High-Risk;;Prostate Cancer,High-Risk Prostate Cancer
393639,Investigational Immunotherapy,Analysis Of Pulmonary Adverse Events Associated With Immune Checkpoint Inhibitors Based On Faers And Vigibase Database,,
262567,Myeloma and other monoclonal gammopathies - Clinical,Efficacy And Safety Of Daratumumab Monotherapy In Newly Diagnosed Patients With Stage 3B Light Chain Amyloidosis: A Phase 2 Study By The European Myeloma Network,Newly Diagnosed;;Stage 3B;;Light Chain Amyloidosis,Newly Diagnosed Stage 3B Light Chain Amyloidosis
262569,Myeloma and other monoclonal gammopathies - Clinical,High Responses Rates With Single Agent Belantamab Mafodotin In Relapsed Systemic Al Amyloidosis,Relapsed;;Systemic;;Al Amyloidosis,Relapsed Systemic Al Amyloidosis
164266,Society for Basic Urologic Research (SBUR),Welcome and Introductory Remarks,,
328106,"Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I",Matching-Adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma,Relapsed;;Refractory;;Mantle Cell Lymphoma,Relapsed/Refractory Mantle Cell Lymphoma
377263,Myeloma and other monoclonal gammopathies - Clinical,Role Of Interleukin 6 And Angiopoietins 1 And 2 In The Evolution Of Patients Diagnosed With Multiple Myeloma,Multiple Myeloma,Multiple Myeloma
213425,MP08: Pediatric Urology: Penis & Scrotum,Long Term Fertility Implications Following Adolescent Testicular Torsion: A Retrospective Analysis of a New York State All-Payer Database,,
295345,Chronic lymphocytic leukemia (CLL): What is the optimal first-line therapy?,Presentation by Expert,Chronic lymphocytic leukemia,Chronic Lymphocytic Leukemia
393651,Melanoma And Other Skin Tumours,Relapse-Free Survival With Adjuvant Dabrafenib/Trametinib Therapy After Relapse On A Prior Adjuvant Checkpoint Inhibitor And Subsequent Surgical Resection In Patients With Braf V600-Mutated Stage Iii/Iv Melanoma,Braf V600-Mutated;;Stage Iii/Iv;;Melanoma,Braf V600-Mutated Stage III/IV Melanoma
393652,Melanoma And Other Skin Tumours,Adjuvant Treatment With Anti-Pd-1 In Acral Melanoma Patients: A Nationwide Study,Acral Melanoma,Acral Melanoma
262579,Myeloma and other monoclonal gammopathies - Clinical,Survival Outcomes Of Patients With Multiple Myeloma In France: A Cohort Study Using The French National Healthcare Database (Snds),Multiple Myeloma,Multiple Myeloma
262577,Myeloma and other monoclonal gammopathies - Clinical,Incidence And Clinical Outcome Of Sars-Cov-2 Infection After Vaccination In Patients With Monoclonal Gammopathy Of Undetermined Significance (Mgus),Sars-Cov-2 Infection;;Monoclonal Gammopathy,Sars-Cov-2 Infection;;Monoclonal Gammopathy
295352,Young Oncologist Brunch 2: How to write and respond to a critical peer review,How to write and respond to a critical peer review,,
377273,Bone marrow failure syndromes incl. PNH - Biology & Translational Research,Preliminary Exploration On Lag-3 Expression Of Bone Marrow-Derived Macrophages In Severe Aplastic Anemia,Severe;;Aplastic Anemia,Severe Aplastic Anemia
410042,"APOL1, Nephrotic Syndrome, and HNF1B: Expanding Phenotypes and Mechanisms in Genetic Diseases",Common Variants in Mendelian Disease Genes as Risk Factors for CKD,CKD,Chronic Kidney Disease
344512,"New Insights into Cancer Initiation, Evolution, Therapy and Survivorship through Big Data Analysis",Ordered and selective patterns of cancer genome evolution revealed by lineage tracing of sporadic p53 loss,cancer,Cancer 
295362,ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer,State of the art first-line management of patients with advanced RCC,advanced;;RCC,Advanced Renal Cell Carcinoma
311747,"Experts Roundtable: Current and Future Payment Models, MIPS, and Other Hot Topics in Practice Management",Q&A,,
393665,Melanoma And Other Skin Tumours,First-Line Nivolumab Plus Ipilimumab In Advanced Melanoma Patients Previously Treated With Adjuvant Systemic Therapy.,Advanced;;Melanoma,Advanced Melanoma
295365,ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer,Q&A and discussion,advanced;;renal cancer,Advanced Renal Cancer
344518,Late-Breaking Research: Chemistry,BI 907828: A highly potent MDM2-p53 antagonist suitable for intermittent dose schedules,,
377287,Infections and SCT complications,"A Novel Approach Of Dual Metagenomics Next-Generation Sequencing For Early Diagnosis Of Blood Stream Infection In Hematologic Patients With Febrile Neutropenia: A Multicenter, Prospective Study",Febrile Neutropenia,Febrile Neutropenia
410057,Maternal and Environmental Factors: Effect on Kidney Formation and Function,Mechanisms of Kidney Injury and Lower Endowment in the Extreme Preterm,Kidney Injury,Kidney Injury
213447,MP09: Prostate Cancer: Detection & Screening I,Quality of Information in Spanish on BRCA and Genetic Testing in Prostate Cancer on YouTube,Prostate Cancer,Prostate Cancer
295375,"Gilead and Kite Oncology - Redefining the Lines of TNBC, Real-world management: improving survival for patients with metastatic TNBC",TNBC today: How can we increase survival for a very heterogenous and aggressive disease?,TNBC ,Triple-Negative Breast Cancer
328146,Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster III,"Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)",Early Stage;;Classic Hodgkin Lymphoma,Early Stage Classic Hodgkin Lymphoma
328150,Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster III,Late Effects Comparison between Two Chemotherapy Regimens for Hodgkin Lymphoma,Hodgkin Lymphoma,Hodgkin Lymphoma
147934,"Gene Therapy, Cellular Immunotherapy And Vaccination - Biology & Translational Research","Selection, Expansion, And New Pretreatment Of Human Natural Killer Cells With Anti-Cd38 Monoclonal Antibody For Efficient Treatment Of Multiple Myeloma.",Multiple Myeloma,Multiple Myeloma
180704,Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I,Assessment of the Clonal Dynamics of Acquired Mutations in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Treated in the Randomized Phase 3 Murano Trial Supports Venetoclax-Rituximab (VenR) Fixed-Duration Combination Treatment (Tx),Relapsed/Refractory;;Chronic Lymphocytic Leukemia,Relapsed/Refractory Chronic Lymphocytic Leukemia
213477,"MP11: Pediatric Urology: Neurogenic Bladder, Reconstruction & Urologic Emergencies",Endoscopic Injection Of The Bladder Neck Using Dextranomer Hyaluronate (Dx/Ha) In The Pediatric Patient: Results Of A Single Center Analysis With Long Term Follow Up,Neurogenic Bladder;;Pediatric,Pediatric Neurogenic Bladder
213478,"MP11: Pediatric Urology: Neurogenic Bladder, Reconstruction & Urologic Emergencies",A Technique to Prevent Stomal Stenosis in Reconstructive Urology,,
295399,Ipsen - Disrupting the landscape: the Plus One in RCC and NSCLC,"Triple, double and monotherapy: what is the sequence for best outcomes?",RCC;;NSCLC,Renal Cell Carcinoma;;Non-Small Cell Lung Cancer
262634,Myeloproliferative neoplasms - Biology & Translational Research,T Cell Response And Omicron Variant Neutralisation Following Vaccination Against Sars-Cov-2 In Patients With Chronic Myeloid Disorders,Chronic Myeloid Disorders,Chronic Myeloid Disorder
213480,"MP11: Pediatric Urology: Neurogenic Bladder, Reconstruction & Urologic Emergencies",Survival analysis among Utah residents with spina bifida born between 1950 and 2015,spina bifida,Spina Bifida
295405,AstraZeneca - Immunotherapy: the evolving treatment landscape in hepatobiliary cancers,Therapeutic approaches in unresectable / advanced HCC,unresectable / advanced;;HCC,Unresectable/Advanced Hepatocellular Carcinoma
393710,Melanoma And Other Skin Tumours,Transforming Growth Factor-Beta-1 And Soluble Co-Inhibitory Immune Checkpoints As Putative Drivers Of Immune Suppression In Advanced Basal Cell Carcinoma,Advanced;;Basal Cell Carcinoma,Advanced Basal Cell Carcinoma
410094,"Liquid ""Gold,"" Urinary Sediment Microscopy: Current Utility of an Old Tool",Value of Urine Microscopy in Clinical Practice: Illustration by Cases,,
262640,Myeloproliferative neoplasms - Biology & Translational Research,Peripheral Blood Cytotoxic T Cells Show Early Exhausted Features In Myelofibrosis Patients,Myelofibrosis ,Myelofibrosis 
328177,Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster I,Primary Cutaneous Gamma-Delta T-Cell Lymphoma (PCGDTCL) Descriptors and Clinicopathologic Determinants of Survival: Analysis of a Pooled Database,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,Primary Cutaneous Gamma-Delta T-Cell Lymphoma
311793,Fellows-In-Training: Roundtables,Roundtable 04 - Career in Private Practice (Adult and Pediatric Rheumatology) IV,Adult;;Pediatric;;Rheumatology,Adult Pediatric Rheumatic Disease
213484,"MP11: Pediatric Urology: Neurogenic Bladder, Reconstruction & Urologic Emergencies",Short and Long Term Renal Outcomes in Clinically Matched Cohorts of Newborns with PUV Managed by Primary Vesicostomy Versus Primary Valve Ablation,Newborns;;PUV,Neonatal Posterior Urethral Valve
311791,Fellows-In-Training: Roundtables,Roundtable 04 - Career in Private Practice (Adult and Pediatric Rheumatology) III,,
311808,Fellows-In-Training: Roundtables,Roundtable 08 - How to Establish a Career Niche IV,,
295427,ESMO Clinical Practice Guidelines session 2,Metastatic non-small-cell lung cancer: Discussion / Q&A,Metastatic;;non-small-cell lung cancer,Metastatic Non-Small-Cell Lung Cancer
393731,Melanoma And Other Skin Tumours,Evaluation Of The Transcriptomic Presence Of Tumor Associated Antigens (Taas) From Antibody Drug Conjugates (Adcs) And Pd-L1 In Melanoma: Options For New Clinical Opportunities,Melanoma,Melanoma
311815,Fellows-In-Training: Roundtables,Roundtable 10 - Early Career Niche in Pediatric Rheumatology: Amplified Pain Syndrome III,Pediatric;;Amplified;;Pain Syndrome III,Pediatric Amplified Pain Syndrome III
262670,Myeloproliferative neoplasms - Clinical,Higher Estimated Plasma Volume Status Is Associated With Increased Thrombotic Risk And Impaired Survival In Patients With Primary Myelofibrosis,Primary;;Myelofibrosis,Primary Myelofibrosis
295442,"Proffered Paper session: NSCLC, metastatic",Invited Discussant LBA54 and 972O,"NSCLC, metastatic",Metastatic Non-Small Cell Lung Cancer
393754,Neuroendocrine Tumours,"A Phase II Single-Arm Interventional Trial Evaluating The Activity And Safety Of Cabozantinib (Cbz) Plus Temozolomide (Tmz) In Lung And Gastroenteropancreatic Neuroendocrine Neoplasms (Gep-Nens) Progressed After Ssa Therapy, Everolimus, Sunitinib Or Prrt: Cabotem Trial",Lung;;Gastroenteropancreatic Neuroendocrine Neoplasms,Lung Neuroendocrine Neoplasm;;Gastroenteropancreatic Neuroendocrine Neoplasm 
377370,Acute lymphoblastic leukemia - Biology & Translational Research,Subclonal And Clonal Variants In Tp53 And Kras Combined With Poor Treatment Response Identify A Subgroup Of Ultra-High-Risk Patients Of Pediatric T-Lymphoblastic Leukemia (T-All),Tp53;;Kras;;Ultra-High-Risk;;Pediatric;;T-Lymphoblastic Leukemia,TP53-Mutated KRAS-Mutated Ultra High-Risk Pediatric T-Lymphoblastic Leukemia
262689,Myeloproliferative neoplasms - Clinical,Responses To Avapritinib In Patients With Advanced Systemic Mastocytosis: Histopathologic Analyses From Explorer And Pathfinder Clinical Studies,Advanced;;Systemic Mastocytosis,Advanced Systemic Mastocytosis
328231,Aggressive Lymphomas: Prospective Therapeutic Trials: Poster III,"The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Orelabrutinib in Chinese Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: Updated Results of a Multicenter, Phase I/IIa Trial",Relapsed or Refractory;;B-Cell Non-Hodgkin Lymphoma,Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
148009,Indolent And Mantle-Cell Non-Hodgkin Lymphoma - Clinical,Real-World Treatment Patterns And Outcomes Of 3455 Previously Untreated Mantle Cell Lymphoma Patients In Us Routine Clinical Practice,Previously Untreated;;Mantle Cell Lymphoma,Previously Untreated Mantle Cell Lymphoma
377385,Chronic myeloid leukemia - Clinical,Impacts On Outcomes And A Predictive Model Of Severe Thrombocytopenia In Patients With Chronic Phase Chronic Myeloid Leukemia Receiving Initial Nilotinib-Therapy,Severe;;Thrombocytopenia;;Chronic Phase;;Chronic Myeloid Leukemia,Severe Thrombocytopenia;;Chronic Phase Chronic Myeloid Leukemia
148013,Indolent And Mantle-Cell Non-Hodgkin Lymphoma - Clinical,Prevalence Of Second Cancer During Long Term Follow-Up In Hairy Cell Leukemia Patients Treated With Cladribine: A Thirty-Year Experience,Hairy Cell Leukemia,Hairy Cell Leukemia
262704,Platelet disorders,Low Serum Bdnf Levels Are Associated With Lower Platelets' Cd62P Reactivity And Increased Bleeding Tendency In Patients With Gaucher Disease,Gaucher Disease,Gaucher Disease
180787,Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster I,Modified Delphi Method Identifies Consensus Areas for Routine Minimal Residual Disease Testing in Multiple Myeloma,Multiple Myeloma,Multiple Myeloma
295477,Mini Oral session: Basic science & translational research,5-hydroxymethycytosine analysis reveals stable epigenetic changes in tumor tissue that enable cfDNA cancer predictions,,
328247,Aggressive Lymphomas: Prospective Therapeutic Trials: Poster I,Mosunetuzumab with Polatuzumab Vedotin Is Effective and Has a Manageable Safety Profile in Patients Aged <65 and >=65 Years with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) and >=1 Prior Therapy: Subgroup Analysis of a Phase Ib/II Study,Aged <65;;Relapsed;;Refractory;;Diffuse Large B-Cell Lymphoma,Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma
229946,PD09: Infertility: Epidemiology & Evaluation I,Low birth weight is associated with sperm DNA fragmentation and assisted reproductive technology outcomes in primary infertile men - results of a cross-sectional study,,
328253,Aggressive Lymphomas: Prospective Therapeutic Trials: Poster I,"Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma",Relapsed/Refractory;;Diffuse Large B-Cell Lymphoma,Relapsed/Refractory Diffuse Large B-Cell Lymphoma
262717,Platelet disorders,Metabolic Abnormality And Glucocorticoid Receptor Modulation Of Myeloid-Derived Suppressor Cells In Immune Thrombocytopenia Patients And An Active Murine Model,Immune Thrombocytopenia,Immune Thrombocytopenia
410176,Improving Clinical Outcomes in Diabetic Kidney Disease,Earlier Intervention in Diabetic Kidney Disease Management Using the In Vitro Diagnostic Test PromarkerD Shows Economic Health Benefits over Current Standard of Care,Diabetic Kidney Disease,Diabetic Kidney Disease
180799,Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster I,"Retrospective Comparison of the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) 21-Day Schedule Vs. 28-Day Schedule in Patients with Newly Diagnosed Multiple Myeloma",Newly Diagnosed;;Multiple Myeloma,Newly Diagnosed Multiple Myeloma
262725,"Quality of life, palliative care, ethics and health economics",Economic Burden Of Transfusion-Dependent Beta-Thalassemia In The United States,Beta-Thalassemia,Beta-Thalassemia
311878,Fellows-In-Training: Roundtables,Roundtable 24 - Salivary Lip Biopsies in Practice IV,,
262728,"Quality of life, palliative care, ethics and health economics",Factors Associated With A Lymphoma Diagnosis Prior To Biopsy,Lymphoma,Lymphoma
377420,Chronic lymphocytic leukemia and related disorders - Biology & Translational Research,Expression Of The Long Non-Coding Rna Malat1 In Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia
344653,Diagnostic and Prognostic Biomarkers 1,Identification of molecular biomarkers differentiating malignant uterine leiomyosarcoma from benign leiomyoma,malignant;;uterine leiomyosarcoma,Malignant Uterine Leiomyosarcoma
180817,Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials: Poster I,"Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone",Newly Diagnosed;;Multiple Myeloma,Newly Diagnosed Multiple Myeloma
328274,Aggressive Lymphomas: Clinical and Epidemiological: Poster II,Prognostic Factors and Outcomes of Adolescent and Adult Burkitt Lymphoma and Leukemiafrom a Low-Middle Income Country: An Experience from Hematology Cancer Consortium,Adolescent;;Adult;;Burkitt Lymphoma;;Leukemia,Adolescent Adult Burkitt Lymphoma;;Adolescent Adult Leukemia
393814,"Nsclc, Early Stage",Personalized Tumor-Informed Circulating Tumor Dna (Ctdna) Analysis For Molecular Residual Disease (Mrd) Detection In Resected Non-Small Cell Lung Cancer (Nsclc) With Common Driver Genes,Resected;;Non-Small Cell Lung Cancer,Resected Non-Small Cell Lung Cancer
213592,MP17: Pediatric Urology: Upper & Lower Urinary Tract,Are pre-operative urine cultures and cystoscopies before ureteral reimplantation clinically useful or cost effective?,,
344667,Diagnostic and Prognostic Biomarkers 1,Detecting and intervening on rare pre-existing resistant subclones to BRAF/MEK inhibitors in metastatic melanoma,metastatic;;melanoma,Metastatic Melanoma
180828,Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials: Poster I,Impact of Daratumumab Monotherapy on Bone Metabolism Parameters in Patients with Relapsed and/or Refractory Multiple Myeloma Who Have Received at Least Two Prior Lines of Therapy Including Lenalidomide and a Proteasome Inhibitor: Outcomes of the Phase 2 Rebuild Study,Relapsed;;Refractory;;Multiple Myeloma,Relapsed and/or Refractory Multiple Myeloma
377438,Myeloma and other monoclonal gammopathies - Biology & Translational Research,Pharmacodynamic Activity Of Gen3014 (Hexabody-Cd38) In Patients With Multiple Myeloma Supports Enhanced Complement Dependent Cytotoxicity Of Gen3014 Compared To Daratumumab,Multiple Myeloma,Multiple Myeloma
311906,Genetic Predisposition and the Balance Between Infection and Autoimmunity,Q&A,,
393826,"Nsclc, Early Stage",Concordance Of Pd-L1 Expression Between Biopsy And Matched Surgical Specimen In Early-Stage Non-Small Cell Lung Cancer: Lc-Scrum-Advantage/Mrd,Early-Stage;;Non-Small Cell Lung Cancer,Early-Stage Non-Small Cell Lung Cancer
393827,"Nsclc, Early Stage",Predicting Pd-L1 Expression Using [18F]Fdg Pet/Ct In Early Stage Non-Small Cell Lung Cancer (Nsclc).,Early Stage;;Non-Small Cell Lung Cancer,Early Stage Non-Small Cell Lung Cancer
213605,MP17: Pediatric Urology: Upper & Lower Urinary Tract,Is Excretory Phase Computerized Tomography Important for Evaluation of High Grade Renal Trauma?: Results from the Traumatic Renal Injury Collaboration for Kids (TRICK),Traumatic Renal Injury,Traumatic Renal Injury
393830,"Nsclc, Early Stage",Real-World Outcomes In Stage I-Iii Resectable Non-Small Cell Lung Cancer (Nsclc): Thassos-Intl Study,Stage I-III;;Resectable;;Non-Small Cell Lung Cancer,Stage I-III Resectable Non-Small Cell Lung Cancer
393832,"Nsclc, Early Stage",Neoadjuvant Therapy With Anti-Pd-1/Pd-L1 Plus Platinum-Base Chemotherapy For Resectable Stage Ii-Iii Non-Small Cell Lung Cancer: A Systematic Review And Meta-Analysis Of Randomized Clinical Trials,Resectable;;Stage Ii-Iii;;Non-Small Cell Lung Cancer,Resectable Stage II-III Non-Small Cell Lung Cancer
164457,Society for Benign Prostate Disease,"Welcome and Why SOBPD Should Exist, Who We Are and Our Mission. Society Benefits, Annual meetings",Benign Prostate Disease,Benign Prostatic Hyperplasia
180842,Experimental Transplantation: Basic and Translational: Poster I,The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation,Graft-Versus-Host Disease,Graft-Versus-Host Disease
262759,"Quality of life, palliative care, ethics and health economics",Health-Related Quality Of Life In Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Treated With Iberdomide Plus Dexamethasone In A Phase 1B/2A Open-Label Dose Escalation Study,Relapsed;;Refractory;;Multiple Myeloma ,Relapsed/Refractory Multiple Myeloma 
164460,Society for Benign Prostate Disease,The Advent of Directed Medical BPH Care-How Alpha Blockers were Developed,BPH,Benign Prostatic Hyperplasia
295539,Supportive care and symptom management,Patient and Public Involvement in Cancer Research: The Needs and Perceptions of Older Adults Living with and After Cancer,Older Adult;;Cancer,Older Adult Cancer
164469,Society for Benign Prostate Disease,Photoselective Vaporization of the Prostate,Benign;;Prostate Disease,Benign Prostate Disease
311932,How Does the Use of Concomitant Methotrexate Affect the Efficacy and Safety of Biologics for Psoriatic Arthritis?,How Does the Use of Concomitant Methotrexate Affect the Efficacy and Safety of Biologics for Psoriatic Arthritis?,Psoriatic Arthritis,Psoriatic Arthritis
344700,Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 1,OvaPrint - a novel cfDNA methylation liquid biopsy for cancer risk assessment in high grade serous ovarian carcinoma,high grade;;serous ovarian carcinoma,High Grade Serous Ovarian Carcinoma
393855,"Nsclc, Metastatic",First-Line Osimertinib In Patients With Egfr Mutated Lung Cancer With Uncommon Mutations (Ocelot Study - Interim Analysis),Egfr;;Mutated;;Lung Cancer,EGFR-Mutated Lung Cancer
344703,Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 1,Development of a genome-wide methylome enrichment platform for multi-cancer early detection (MCED),cancer,Cancer
230018,Breast Cancer-Local/Regional/Adjuvant,Breast cancer: Online education's effect on clinician ability to assess risk of recurrence and understanding the latest data.,Breast cancer,Breast Cancer
148103,Myelodysplastic Syndromes - Biology & Translational Research,Cohesin Mutations Are Associated With A Poor Prognosis Phenotype And A Worse Clinical Outcome In Low-Risk Myelodysplastic Syndromes Patients,Low-Risk;;Myelodysplastic Syndromes,Low-Risk Myelodysplastic Syndrome
262793,Sickle cell disease,Long-Term Follow-Up Of Dutch Patients With Sickle Cell Disease Diagnosed By Neonatal Screening - Effect On The Morbidity And Mortality In The Netherlands.,Sickle Cell Disease,Sickle Cell Disease
328332,Aggressive Lymphomas: Clinical and Epidemiological: Poster I,Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group,Sars-Cov-2 Infection;;Primary CNS Lymphoma,Sars-Cov-2 Infection;;Primary CNS Lymphoma
262802,Stem cell transplantation - Clinical,Allogeneic Hematopoietic Stem Transplantation (Hsct) In Patients Over 60 Years. Retrospective Experience Of Two Spanish Centers Between 2015-2020,,
148116,Myelodysplastic Syndromes - Biology & Translational Research,Mesenchymal Stromal Cells As A Potential Therapeutic Tool In Enhancing Residual Healthy Haematopoiesis In Low-Risk Mds Patients,Low-Risk;;Mds,Low-Risk Myelodysplastic Syndrome
377489,Acute lymphoblastic leukemia - Clinical,Prophylactic And Preemptive Use Of Dli Compare Favourably To Their Therapeutic Use In Adult Acute Lymphoblastic Leukemia (All) - Results Of A Multicentre Retrospective Study,Adult;;Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia
311960,Ignite Session 1C,"Phosphofructokinase P Fine-Tunes T Regulatory Cell Metabolism, Function and Stability in Systemic Autoimmunity",,
230042,Breast Cancer-Local/Regional/Adjuvant,Predictive value of circulating tumor cells FTH1 gene on the efficacy of neoadjuvant chemotherapy in non-metastatic breast cancer.,non-metastatic;;breast cancer,Non-Metastatic Breast Cancer
213661,MP20: Trauma/Reconstruction/Diversion: External Genitalia Reconstruction and Urotrauma (including transgender surgery) I,A Pilot Study of Outcomes after Robot-Assisted Sigmoid Vaginoplasty for Gender Dysphoria,Gender Dysphoria,Gender Dysphoria
410269,Interventions to Reduce CKD Progression,Impact of Primary Kidney Disease on the Effects of Empagliflozin in Patients with CKD,Primary Kidney Disease;;CKD,Primary Kidney Disease;;Chronic Kidney Disease
393888,"Nsclc, Metastatic",Updated Patient-Reported Outcomes From The Crown Study: Analyses In First-Line Alk+ Patients With (W) And Without (W/O) Baseline Brain Metastases (Bms) And W Or W/O Central Nervous System Adverse Events (Cns Aes),First-Line;;Alk+;;Metastatic;;Nsclc,First-Line ALK-Postive Metastatic Non-Small Cell Lung Cancer
148133,Myelodysplastic Syndromes - Clinical,Venetoclax Combined With Azacitidine In The Treatment Of Relapsed/Refractory High-Risk Myelodysplastic Syndromes And Acute Myeloid Leukemia: A Retrospective Single-Center Study,Relapsed;;Refractory;;High-Risk;;Myelodysplastic Syndromes;;Acute Myeloid Leukemia,Relapsed/Refractory High-Risk Myelodysplastic Syndrome;;Relapsed/Refractory High-Risk Acute Myeloid Leukemia
230055,Breast Cancer-Local/Regional/Adjuvant,Axillary surgery after neoadjuvant chemotherapy in breast cancer patients downstaging from cN+ to ycN0.,breast cancer,Breast Cancer
230053,Breast Cancer-Local/Regional/Adjuvant,Neutrophil-lymphocyte ratio and prediction of pathological complete response to neoadjuvant treatment in breast cancer.,breast cancer,Breast Cancer
410286,"Kidney Transplantation: Biomarkers, New and Old",Differential cfDNA Methylation in Kidney Allograft Rejection,,
410288,"Kidney Transplantation: Biomarkers, New and Old",Elevated Glycolytic Markers in Urinary Extracellular Vesicles in Kidney Transplant T Cell-Mediated Rejection,,
410290,"Kidney Transplantation: Biomarkers, New and Old",Uncontrolled Hypertension Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients: A Nationwide Population-Based Study,Hypertension ,Hypertension 
230073,Breast Cancer-Local/Regional/Adjuvant,Impacts of subtypes on clinical feature and outcome of male breast cancer.,breast cancer,Breast Cancer
393915,"Nsclc, Metastatic",Efficacy Of First-Line Treatment Options In Advanced Her2-Altered Non-Small Cell Lung Cancer: A Multi-Center Retrospective Study,First-Line;;Advanced;;Her2-Altered;;Non-Small Cell Lung Cancer,First-Line Advanced HER2-Altered Non-Small Cell Lung Cancer
148158,Myeloma And Other Monoclonal Gammopathies - Biology & Translational Research,Tumor Associated Macrophages Inhibit Cd8+T Cells Immune Responses Via Pd-1/Pd-L1 Pathway In Multiple Myeloma,Multiple Myeloma,Multiple Myeloma
262851,Stem cell transplantation - Clinical,Efficacy And Safety Comparison Of Calcineurin Inhibitors Used For Gvhd Prophylaxis In Hematopoietic Stem Cell Transplantation In Children With Thalassemia,Thalassemia,Thalassemia
213700,"MP22: Trauma/Reconstruction/Diversion: Urethral Reconstruction (including Stricture, Diverticulum) I",How is health-related quality of life affected by salvage cystectomy and urinary diversion as a last-line option for benign disease,,
180933,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster I",Screening Chest CT Prior to Allogenic Transplantation - High Rates of Occult Abnormalities,,
180932,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster I",The Impact of Letermovir (LTV) Prophylaxis on Early Cytomegalovirus Infection (CMVi) and Outcomes in the Adult Allogeneic Hematopoietic Cell Transplantation (alloHCT) Recipients with High-Risk Donor Type,Early;;Cytomegalovirus Infection,Early Cytomegalovirus Infection
393929,"Nsclc, Metastatic",Real-World Routine Kras Testing Practices In France For Patients (Pts) With Advanced Or Metastatic (Am) Non-Small Cell Lung Cancer (Nsclc): Data From The Esme Cohort,Advanced;;Metastatic;;Non-Small Cell Lung Cancer,Advanced Or Metastatic Non-Small Cell Lung Cancer
393942,"Nsclc, Metastatic",Recurrence Of Infusion-Related Reaction (Irrs) Associated To Avimantamab,Nsclc;;Metastatic,Metastatic Non-Small Cell Lung Cancer
213726,MP23: Bladder Cancer: Invasive III,Circulating tumor DNA is a strong predictor in patients treated with systemic therapy for urothelial carcinoma,urothelial carcinoma,Urothelial Carcinoma
230112,Breast Cancer-Local/Regional/Adjuvant,Survival trends of patients with Paget disease of the breast: A National Cancer Database (NCDB) study.,Paget disease of the breast,Paget Disease of the Breast
410337,"Bioengineering, Augmented Intelligence, Digital Health, and Data Science",A Novel Glomerular Endothelium-Targeting Adeno-Associated Virus (AAV) Delivers Bacterial Proteinase to Treat Glomerulonephritis,Glomerulonephritis,Glomerulonephritis
295653,"Young Oncologist Forum: Going on a Research Journey: From grant writing, over PhD to team management",Discussion,,
328423,Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster II,"ASC4START: A Phase IIIb, Open-Label, Randomized Study of Tolerability and Efficacy of Asciminib Versus Nilotinib in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Chronic Phase",Newly Diagnosed;;Philadelphia Chromosome;;Positive;;Chronic Myelogenous Leukemia;;Chronic Phase,Newly Diagnosed Ph-Positive Chronic Myelogenous Leukemia in Chronic Phase
410348,COVID-19: A New Understanding and Lessons Learned,Excess Mortality During the COVID-19 Pandemic in a Mid-Sized Dialysis Provider,COVID-19,COVID-19 Infection
328431,Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III,Cancer-Related Gene Mutations Drive Resistance to the Third-Generation Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia,Chronic Myeloid Leukaemia,Chronic Myeloid Leukaemia
328438,Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III,Digital Droplet (dd) Polymerase Chain Reaction (PCR) Assays Offer Limited Advantages over Conventional Reverse-Transcriptase Quantitative PCR (RT-qPCR) for the Prediction of Molecular Recurrence after Treatment Discontinuation in Chronic Myeloid Leukemia (CML): Results from the Destiny Study,Chronic Myeloid Leukemia,Chronic Myeloid Leukemia
328439,Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III,Targeted Next-Generation Sequencing Identifies Additional Mutations Other Than BCR-ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study,BCR-ABL;;Chronic Myeloid Leukemia,BCR-ABL-Fusion Chronic Myeloid Leukemia
180989,Autologous Transplantation: Clinical and Epidemiological: Poster I,Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population,,
328455,Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I,Subjects with Chronic Myeloid Leukemia Identified As Intermediate- or High-Risk Subjects Using the Imatinib Therapy Failure (IMTF) Model Benefit from Initial Therapy with a Second-Generation Tyrosine Kinase Inhibitor,Chronic Myeloid Leukemia;;Intermediate;;High-Risk,Intermediate-Risk High-Risk Chronic Myeloid Leukemia
148233,Myeloma And Other Monoclonal Gammopathies - Clinical,"Survival Among Older Patients With Previously Treated Multiple Myeloma Treated With Selinexor, Bortezomib, And Dexamethasone (Xvd) In The Boston Study",Older;;Previously Treated;;Multiple Myeloma,Elderly Previously Treated Multiple Myeloma
262924,Acute lymphoblastic leukemia - Clinical,A Phase 1/2 Study To Evaluate Ponatinib With Chemotherapy In Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Or With T315I Mutation,Relapsed;;Intolerant;;Philadelphia Chromosome;;Positive;;Acute Lymphoblastic Leukemia;;T315I Mutation,Relapsed/Intolerant Ph-Positive T315I Mutated Acute Lymphoblastic Leukemia
410383,Kidney Transplantation: New Translational Insights,Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Real-World Analysis Using a Global Federated Database,,
377619,Bleeding disorders (congenital and acquired),Discontinuation Of Treatment With Thrombopoietin Receptor Agonists In Patients With Immune Thrombocytopenia: A Single-Center Clinical Experience,Immune Thrombocytopenia,Immune Thrombocytopenia
213784,MP26: Stone Disease: Epidemiology & Evaluation I,Rural Hospital Location is Associated with Higher Reported Prices for Ureteroscopy with Laser Lithotripsy Among Commercially Insured Patients,Stone Disease,Stone Disease
394009,"Nsclc, Metastatic",Challenge Of Systemic First-Line Treatment Of Elderly Lung Cancer Patients,First-Line;;Elderly;;Lung Cancer,First-Line Elderly Lung Cancer
344862,Targeting the Tumor Microenvironment,"Mini-tumors: Pre-clinical HCI assays to screen anti-cancer drugs in the context of organoids, cancer-associated fibroblasts and immune cells",cancer,Cancer
148257,Myeloma And Other Monoclonal Gammopathies - Clinical,Overall And Complete Response Rates As Potential Surrogates For Overall Survival In Relapsed Refractory Multiple Myeloma,Relapsed;;Refractory;;Multiple Myeloma,Relapsed Refractory Multiple Myeloma
295712,"Empowering young cancer nurses academically, clinically and in career progression",The impact of an Education WhatsApp Group to support nurses working in an acute oncology/haematology setting during the Covid-19 pandemic,Covid-19,Covid-19 Infection
230183,Breast Cancer-Metastatic,Treatment of alpelisib induced hyperglycemia with sodium-glucose cotransporter-2 inhibitors: A single institution experience.,hyperglycemia ,Hyperglycemia 
394023,"Nsclc, Metastatic",Gut Microbiome Is Associated With The Clinical Response To Anti-Pd-1 Based Immunotherapy In Untreated Advanced Non-Small-Cell Lung Cancer,Untreated;;Advanced;;Non-Small-Cell Lung Cancer,Untreated Advanced Non-Small-Cell Lung Cancer
410410,Glomerular Diseases: From Multiomics to Mechanisms,IFNg-Induced APOL1 Expression and Pyroptotic Angiopathy in Human Kidney Organoids Mirrors a Nephrotic Gene Signature in Patient Biopsies,Glomerular Disease,Glomerular Disease
230186,Care Delivery and Regulatory Policy,Characteristics and outcomes of COVID-19 in adult cancer patients: Tertiary cancer center experience.,COVID-19;;adult;;cancer,COVID-19 Infection;;Adult Cancer
344870,Targeting the Tumor Microenvironment,"A half-life extended, tumor-activated IL-12 increased the infiltration of effector immune cells into the tumor microenvironment and demonstrated anti-tumor activity in syngeneic mouse models",tumor ,Tumor 
394030,"Nsclc, Metastatic","Harmoni: Randomized, Double-Blind, Multi-Center, Phase III Clinical Study Of Ivonescimab Or Placebo Combined With Pemetrexed And Carboplatin In Patients With Egfr-Mutant Locally Advanced Or Metastatic Non-Squamous Nsclc Who Have Progression Following Egfr-Tki Treatment", Egfr;;Mutant;;Locally Advanced;;Metastatic;;Non-Squamous Nsclc,EGFR-Mutant Locally Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer
394031,"Nsclc, Metastatic",Tropion-Lung07: A Phase III Trial Of Datopotamab Deruxtecan (Dato-Dxd) Plus Pembrolizumab (Pembro) With Or Without Platinum Chemotherapy (Pt-Ct) As First-Line (1L) Therapy In Advanced/Metastatic (Adv/Met) Non-Small Cell Lung Cancer (Nsclc) With Pd-L1 Expression,First-Line;;Advanced;;Metastatic;;Non-Small Cell Lung Cancer,First-Line Advanced/Metastatic Non-Small Cell Lung Cancer
148272,Myeloma And Other Monoclonal Gammopathies - Clinical,Survival And Outcomes Of Newly-Diagnosed Multiple Myeloma Patients Stratified By Transplant Status Diagnosed Between 2007-2018: Real-World Analysis From The Canadian Myeloma Research Group Database,Newly-Diagnosed;;Multiple Myeloma,Newly-Diagnosed Multiple Myeloma
262962,Acute myeloid leukemia - Clinical,Acute Promyelocytic Leukemia And Thrombosis: How To Identify The High-Risk Patients?,Acute Promyelocytic Leukemia;;Thrombosis,Acute Promyelocytic Leukemia;;Thrombosis
181042,Health Services Research-Non-Malignant Conditions: Poster I,Improving Completion Rates of Transcranial Doppler Ultrasounds in Children with Sickle Cell Disease Using Quality Improvement Efforts: In-Clinic Vs. Population-Based Assessments,Children;;Sickle Cell Disease ,Childhood Sickle Cell Disease 
181043,Health Services Research-Non-Malignant Conditions: Poster I,Integrative Hematology Oncology Fellowship Program: A National Survey Based Analysis of Need,,
181049,Health Services Research-Non-Malignant Conditions: Poster I,The Telemedicine Experience for Individuals with Sickle Cell Disease,Sickle Cell Disease,Sickle Cell Disease
377658,Acute myeloid leukemia - Clinical,Early Severe Adverse Events Of Acute Myeloid Leukemia Therapy Depending On The Induction Therapy Regimen,Acute Myeloid Leukemia ,Acute Myeloid Leukemia 
394045,Oesophagogastric Cancer,"Camrelizumab Plus Chemotherapy Versus Concurrent Chemoradiotherapy As Neoadjuvant Therapy For Resectable Thoracic Oesophageal Squamous Cell Cancer (Revo): A Multicenter, Randomized, Open-Label, Phase II Trial",Resectable;;Thoracic Oesophageal Squamous Cell Cancer ,Resectable Thoracic Oesophageal Squamous Cell Cancer 
213817,"MP28: Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making III","Burden of depression and anxiety in men with high-risk, intermediate-risk or low-risk prostate cancer",high-risk;;intermediate-risk;;low-risk;;prostate cancer,High-Risk Prostate Cancer;;Intermediate-Risk Prostate Cancer;;Low-Risk Prostate Cancer
312127,Ignite Session 8A,Genetic Interactions Between T-Cell Receptor Polymorphisms and HLA Amino Acids Contribute to the Risk of Rheumatoid Arthritis,Rheumatoid Arthritis,Rheumatoid Arthritis
262973,Acute myeloid leukemia - Clinical,Efficacy Of Azacitidine And Venetoclax In Aml Patients May Be Limited By Interactionwith Posaconazole And Lack Of Standardised Treatment Protocol. Real World Data From 3 Major Centres In Singapore.,Aml,Acute Myeloid Leukemia
410433,Coronavirus (COVID-19),Ethical Analysis on Mandating COVID-19 Vaccination Prior to Kidney Transplantation in Brazil,COVID-19,COVID-19 Infection
181055,Health Services Research-Non-Malignant Conditions: Poster I,Prospective Study to Reduce Clostridium Difficile Infection in Patients Receiving Autologous Stem Cell Transplantation,Clostridium Difficile Infection,Clostridium Difficile Infection
262979,Acute myeloid leukemia - Clinical,Characteristics And Outcome Of Patients With Acute Promyelocytic Leukemia In Southern Tunisia,Acute Promyelocytic Leukemia,Acute Promyelocytic Leukemia
410436,Acute Kidney Injury,Comparison of 4 Predictive Scoring Methods as Assessment Tools for Cardiac Surgery Associated-Acute Kidney Injury in Post Coronary Artery Bypass Surgery Patients: A Single-Center Retrospective Study,Acute Kidney Injury,Acute Kidney Injury
312133,Ignite Session 8A,Restoration of NAD+ Levels in Rheumatoid Arthritis with NAD+ Boosters as a Novel Therapeutic Strategy to Resolve Acute Inflammation,Rheumatoid Arthritis,Rheumatoid Arthritis
328516,Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III,INCB057643 Monotherapy in Patients with Relapsed or Refractory Myelofibrosis: A Phase 1 Study,Relapsed;;Refractory;;Myelofibrosis,Relapsed/Refractory Myelofibrosis
295751,"Proffered Paper session 2: GI, lower digestive",Genomic mechanisms of acquired resistance of patients (pts) with BRAF V600E-mutant (mt) metastatic colorectal cancer (mCRC) treated in the BEACON study,BRAF V600E-mutant;;metastatic;;colorectal cancer,BRAF V600E-Mutated Metastatic Colorectal Cancer
344908,Drug Resistance in Molecular Targeted Therapies 2,"PHI-501, a novel pan-RAF/DDRs dual kinase inhibitor, overcomes BRAF or MEK inhibitor resistance in melanoma",melanoma,Melanoma
213839,MP29: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology III,Aquablation in very large prostates (>150mL): technique and multicenter case series,Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia
148309,Myeloproliferative Neoplasms - Clinical,Jak2V617F Allele Burden: An Independent Predictor Of Overt Fibrosis In Primary Myelofibrosis,Primary;;Myelofibrosis,Primary Myelofibrosis
344918,Drug Resistance in Molecular Targeted Therapies 2,b-Escin eradicates cancer stem-like population in HER2-positive breast cancer with trastuzumab resistance,HER2;;positive;;breast cancer,HER2-Positive Breast Cancer
295765,What is the optimal therapeutic approach in high-risk endometrial cancer?,Can the molecular classification guide adjuvant medical treatment?,high-risk;;endometrial cancer,High-Risk Endometrial Cancer
181083,Health Services Research-Lymphoid Malignancies: Poster I,"Awareness, Knowledge, and Preferences of United States (US) Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration (FD) Therapy and Minimal (Measurable) Residual Disease (MRD)",Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia
263003,Acute myeloid leukemia - Clinical,Utility Of Flt3 Inhibitors In Patients With Acute Myeloid Leukemia (Aml) And T(6;9)(P22;Q34),Acute Myeloid Leukemia,Acute Myeloid Leukemia
295775,"Management of brain metastases: Systemic treatment, radiosurgery or both?",Management of treatment-related neurological complications,brain metastases,Brain Metastasis
410465,Acute Kidney Injury,A Rare Case of ANCA-Mediated Acute Interstitial Nephritis Without Glomerulonephritis,ANCA-Mediated;;Acute Interstitial Nephritis,ANCA-Mediated Acute Interstitial Nephritis
295778,Young Oncologist Brunch 3: Molecular Tumor Board: A luxury or a necessity?,Discussion led by Chair,,
410466,Acute Kidney Injury,AKI and Spontaneous Rupture of the Urinary Collecting System,AKI,Acute Kidney Injury
394087,Oesophagogastric Cancer,Gut Microbiome And Metabolome Are Associated With The Response To Chemoradiotherapy In Patients With Esophageal Cancer,Esophageal Cancer,Esophageal Cancer
394098,Oesophagogastric Cancer,Factors Associated With Uptake Of Adjuvant Nivolumab In A Nationwide Esophageal Cancer Patient Cohort,Esophageal Cancer,Esophageal Cancer
181105,Outcomes Research-Non-Malignant Conditions: Poster I,Vaso-Occlusive Events in Pediatric Sickle Cell Disease: Quantifying Social Disadvantage and Its Impact on Hospitalizations,Pediatric;;Sickle Cell Disease,Pediatric Sickle Cell Disease
181110,Outcomes Research-Non-Malignant Conditions: Poster I,Sleep Characterization of Adolescent and Young Adult Patients with Sickle Cell Disease Using the Pittsburgh Sleep Quality Index,Adolescent;;Young Adult;;Sickle Cell Disease,Adolescent Young Adult Sickle Cell Disease
181112,Outcomes Research-Non-Malignant Conditions: Poster I,Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center,Sars-Cov-2- Pneumonia,Sars-Cov-2- Pneumonia
181114,Outcomes Research-Non-Malignant Conditions: Poster I,Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease,Sickle Cell Disease;;Venous Thromboembolism,Sickle Cell Disease;;Venous Thromboembolism
164735,The Interplay Between COVID and other Infections,Reduction in Bloodborne Pathogen Splash Exposures After Implementation of Universal Masking and Eye Protection for COVID-19,,
263044,Aggressive Non-Hodgkin lymphoma - Clinical,No Impact Of Statin Use On Response And Survival Rates In Newly Diagnosed Dlbcl Patients Treated With R-Da-Epoch,Newly Diagnosed;;Dlbcl,Newly Diagnosed Diffuse Large B-Cell Lymphoma
344966,New Drug Targets,Development of an antibody-drug conjugate panel targeting high grade serous ovarian cancer,high grade;;serous ovarian cancer,High Grade Serous Ovarian Cancer
295814,Gilead and Kite Oncology - Break Expectations: Novel approaches in triple-negative and HR+/HER2- metastatic breast cancer,Stepping into the emerging needs in metastatic breast cancer,metastatic;;breast cancer,Metastatic Breast Cancer
377741,Stem cell transplantation - Clinical,Unmanipulated Peripheral Haploidentical Haematopoietic Stem Cell Transplant Is An Effective Consolidative Strategy For High-Risk Acute Myeloid Leukaemia And Myelodysplastic Syndrome,High-Risk;;Acute Myeloid Leukaemia;;Myelodysplastic Syndrome,High-Risk Acute Myeloid Leukaemia;;High-Risk Myelodysplastic Syndrome
377743,Acute lymphoblastic leukemia - Clinical,Inotuzumab Ozogamicin Treatment In Adult Patients With Relapsed Or Refractory Philadelphia Chromosome-Negative Cd22-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life French Study,Adult;;Relapsed;;Refractory;;Philadelphia Chromosome-Negative;;Cd22-Positive;;B-Cell Precursor Acute Lymphoblastic Leukemia,Adult Relapsed Or Refractory Ph-Negative Cd22-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
164756,Updates in Mycobacteria,High-Dose Rifampin-containing Regimens for the Treatment of TB Meningitis,Tuberculous meningitis,Tuberculous Meningitis
263060,Aggressive Non-Hodgkin lymphoma - Clinical,Burkitt Lymphoma International Prognostic Index (Bl-Ipi): Is It Efficient Enough In Adult Burkitt Lymphoma Patients?,Adult;;Burkitt Lymphoma,Adult Burkitt Lymphoma
394135,Palliative Care,Integrated Palliative Care For Patients Referred For Chimeric Antigen Receptor T-Cell (Car-T) Therapy: A Service Evaluation,,
312224,Knowledge Bowl Preliminary Round,Alarcon's NETting Neutrophils,,
344993,Innate Immunity to Tumors,Sex differences in the innate immune response to lung cancer,lung cancer,Lung Cancer
263082,Aggressive Non-Hodgkin lymphoma - Clinical,Zanubrutinib In Combination With Lenalidomide And Rituximab Versus R-Minichop In Unfit Or Frail Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Aged Over Or Equal To 70 Years,Newly Diagnosed Diffuse Large B-Cell Lymphoma,Elderly Newly Diagnosed Diffuse Large B-Cell Lymphoma
345008,Targeting Replication Stress and the Immune Microenvironment,POLE-specific variant classification strategy is critical for identifying patients who may benefit from immunotherapy,,
148407,Sickle Cell Disease,Gbt021601 Improves The Pathophysiology Of Sickle Cell Disease In A Murine Model,Sickle Cell Disease,Sickle Cell Disease
181176,"Hemoglobinopathies, Excluding Thalassemia: Basic and Translational: Poster II",Identification of Small Molecules That Induce Therapeutic Levels of Fetal Hemoglobin for Treatment of Sickle Cell Disease By Pairing Machine Learning with High-Resolution Single Cell RNA Sequencing Maps of Adult and Fetal Human Erythropoiesis,Sickle Cell Disease,Sickle Cell Disease
295865,"Mini Oral session: GI, lower digestive",Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer,resected;;stages I-III;;colorectal cancer,Resected Stage I-III Colorectal Cancer
328644,Myelodysplastic Syndromes - Clinical and Epidemiological: Poster III,Validation of a Novel Algorithm with a High Specificity in Ruling out MDS,MDS,Myelodysplastic Syndrome
312263,Moving on Up: Changing How We Define Early Knee OA and Get People Moving,Biomarker-Based Stratification in Osteoarthritis Patients and in Those at Risk: Advances in the Field,Osteoarthritis ,Osteoarthritis 
394187,Pancreatic Cancer,Clinical And Molecular Features Of Young Onset Pancreatic Adenocarcinoma,Young Onset;;Pancreatic Adenocarcinoma,Young Onset Pancreatic Adenocarcinoma
230348,Central Nervous System Tumors,"Compliance, adverse events and quality of life of patients in a phase 3 study comparing temozolomide with PCV as adjuvant chemotherapy in grade 2 and 3 glioma.",Central Nervous System Tumors;;grade 2;;3 ,Grade 2 Grade 3 Central Nervous System Tumor
213966,"MP35: Sexual Function/Dysfunction: Medical, Hormonal & Non-surgical Therapy I",Characteristics of Systemic Testosterone Therapy for Female Hypoactive Sexual Desire Disorder - A Claims Database Analysis,Hypoactive Sexual Desire Disorder,Hypoactive Sexual Desire Disorder
148434,Stem Cell Transplantation - Clinical,Minimal Residual Disease Monitoring And Preemptive Immunotherapies For Frequent 11Q23 Rearranged Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation,11Q23;;Rearranged;;Acute Leukemia,11Q23 Rearranged Acute Leukemia
394195,Pancreatic Cancer,Diagnostic Performance Of Blood-Based Dna Methylation Assay Using Epigenetic-Specific Peptide Nucleic Acid In Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma
345045,Novel Antitumor Agents 1,Targeting CD73-adenosine axis for the treatment of multiple myeloma,multiple myeloma,Multiple Myeloma
230358,Central Nervous System Tumors,Assessment of neurocognitive functions using ACE-III scale in patients with high-grade glioma receiving adjuvant chemoradiation.,high-grade;;glioma,High-Grade Glioma
230361,Central Nervous System Tumors,The effects of vascular endothelial cells on regulating post-irradiation microglia phenotype in irradiation-induced brain injury.,brain injury,Brain Injury
345049,Adaptive Immunity to Tumors,Serological responses to tumor-associated adducts in pancreatic cancer,pancreatic cancer,Pancreatic Cancer
377819,Sickle cell disease,Characterisation Of Quality Of Life-Linked Patient-Reported Outcomes Through A Digital And Continuous Remote Monitoring Ecosystem In Sickle Cell Disease.,Sickle Cell Disease,Sickle Cell Disease
181215,"Granulocytes, Monocytes, and Macrophages: Poster II",Safety of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis (HLH): Relationship to Treatment Exposure,Pediatric;;Primary;;Hemophagocytic Lymphohistiocytosis,Pediatric Primary Hemophagocytic Lymphohistiocytosis
213985,MP36: Renal Transplantation & Vascular Surgery,Robotic Bilateral Nephrectomy for Large Kidneys with Adult Polycystic Kidney Disease with Da Vinci Xi and Da Vinci SP,Adult;;Polycystic Kidney Disease,Adult Polycystic Kidney Disease
181218,Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II,Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma,B-Cell Lymphoma,B-Cell Lymphoma
181219,Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II,Chronically Elevated Interleukin-6 Disturbs the Coagulation Cascade in Mice,Acquired;;Congenital;;Immunodeficiency Disorders,Acquired Immunodeficiency Disorder;;Congenital Immunodeficiency Disorder
328676,Myelodysplastic Syndromes - Clinical and Epidemiological: Poster I,The Risk of Cerebrovascular Accident in Patients with Myelodysplastic Syndrome in the United States: A Nationwide Population-Based Study,Myelodysplastic Syndrome,Myelodysplastic Syndrome
213989,MP37: Infections/Inflammation/Cystic Disease of the Genitourinary Tract: Prostate & Genitalia,Pilot Trial for PIVoT: Prevention of recurrent urinary tract Infection using Vaginal Testosterone,recurrent;;urinary tract Infection,Recurrent Urinary Tract Infection
295910,How can we use ctDNA for early detection of cancer?,Discussion led by Chair,cancer,Cancer
213982,MP36: Renal Transplantation & Vascular Surgery,The effect of renal transplantation on erectile functions in patients with end-stage renal disease.,end-stage;;renal disease,End-Stage Renal Disease
295920,Oligometastatic disease and oligoprogression in breast cancer,Systemic therapeutic options,Oligometastatic disease;;breast cancer,Oligometastatic Disease;;Breast Cancer
263162,"Enzymopathies, membranopathies and other anemias",The Value Of Anemia For Organ Damage Evaluation In Systemic Sclerosis Patients:A Multi-Center Retrospective Study,Systemic Sclerosis,Systemic Sclerosis
410619,"Fluid, Electrolytes, and Acid-Base Disorders",A Rare Case of Zonisamide-Induced Distal Renal Tubular Acidosis (RTA),Distal Renal Tubular Acidosis,Distal Renal Tubular Acidosis
410621,"Fluid, Electrolytes, and Acid-Base Disorders",Trimethoprim-Sulfamethoxazole-Associated Severe Hyponatremia,Severe;;Hyponatremia,Severe Hyponatremia
263163,"Enzymopathies, membranopathies and other anemias",Clinical Characteristics And Risk Factors Of Anemia In Patients With Systemic Sclerosis From The Pkuph-Ssc Cohort,Systemic Sclerosis,Systemic Sclerosis
214013,MP38: Sexual Function/Dysfunction: Basic Research & Pathophysiology,"Vascular, Neurologic and Hormonal Abnormalities in Men with Persistent Sexual Dysfunction after Discontinuation of Finasteride",Sexual Dysfunction,Sexual Dysfunction
394242,Policy And Preventive Strategies,Young Adult Lung Cancer Demands More Attention In A Low-Resource Area: Bangladesh Perspective,Young Adult;;Lung Cancer,Young Adult Lung Cancer
328700,Chronic Lymphocytic Leukemias: Basic and Translational: Poster II,Metabolic Abnormalities Associated with T-Cell Exhaustion in CLL Eu-TCL1 Murine Model,CLL ,Chronic Lymphocytic Leukemia
312328,Pediatric Thieves Market Poster,A Perplexing Situation,,
328712,Chronic Lymphocytic Leukemias: Basic and Translational: Poster III,High-Throughput Proteomics Identifies THEMIS2 As Biomarker of Inferior Treatment-Free Survival in Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia
181258,Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster II,"Exposure-Response Relationship between Von Willebrand Factor (VWF) Activity and Bleeding Events Following Prophylaxis with Recombinant VWF (rVWF, vonicog alfa) in Patients with Severe Von Willebrand Disease (VWD)",Severe;;Von Willebrand Disease,Severe Von Willebrand Disease
345103,Cancer-associated Inflammation and Microbiome,Single-cell analysis of immune and stroma cell remodeling in renal cell carcinoma primary tumors and bone metastatic lesions,renal cell carcinoma,Renal Cell Carcinoma
377875,Bleeding disorders (congenital and acquired),Alloantibodies In Von Willebrand Disease: About 6 Cases In Southern Tunisia,Von Willebrand Disease,Von Willebrand Disease
312341,Pediatric Thieves Market Poster,"Red but White, Itchy but Painful, Controlled yet Uncontrolled",,
148508,Thalassemias,Possible Correlation Of Mixed Chimerism With Post-Transplant Outcome In Patients With B Thalassemia:Risk Of Graft Failure,B Thalassemia,B Thalassemia
328738,Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II,The Outcomes of Covid-19 in Patients with CLL during the Omicron Sub-Variants Surge,CLL,Chronic Lymphocytic Leukemia
410659,Geriatric Nephrology,External Validation of a Risk Prediction Tool in Determining Early Death Among Elderly Patients Initiated on Dialysis,,
263205,Indolent and mantle-cell non-Hodgkin lymphoma - Clinical,First-Line Treatment In Advanced Stage Folicular Lymphoma: A Single-Center Experience With R-Chop Vs Bendamustine-Rituximab.,First-Line;;Advanced Stage;;Folicular Lymphoma,First-Line Advanced Stage Folicular Lymphoma
312364,Polymyalgia Rheumatica: New Tricks for an Old Disease,Balancing Risks and Benefits of Adding Immunosuppression to Steroids in PMR,PMR,Polymyalgia Rheumatica
295985,Novartis - Evidence-Based Practice in HR+/HER2âˆ’ Advanced Breast Cancer: Illuminating the Treatment Path for Patients,Welcome and Introduction,HR+;;HER2;;Advanced;;Breast Cancer,HR-Positive HER2 Advanced Breast Cancer
394296,Prostate Cancer,Impact Of Intensified Androgen Deprivation Therapy (Adti) In The Metastatic Castration-Sensitive Prostate Cancer (Mcspc) Setting On Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Disease Characteristics And Survival Outcomes,Metastatic;;Castration-Sensitive Prostate Cancer,Metastatic Castration-Sensitive Prostate Cancer
345147,Innovative Approaches for Tumor Profiling and Data Analysis 1,Evaluation of a 293 gene oncology-focused exome sequencing panel for screening of ovarian cancer patients for BRCA mutations as a prerequisite for autologous cellular immunotherapy manufacturing,ovarian cancer,Ovarian Cancer
377920,Myeloproliferative neoplasms - Clinical,Atypical Chronic Myeloid Leukemia (Acml) And Autoimmune Disease: Report Of Two Cases.,Atypical Chronic Myeloid Leukemia;;Autoimmune Disease,Atypical Chronic Myeloid Leukemia;;Autoimmune Disease
148549,Transfusion Medicine,Evaluation Of Red Blood Cell Autoantibodies And Associated Thrombotic Risk In A Tertiary Care Centre In Spain,,
263238,Infections in hematology (incl. supportive care/therapy),Protection Of Patients With Hematologic Malignancy From Severe Infection During Pandemia: Estonian Two Centres Experience,Hematologic Malignancy,Hematologic Malignancy
410696,Glomerular Diseases,Late-Onset Lupus Nephritis Presenting as Acute Decompensated Heart Failure,Late-Onset;;Lupus Nephritis,Late-Onset Lupus Nephritis
164938,ID Complications associated with Novel Cellular & Immunotherapies in Cancer,Infectious Complications of CD19-targeted Chimeric Antigen Receptor-modified T (CAR-T)-cell Immunotherapy,Cancer,Cancer
345167,Cancer Cachexia,Integrin-mediated lipolysis by pancreatic cancer-derived extracellular vesicles in cancer-associated cachexia,cancer;;associated;;cachexia,Cancer-Associated Cachexia
263249,Lymphoma Biology & Translational Research,Tp53 Gene Mutation Diversity In Russian Patients With B-Cell Lymphomas,B-Cell Lymphomas,B-Cell Lymphoma
263250,Lymphoma Biology & Translational Research,"Surgical Specimens Of Indolent And Aggressive B-Nhls Show Differences In Their Flow-Cytometry Profile Of Ploidy, Proliferating Fraction And Proportion Of Tumor-Associated Myeloid And T-Cell Subsets",Indolent;;Aggressive;;B-Nhls,Indolent Aggressive B-cell non-Hodgkin lymphoma
410708,Glomerular Diseases,Porphyria Cutanea Tarda and Systemic Lupus Erythematosus: An Unusual Association in a Patient with Nephritic Syndrome,Porphyria Cutanea Tarda;;Systemic Lupus Erythematosus;;Nephritic Syndrome,Porphyria Cutanea Tarda;;Systemic Lupus Erythematosus;;Nephritic Syndrome
279637,Gilead and Kite Oncology: Chimeric antigen receptor T cells case studies: navigating patient management,Managing relapsed/refractory mantle cell lymphoma: a case study,relapsed;;refractory;;mantle cell lymphoma,Relapsed/Refractory Mantle Cell Lymphoma
181344,Bone Marrow Failure: Poster II,Intensive Immunosupressive Therapy Combining with Eltrombopag for Adult Chinese Patients with Severe Aplastic Anemia,Adult;;Severe Aplastic Anemia,Adult Severe Aplastic Anemia
148578,Acute Lymphoblastic Leukemia - Clinical,L-Asparaginase Associated Acute Pancreatitis In Children With Acute Lymphoblastic Leukemia,Children;;Acute Pancreatitis;;Acute Lymphoblastic Leukemia,Childhood Acute Pancreatitis;;Acute Lymphoblastic Leukemia
410725,"Health Maintenance, Nutrition, and Metabolism",Intradialytic Amino Acids Improved Malnutrition Markers in ESRD with Complex Congenital Heart Disease on Peritoneal Dialysis,,
328806,Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster II,Inhibition of Oxidative Phosphorylation and Glycolysis Reduces Viability in Multiple Myeloma By Affecting mTOR-Mediated Protein Synthesis,Multiple Myeloma,Multiple Myeloma
312429,Review Course,Wrap-Up,,
214129,MP45: Prostate Cancer: Markers,MicroRNA 185-5p is a novel biomarker associated with high-risk pathology at radical prostatectomy in patients with low-risk disease at diagnosis,Prostate Cancer,Prostate Cancer
296059,"Breast cancer, early stage","Cosmesis (CA), late effects (LE) and Patient reported outcome measures (PROM) in high risk breast cancer (BC) treated with hypo-fractionated radiotherapy (RT): real world outcome from a developing country.",high risk;;breast cancer ,High Risk Breast Cancer 
296071,Melanoma and other skin tumours,Efficacy and tolerability of neoadjuvant treatment with T-VEC in difficult to resect primary basal cell carcinoma: a phase II clinical trial (NeoBCC),primary;;basal cell carcinoma,Primary Basal Cell Carcinoma
394376,Renal Cancer,Adjuvant Everolimus (Eve) In Patients (Pts) With Completely Resected Very High-Risk Renal Cell Cancer (Rcc) And Clear Cell Histology: Results From The Phase Iii Swog S0931 (Everest) Trial,Resected;;Very High-Risk;;Renal Cell Cancer,Resected Very High-Risk Renal Cell Cancer
230538,Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology,Comparative oncology analysis using genomic profiling of canine cancers by tissue and liquid biopsy testing reveals actionable somatic alterations with orthologs in human cancers.,cancers,Cancer
345226,"Oncolytic Viruses, Anticancer Vaccines, and Other Immunomodulatory Therapies",Extracellular vesicles (EV) - mediators of therapeutic vaccination? In vivo and in vitro characterization of EVs generated after infection of human and murine cells with therapeutic poxviruses,,
165004,Controversies and Challenges in Pediatric Transplant ID,The Impact of Molecular Diagnostics on the Management of Viral Infections in Pediatric Transplant Recipients,Viral Infection;;Pediatric,Pediatric Viral Infection
345225,"Oncolytic Viruses, Anticancer Vaccines, and Other Immunomodulatory Therapies",Sensitizing breast cancers to immune checkpoint inhibitors through CD27 agonism and vaccination against tumor-associated antigen,breast cancers,Breast Cancer
263309,Myeloma and other monoclonal gammopathies - Biology & Translational Research,Crispr-Cas9 Knockout Screen Identifies Rna Modification Enzymes Essential For Cell Survival In Multiple Myeloma,Multiple Myeloma,Multiple Myeloma
263312,Myeloma and other monoclonal gammopathies - Clinical,"Trial-In-Progress: Phase Ii Study Of Phe885, A B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy, In Adults With Relapsed And/Or Refractory Multiple Myeloma",Adults;;Relapsed;;Refractory;;Multiple Myeloma,Adult Relapsed/Refractory Multiple Myeloma
296081,Colorectal cancer,Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal Cancer (mCRC): Patient-reported outcomes (PROs) from ph 2 study MOUNTAINEER,HER2;;positive;;metastatic;;colorectal Cancer,HER2-Positive Metastatic Colorectal Cancer
197778,Mitochondrial Interventions: Small Molecule and Gene Therapy (Mitochondrial Interventions: Small Molecule and Gene Therapy),Mitochondrial Interventions: Small Molecule and Gene Therapy,,
296082,"NSCLC, metastatic",A multicenter study of incidence of drug-induced lung disease in first-line osimertinib therapy and continuation of osimertinib administration,lung disease,Lung Disease
296084,Colorectal cancer,"The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer - the randomized NORDIC9-study",older;;metastatic colorectal cancer,Elderly Metastatic Colorectal Cancer
263316,Myeloma and other monoclonal gammopathies - Clinical,Chemo Or Chemo-Free Regimens In Heavily Pretreated Multiple Myeloma? Role Of Bendamustine-Bortezomib-Dexamethasone (Bvd) In Novel Agents' Era,Heavily Pretreated;;Multiple Myeloma,Heavily Pretreated Multiple Myeloma
148631,Aggressive Non-Hodgkin Lymphoma - Clinical,Relationship Between Genetic Aberrations In The 17P13/Tp53 Locus And Immunohistochemical Protein P53 Expression In Tumor Cells Of Diffuse Large B-Cell Lymphoma,Diffuse Large B-Cell Lymphoma,Diffuse Large B-Cell Lymphoma
312472,The Ears Have It: Autoimmune Hearing Loss and Relapsing Polychondritis,A New Classification of Ear Chondritis Revealed by Genetic Studies,Ear Chondritis,Ear Chondritis
410777,Pediatric Nephrology,Ravulizumab De Novo in Pediatric Patients with Atypical Hemolytic Uremic Syndrome (aHUS): First Worldwide Cases,De Novo;;Pediatric;;Atypical Hemolytic Uremic Syndrome,De Novo Pediatric Atypical Hemolytic Uremic Syndrome
345240,"Oncolytic Viruses, Anticancer Vaccines, and Other Immunomodulatory Therapies","CRB-601, an avb8 blocking antibody, prevents activation of TGFb and exhibits anti-tumor activity associated with immune cell remodeling of the tumor microenvironment",,
148636,Aggressive Non-Hodgkin Lymphoma - Clinical,Health-Related Quality Of Life Effect Of Mogamulizumab By Patient Blood Involvement,Aggressive;;Non-Hodgkin Lymphoma,Aggressive Non-Hodgkin Lymphoma
263328,Myeloma and other monoclonal gammopathies - Clinical,Opportunities Of Therapy In Patients With Newly Diagnosed Multiple Myeloma With Dialysis-Dependent Renal Impairment,Newly Diagnosed;;Multiple Myeloma,Newly Diagnosed Multiple Myeloma
296096,SCLC,"DeLLphi-303: phase 1b first-line combination study of tarlatamab, a DLL3-targeting half-life extended bispecific T-cell engager (HLE BiTEÂ®), with carboplatin, etoposide, and PD-L1 inhibition in extensive stage small cell lung cancer (ES-SCLC)",extensive stage;;small cell lung cancer ,Extensive Stage Small Cell Lung Cancer 
165030,The Tiny but Fierce Beasts of COVID-19 & Healthcare Epidemiology - Controversies in Pediatric Infection Prevention,To See or Not To See: COVID-19 Visitor Restrictions in Pediatric Healthcare Settings,COVID-19,COVID-19 Infection
328871,Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I,Bortezomib Resistant Multiple Myeloma Shows a Specific Dependency on Ecpas in Vitro and In Vivo,Multiple Myeloma,Multiple Myeloma
148649,Aggressive Non-Hodgkin Lymphoma - Clinical,Dose-Adjusted Edoch-Rituximab In Elderly Patients With High Grade Diffuse Large B-Cell Lymphoma,Elderly;;High Grade;;Diffuse Large B-Cell Lymphoma,Elderly High Grade Diffuse Large B-Cell Lymphoma
148651,Aggressive Non-Hodgkin Lymphoma - Clinical,"Front-Mind: A Phase Iii, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy And Safety Of R-Chop + Tafasitamab + Lenalidomide Vs R-Chop Alone For Newly-Diagnosed High-Risk Dlbcl",Newly-Diagnosed;;High-Risk;;Dlbcl,Newly-Diagnosed High-Risk Diffuse Large B-Cell Lymphoma
230572,Gastrointestinal Cancer-Colorectal and Anal,A multiple centers real-world study of regorafenib treatment modalities in Chinese metastatic colorectal cancer patients.,metastatic;;colorectal cancer,Metastatic Colorectal Cancer
181422,Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II,The Sumoylation Inhibitor TAK-981 in Combination with the CD19-Targeting Antibody Tafasitamab Shows Enhanced Anti-Tumor Activity in Preclinical B-Cell Lymphoma Models,B-Cell Lymphoma,B-Cell Lymphoma
296109,Investigational immunotherapy,Early mortality in patients with cancer treated with immunotherapy in routine practice,cancer ,Cancer
148656,Bleeding Disorders (Congenital And Acquired),Inhibitors In Mild Haemophilia A: Experience Of A Single Spanish Center,Mild;;Haemophilia A,Mild Haemophilia A
279728,YoungEHA Research Meeting - Session 5: Microenvironment in benign and malignant hematology & Closing,Deciphering the role of the bone marrow microenvironment in hematological malignancies using 3D Human Organotypic Marrow Environment (3D-HOMEs),hematological malignancies,Hematological Malignancy 
214197,MP48: Prostate Cancer: Advanced (including Drug Therapy) III,When Node-Positive Prostate Cancer Should Be Considered A Systemic Disease? Assessing The Prognostic Role Of Preoperative 68Ga-PSMA PET/CT Results In Patients With Lymph Node Invasion At Final Pathology,Node-Positive;;Prostate Cancer,Node-Positive Prostate Cancer
230598,Gastrointestinal Cancer-Colorectal and Anal,Clinical and prognostic features of BRAF V600E-mutant resectable colorectal cancer: A single-center retrospective analysis of Chinese patients.,BRAF V600E-mutant;;resectable;;colorectal cancer,BRAF V600E-mutated Resectable Colorectal Cancer
378058,You have a new match! Pairing treatments and patients together for optimal treatment in chronic lymphocytic leukaemia (CLL),Tailoring treatment in CLL: Selecting the right treatment and duration for the right patient in relapse setting,CLL,Chronic Lymphocytic Leukemia
279755,Jazz Pharmaceuticals: Should we expect long term survival in high-risk Acute Myeloid Leukaemia (AML)?,How should Measurable Residual Disease (MRD) assessment inform treatment decisions?,high-risk;;Acute Myeloid Leukaemia,High-Risk Acute Myeloid Leukemia
181452,"Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II",Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia,Philadelphia Chromosome;;Positive;;Acute Lymphoblastic Leukemia,Ph-Positive Acute Lymphoblastic Leukemia
181453,"Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II",A Phase II Study of Inotuzumab Ozogamicin for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia,Measurable Residual Disease-Positive;;B-Cell Acute Lymphoblastic Leukemia,MRD-Positive B-Cell Acute Lymphoblastic Leukemia
263373,Myeloproliferative neoplasms - Clinical,"Primary Myelofibrosis In Young Patients <=50 Years: Clinicopathological Characteristics, Genetic Landscape And Disease Outcome. A Single Center Experience",Primary Myelofibrosis;;Young,Adult Primary Myelofibrosis
148685,Chronic Lymphocytic Leukemia And Related Disorders - Clinical,Clinical Features Of Large Granular Lymphocytic Leukemia-Associated Pure Red Cell Aplasia: Results From A Single Center In China,Large Granular Lymphocytic Leukemia;;Pure Red Cell Aplasia,Large Granular Lymphocytic Leukemia;;Pure Red Cell Aplasia
279766,Takeda: Long term proteasome inhibition for multiple myeloma in the era of COVID,Current challenges for patient management, COVID;;multiple myeloma, COVID;;Multiple Myeloma
214230,MP50: Kidney Cancer: Localized: Surgical Therapy III,Implications of Positive Surgical Margins following Robotic Partial Nephrectomy,Kidney Cancer,Kidney Cancer
230619,Gastrointestinal Cancer-Colorectal and Anal,Modifiable and non-modifiable risk factors associated with early-onset colorectal cancer: Analysis of the National Health Interview Survey.,early-onset;;colorectal cancer,Early-Onset Colorectal Cancer
197852,Accelerated Brain Aging in Neuropsychiatric Disorders: Methodological Challenges and and Potential Applications to Prognosticate Clinical Outcomes,Accelerated Brain Aging is Independently Associated with Increased Likelihood of All-Cause Mortality: Findings from the Second Wave of Dallas Heart Study (DHS-2),Neuropsychiatric Disorders,Neuropsychiatric Disorder
328928,Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster II,Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma,Multiple Myeloma,Multiple Myeloma
296164,Colorectal cancer,Assessing nivolumab in class II expressing microsatellite stable (pMMR) colorectal cancer (CRC): Results of the ANICCA-Class II trial,microsatellite stable;;pMMR;;Colorectal cancer,Microsatellite Stable pMMR Colorectal cancer
197861,"Cannabis, Developmental periods, Neurocognitive and Mental Health Outcomes",Prenatal Cannabis Exposure and Outcomes during Middle Childhood,Prenatal;;Cannabis Exposure,Prenatal Cannabis Exposure
197863,"Cannabis, Developmental periods, Neurocognitive and Mental Health Outcomes",Differential Effects of Adolescent versus Early Adult Cannabis Initiation on Longitudinal Brain Development: Evidence for Adolescence as a Period of Vulnerability,,
148704,Chronic Lymphocytic Leukemia And Related Disorders - Clinical,Subcutaneous Immunoglobulins Use In Immunodeficiency Secondary To Chronic Lymphocytic Leukaemia: Monocentric Experience In Covid-19 Era,Chronic Lymphocytic Leukaemia,Chronic Lymphocytic Leukaemia
148706,Chronic Myeloid Leukemia - Biology & Translational Research,Pattern Of Minimal Residual Disease In Tunisian Chronic Myeloid Leukemia Patients,Chronic Myeloid Leukemia,Chronic Myeloid Leukemia
296166,"Breast cancer, early stage",Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group,breast cancer,Breast Cancer
296175,Colorectal cancer,Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST),first-line;;metastatic;;colorectal cancer,First-Line Metastatic Colorectal Cancer
197874,Cell-Type Specific Molecular Biology of Addiction,Neuron Subtype Specific Molecular Mechanisms in Fentanyl Abstinence,,
197882,Evidence of adult neurogenesis in human brain and its changes with aging and disease,Altered Adult Neurogenesis and Cognition in Mesial Temporal Lobe Epilepsy Patients,Mesial Temporal Lobe Epilepsy,Mesial Temporal Lobe Epilepsy
148732,"Enzymopathies, Membranopathies And Other Anemias",Diagnostic Importance Of Bone Marrow Aspiration In Children With Anemia Of Unknown Etiology,Children;;Anemia ,Childhood Anemia
394495,Sclc,Novel Nomogram Based On The Expression Of Dll3 And Pd-L1 For Predicting The Prognosis Of Small Cell Lung Cancer Patients,Small Cell Lung Cancer,Small Cell Lung Cancer
181510,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications,Childhood;;AML,Childhood Acute Myeloid Leukemia
181511,"Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II",Functional Consequence and Therapeutic Targeting of Cryptic ALK Fusions (ALKfus) in Monosomy7 AML,AML,Acute Myeloid Leukemia
328968,Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III,"Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study",Relapsed/Refractory;;Multiple Myeloma,Relapsed/Refractory Multiple Myeloma
165128,Adult Vaccines,Modeled Impact of the COVID-19 Pandemic and Associated Reduced Adult Vaccinations on Herpes Zoster in the United States,Herpes Zoster,Herpes Zoster Infection
296202,Basic Science,Gene expression profile (GEP) of extensive small-cell lung cancer (eSCLC) patients (pts) receiving first-line platinum-etoposide plus atezolizumab (PEA),extensive;;small-cell lung cancer,Extensive Stage Small-Cell Lung Cancer
148747,Hodgkin Lymphoma - Clinical,Prognostic Factors Of Worse Survival In Newly Diagnosed Advanced-Stage Hodgkin Lymphoma In Taiwan: A Nationwide Retrospective Study,Newly Diagnosed;;Advanced-Stage;;Hodgkin Lymphoma,Newly Diagnosed Advanced-Stage Hodgkin Lymphoma
312583,Detection/Diagnosis: Detection/Diagnosis - Other,Improving The Performance Of Early Breast Cancer Diagnosis By A Model Combining Breast Ultrasound With Methylation Markers In Non-Invasive Circulating Tumor Dna,Early;;Breast Cancer,Early Breast Cancer
378125,Adult acute lymphoblastic leukemia (EWALL),The US experience in ALL,ALL,Acute Lymphoblastic Leukemia
312590,Detection/Diagnosis: Detection/Diagnosis - Other,Orphan Non-Coding Rnas For Early Detection Of Breast Cancer With Liquid Biopsy,Breast Cancer,Breast Cancer
263441,Sickle cell disease,Variant Haemoglobin Assessment And Correlation With Phenotypic Presentation At Diagnosis In Sickle Cell Disease : A Single Centre Retrospective Analysis Of Central Gujarat Cohort,Sickle Cell Disease,Sickle Cell Disease
296214,Melanoma and other skin tumours,Safety and efficacy of infrequent tebentafusp treatment omissions in patients with metastatic uveal melanoma,metastatic;;uveal melanoma,Metastatic Uveal Melanoma
165143,Adult Vaccines,Immunologic Hyporesponsiveness with Subsequent Dosing of Meningococcal Vaccines: Re-Evaluating the Current Paradigm,,
378137,Mesenchymal stromal cells: Progress in biology and engineering of mesenchymal stromal cells,Regulation of GvHD in the hematopoietic niche,GvHD ,Graft-Versus-Host Disease
296217,Melanoma and other skin tumours,Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: 5-year results of the EORTC 1325-MG/Keynote-054 double-blinded phase 3 trial,high-risk;;stage III;;melanoma,High-Risk Stage III Melanoma
279835,Aging and Hematology: Real-world evidence of CAR T-cell therapy in older adults in Europe,RWD of CAR T-cell therapy in older adults: The UK experience,,
378147,Diagnosis in hematological diseases: Morphology and flow cytometry: 2.0 diagnostics in hematology: The role of artificial intelligence,AI approach for advanced analysis of flow-cytometryc data,,
410917,"AI, Digital Health, Data Science - I",Integrating Electronic Health Data Records to Develop and Validate a Predictive Model of Hospital-Acquired AKI in Non-Critically Ill Patients,AKI,Acute Kidney Injury
230700,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Initial efficacy and biomarker analysis of a phase 1b study targeting IL-1b and PD-1 with chemotherapy in metastatic pancreatic cancer (PanCAN-SR1).,metastatic;;pancreatic cancer,Metastatic Pancreatic Cancer
197935,Poster Session I (In-Person),No Signs of Neurodegenerative Effects in 15q11.2 BP1-BP2 Copy Number Variant Carriers,,
230706,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary","Tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC, RATIONALE 302): Impact on health-related quality of life (HRQoL).",second-line;;advanced;;metastatic;;esophageal squamous cell carcinoma,Second-Line Advanced or Metastatic Esophageal Squamous Cell Carcinoma
214324,MP55: Prostate Cancer: Localized: Ablative Therapy,Using Magnetic Resonance Imaging to Define Focal Therapy Templates in Patients with Intermediate-Risk Prostate Cancer,Intermediate-Risk;;Prostate Cancer,Intermediate-Risk Prostate Cancer
329014,Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III,Hypercalcemia in Individuals with Monoclonal Gammopathy of Undetermined Significance: Results from the Istopmm Study,Monoclonal Gammopathy,Monoclonal Gammopathy
181569,Lymphomas: Translational-Non-Genetic: Poster II,Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma,Diffuse Large B Cell Lymphoma,Diffuse Large B Cell Lymphoma
197955,Poster Session I (In-Person),Mutations in Kalrn Disrupt Gamma-Band Oscillations in the Auditory Cortex of Adult Mice,,
148806,Myelodysplastic Syndromes - Biology & Translational Research,Suppression Of Akr1B1 Reduces Cell Proliferation And Enhances Sensitivity To Hypomethylating Agents By Inhibiting Mtorc1 Signaling Pathway In High-Risk Myelodysplastic Syndrome,High-Risk;;Myelodysplastic Syndrome,High-Risk Myelodysplastic Syndrome
148807,Myelodysplastic Syndromes - Biology & Translational Research,"Polymorphism Of Gstm1, Gstt1 And Cytokine Genes In Patients With Myelodysplastic Syndrome",Myelodysplastic Syndrome,Myelodysplastic Syndrome
214345,MP56: Bladder Cancer: Invasive V,The role of FDG PET in the staging of bladder cancer patients candidate for radical cystectomy,bladder cancer,Bladder Cancer
312650,Treatment - Surgery And Radiotherapy: Radiotherapy,Role Of Postmastectomy Radiation Therapy In Breast Cancer Patients According To Pathologic Nodal Status After Neoadjuvant Chemotherapy,Breast Cancer,Breast Cancer
181581,"Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II","Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Elderly Patients with Mantle Cell Lymphoma",High-Risk;;Elderly;;Mantle Cell Lymphoma,High-Risk Elderly Mantle Cell Lymphoma
148814,Myelodysplastic Syndromes - Clinical,A Phase 3 Study Of The Efficacy And Safety Of Luspatercept Versus Epoetin Alfa For The Treatment Of Anemia Due To Lower-Risk Mds In Esa-Naive Patients Requiring Rbc Transfusions (The Commands Trial),Lower-Risk;;Mds,Low-Risk Myelodysplastic Syndrome
394576,Supportive Care,Prevention Of Taxane Chemotherapy Induced Nail Changes And Peripheral Neuropathy By Application Of Extremity Cooling: A Prospective Single Center Study With Intrapatient Comparison,Peripheral Neuropathy,Peripheral Neuropathy
263509,Presidential Symposium,Genetic And Epigenetic Factors Driving Primary Mediastinal B-Cell Lymphoma Pathogenesis And Outcome,Primary Mediastinal B-Cell Lymphoma,Primary Mediastinal B-Cell Lymphoma
394584,Supportive Care,Initial Geriatric Assessment And Chemotherapy Tolerability Treatment In Brazilian Patients With Malignant Neoplasm Of The Digestive System.,Malignant;;Neoplasm,Malignant Neoplasm
263513,From biology to preclinical models in ALL,Ubtf-Atxn7L3 Gene Fusion Due To 17Q21.31 Deletion Defines Novel High-Risk All Subtype Amenable To Mrd-Based Treatment Intensification,High-Risk;;All,High-Risk Acute Lymphoblastic Leukemia
345435,Tumor Organoids for Therapeutic Testing,Cellos: High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology,,
230744,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Genomic determinants and clinical relevance of cancer-associated thrombosis in biliary tract cancers.,cancer-associated;;thrombosis;;biliary tract cancers,Cancer-Associated Thrombosis;;Biliary Tract Cancer
197976,Poster Session I (In-Person),Early-Life Trauma Exposure: The Role of vmPFC in Resilience to Trauma,Trauma,Trauma
296288,"Head and neck cancer, excluding thyroid",Real World Evidence of First-line Cetuximab (CX) plus Paclitaxel (PX) in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN),Recurrent;;Metastatic;;Squamous Cell Carcinoma of the Head and Neck,Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
148828,Myeloma And Other Monoclonal Gammopathies - Biology & Translational Research,Validation Of Algorithms To Identify First-Line Therapy (Induction And Maintenance) For Multiple Myeloma For Use In Electronic Healthcare Databases,First-Line;;Multiple Myeloma,First-Line Multiple Myeloma
230749,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Clinical utility of immunotherapy hyperprogressive genes in hepatocellular carcinoma patients.,hepatocellular carcinoma,Hepatocellular Carcinoma
148829,Myeloma And Other Monoclonal Gammopathies - Clinical,A Clinical-Decision Tool To Improve The Strategy Of Multiple Myeloma Treatment,Multiple Myeloma,Multiple Myeloma
296292,Hepatocellular carcinoma (HCC),Prognosis-related molecular subtypes and immune features associated with hepatocellular carcinoma,hepatocellular carcinoma,hepatocellular carcinoma
279909,Pediatric hematology: Immunodeficiency-related lymphoproliferative disorders,Classification of immunodeficiency-related lymphoproliferative disorders,immunodeficiency-related lymphoproliferative disorders,Immunodeficiency-Related Lymphoproliferative Disorder
378207,Interactive Session: Chronic Lymphocytic Leukemia (CLL) and Beyond - Management of the Infection Burden,Interactive Panel Discussion: Challenging Cases Involving Infections Associated with CLL,CLL,Chronic Lymphocytic Leukemia
394614,Supportive Care,"Mortality Within 30 Days After Last Dose Of Intravenous Systemic Anti-Cancer Therapy: Single-Center, One-Year, Retrospective Analysis",,
345465,Mouse Models of Human Cancer,A non-surgical approach to develop an orthotopic colorectal cancer mouse model,colorectal cancer,Colorectal Cancer
214394,MP58: Prostate Cancer: Detection & Screening VII,ATM mutations are associated with high-risk architectural features in men with familial prostate cancer,familial;;prostate cancer,Familial Prostate Cancer 
394619,Supportive Care,Venous Thromboembolism (Vte) In Patients With Advanced High Grade Ovarian Carcinoma (Ahgoc) Receiving Parp Inhibitors,Advanced;;High Grade;;Ovarian Carcinoma,Advanced High Grade Ovarian Carcinoma
148861,Myeloma And Other Monoclonal Gammopathies - Clinical,Lenalidomide Versus Thalidomide Or Bortezomib As Maintenance Regimen For Non-Transplant Patients With Multiple Myeloma: Multi-Center Real World Experiences In China,Multiple Myeloma,Multiple Myeloma
181632,Aggressive Lymphomas: Prospective Therapeutic Trials: Poster II,Glofitamab Monotherapy Provides Durable Responses after Fixed-Length Dosing in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (pts),Relapsed;;Refractory;;Non-Hodgkin Lymphoma,Relapsed/Refractory Non-Hodgkin Lymphoma
198019,Poster Session I (In-Person),"Hippocampal volume, FKBP5 genetic risk alleles, and childhood trauma interact to increase vulnerability to chronic multisite musculoskeletal pain",childhood;;trauma;;chronic;;multisite musculoskeletal pain,Chronic Multisite Musculoskeletal Pain;;Childhood Trauma
329094,Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Poster II,"Updated Interim Results from a Phase 1 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC(r)) Targeting B Cell Maturation Antigen (BCMA) for Relapsed/Refractory Multiple Myeloma (RRMM)",Relapsed;;Refractory;;Multiple Myeloma,Relapsed/Refractory Multiple Myeloma
148870,Myeloma And Other Monoclonal Gammopathies - Clinical,Real World Evidence Of Carfilzomib In Relapsed Refractory Multiple Myeloma (Rrmm),Relapsed;;Refractory;;Multiple Myeloma,Relapsed/Refractory Multiple Myeloma
312715,Tumor Cell And Molecular Biology: Drug Resistance,Establishment And Characterization Of Two Er+/Her2- Xpdx Models Developed Sequentially Before And After Acquired Resistance To The Cdk4/6 Inhibitor Palbociclib From A Patient With Metastatic Breast Cancer,Metastatic;;Breast Cancer,Metastatic Breast Cancer
198028,Poster Session I (In-Person),Exposure to Prenatal Stress Induces Sex-Specific Vulnerability to Psychopathologic Domains in Adolescent Rats,,
329101,Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Poster II,Free from Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial): A Pilot Study of Minimal Residual Disease (MRD)-Driven Discontinuation of Maintenance,Multiple Myeloma,Multiple Myeloma
312718,Treatment - Types And Sites Of Breast Cancer: Brain Metastases,Efficacy And Safety Of Pyrotinib-Based Therapy In The Treatment Of Her2-Positive Breast Cancer Patients With Brain Metastases:A Multi-Center Real-World Study,Her2;;Positive;;Breast Cancer;;Brain Metastases,Brain Metastasis;;Her2-Positive Breast Cancer
148877,Myeloma And Other Monoclonal Gammopathies - Clinical,Analysis Of Delay In The Diagnosis Of Multiple Myeloma In A Sanitary Region Of Southern Spain.,Multiple Myeloma,Multiple Myeloma
312723,Treatment - Adjuvant Therapy: Adjuvant Therapy - Targeted,"A Randomized Phase Ii Trial Targeting Disseminated Dormant Tumor Cells With Hydroxychloroquine, Everolimus Or The Combination To Prevent Recurrent Breast Cancer (""Clever"")",Recurrent;;Breast Cancer,Recurrent Breast Cancer
181651,Aggressive Lymphomas: Clinical and Epidemiological: Poster II,"Validation of New International Prognostic Scores, Including Baseline Peripheral Blood Variables, in Patients with Diffuse Large B-Cell Lymphoma and HIV Infection Treated with R-CHOP and Combined Antiretroviral Therapy. Retrospective Study from Spanish Lymphoma Group Geltamo",Diffuse Large B-Cell Lymphoma;;HIV Infection,Diffuse Large B-Cell Lymphoma;;Human Immunodeficiency Virus Infection
329119,Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Poster III,Analysis of Transplant-Eligible Patients (Pts) Who Received Frontline Daratumumab (DARA)-Based Quadruplet Therapy for the Treatment of Newly Diagnosed Multiple Myeloma (NDMM) with High-Risk Cytogenetic Abnormalities (HRCA) in the Griffin and Master Studies,Newly Diagnosed;;Multiple Myeloma,Newly Diagnosed Multiple Myeloma
279967,Janssen: Immunotherapy: evolution or revolution in the cure of multiple myeloma,How will we treat high-risk multiple myeloma in the future?,high-risk;;multiple myeloma,High-Risk Multiple Myeloma
263586,Treatment and monitoring in CML,"International, Prospective Study Comparing Nilotinib Versus Imatinib With Early Switch To Nilotinib To Obtain Sustained Treatment-Free Remission In Patients With With Chronic Myeloid Leukemia",Chronic Myeloid Leukemia,Chronic Myeloid Leukemia
148899,Myeloproliferative Neoplasms - Clinical,"A Phase 1 Study Of Tp-3654, An Oral Pim Kinase Inhibitor, In Patients With Intermediate-2 Or High-Risk Primary Or Secondary Myelofibrosis",Intermediate;;High-Risk;;Primary;;Secondary;;Myelofibrosis,Intermediate-Risk High-Risk Primary Myelofibrosis;;Intermediate-Risk High-Risk Secondary Myelofibrosis
378277,Pediatric acute myeloid leukemia (AML),Clinical trials in pediatric leukemia,pediatric;;leukemia,Pediatric Leukemia
394663,"Thoracic Malignancies, Other",Quality Of Life (Qol) Of Patients (Pts) With Advanced Malignant Pleural Mesothelioma (Ampm) Treated In A Real-World Setting,Advanced;;Malignant;;Pleural Mesothelioma,Advanced Malignant Pleural Mesothelioma
411051,"CKD Progression and Complications: Diagnosis, Prognosis, Risk Factors",Implications of the Acute and Chronic GFR Slopes for Time-to-Event End Points in Clinical Trials of CKD,CKD,Chronic Kidney Disease
378288,What is hot in hemophilia?,Gene therapy in practise,hemophilia,Hemophilia
198070,Poster Session I (In-Person),Systemic Inflammation Response Index (SIRI) May Predict Treatment Response in Treatment-Resistant Bipolar Depression (TRBDD),Treatment-Resistant;;Bipolar Depression,Treatment-Resistant Bipolar Depression
329150,Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Poster I,Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients (>= 65; < 80 Years). IFM2020-05/Benefit,Newly Diagnosed;;Non-Frail;;Multiple Myeloma;;Elderly,Elderly Newly Diagnosed Non-Frail Multiple Myeloma
329153,Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Poster I,"Quadruplet Induction, Autologous Transplantation and Minimal Residual Disease Adapted Consolidation and Treatment Cessation in Older Adults >=70y with Newly Diagnosed Multiple Myeloma: A Subgroup Analysis of the Master Trial",Older Adults;;Newly Diagnosed;;Multiple Myeloma,Elderly Newly Diagnosed Multiple Myeloma
198082,Virtual Poster Session I,Callous-Unemotional Traits Moderate the Relationship between Irritability and Threatening Responding,,
181700,Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II,The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation and Immune Attack,MPN;;Progression,Progressive Myeloproliferative Neoplasm
263626,Iron regulation in hematological disorders,Alteration Of Iron Homeostasis Through Genetic And Pharmacologic Modulation Of Ferroportin Modifies Mds Pathophysiology In A Preclinical Mouse Model,Mds,Myelodysplastic Syndrome
296396,Palliative care,"Associations between Psycho-Social-Spiritual Interventions, Reduced Aggressive End-of-Life Measures, and Increased Time after Final Oncologic Treatment",,
394706,Translational Research (Agnostic),Novel Genetic Markers Associated With Immune Checkpoint Inhibitor Induced Immune-Related Adverse Events,,
329172,Experimental Transplantation: Basic and Translational: Poster II,Re-Sensitization of Allogeneic T Cell Resistant Murine AML with Pegylated IFN-Gamma,AML,Acute Myeloid Leukemia
198103,Virtual Poster Session I,Perceived Touch Deprivation is Associated with Increased Severity of the Body Focused Repetitive Behaviors [BFRB],,
230872,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Conversion surgery following immuno-chemotherapy in initially-unresectable esophageal squamous cell carcinoma: A real-world multicenter study.,unresectable;;esophageal squamous cell carcinoma,Unresectable Esophageal Squamous Cell Carcinoma
230874,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Surgical intervention of hepatocellular carcinoma with wedge versus segmental resection: A SEER database analysis.,hepatocellular carcinoma,Hepatocellular Carcinoma
263643,Myeloma and other monoclonal gammopathies: Translational and Biology,Functional Subsets Of Plasma Cells Associated With Amyloid Production Andvenetoclax Sensitivity In Al Amyloidosis,Al Amyloidosis,Al Amyloidosis
280029,Myeloma: Non transplant-eligible MM,Treatment of MM patients based on their frailty status,MM ,Multiple Myeloma
312805,Prognostic&Predictive Factors:Prognosis-Biomarkers Of Natural History-Prog Factors-Clin Testing&Val,Performance Of Tumor Vascularity As A Biomarker Is Correlated With The Change Of Tumor Vascularity After Preoperative Systemic Treatment In Patients With Breast Cancer, Breast Cancer, Breast Cancer
394726,Translational Research (Agnostic),Berberine Associated To Sglt-2I Exerts Synergistic Cardioprotective Effects In Cardiac Cells Exposed To The Her2-Blocking Agent Trastuzumab Through Pampk Activation And Reduction In Interleukin-6 Levels,,
329193,Experimental Transplantation: Basic and Translational: Poster III,Single-Cell Multiomics for Residual Disease Detection in Acute Myelogenous Leukemia after Allogeneic Hematopoietic Cell Transplantation,Acute Myelogenous Leukemia,Acute Myelogenous Leukemia
378351,Mechanisms of chemotherapy resistance in ALL,Non-genetic mechanisms of resistance in B-ALL,B-ALL,B-Cell Acute Lymphoblastic Leukemia
230896,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Racial and socioeconomic factors associated with palliative care utilization in pancreatic cancer: An analysis of National Inpatient Sample.,pancreatic cancer,Pancreatic Cancer
394737,Translational Research (Agnostic),Development Of An Oncolytic Virus For The Treatment Of High Grade Serous Ovarian Cancer And Other Stromal Rich Tumours,High Grade;;Serous Ovarian Cancer,High Grade Serous Ovarian Cancer
214515,PD10: Bladder Cancer: Invasive II,"Global variation in quality of transurethral resection of bladder surgery, results from the RESECT study.",Bladder Cancer,Bladder Cancer
329204,Experimental Transplantation: Basic and Translational: Poster I,Absence of ILC2 Recovery Post-Transplant Is Mediated By Epigenetic Conversion of ILC2 to Pro-Inflammatory ILC1-like Cells,,
214519,PD11: Prostate Cancer: Detection & Screening II,Acquired and Congenital Spinal Cord Injury is Associated with Lower Likelihood of PSA Screening,Prostate Cancer,Prostate Cancer
296440,Oesophagogastric cancer,Radiomics biomarkers are associated with survival in patients with Oesophageal Adenocarcinoma,Oesophageal Adenocarcinoma,Oesophageal Adenocarcinoma
181759,Myelodysplastic Syndromes - Clinical and Epidemiological: Poster II,Treatment Patterns and Overall Survival in Patients with Intermediate-Risk MDS: A Retrospective Analysis in the Spanish MDS Registry,Intermediate-Risk;;MDS,Intermediate-Risk Myelodysplastic Syndrome
181766,Myelodysplastic Syndromes - Clinical and Epidemiological: Poster II,Targeting MDS Stem Cells with Omacetaxine and Azacitidine for Newly Diagnosed High Grade Patients: Phase 1 Trial Results and Preliminary Mechanistic Studies,Newly Diagnosed;;High Grade;;MDS,Newly Diagnosed High Grade Myelodysplastic Syndrome
345609,Small Molecule Therapeutic Agents,Tepotinib treatment inhibits tumor growth and affects tumor permeability in an intracranial PDX model of MET-amplified NSCLC brain metastasis,MET;;amplified;;NSCLC;;brain metastasis,MET-Amplified Non-Small Cell Lung Cancer;;Brain Metastasis
149004,Thalassemias,Role Of Telemedicine In Management Of Adult Egyptian Thalassaemia Patients During Covid-19 Pandemic; Patients Survey,Adult;;Egyptian Thalassaemia,Adult Egyptian Thalassaemia
280076,Incyte: The Evolving landscape in the Treatment of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia,Chemotherapy plus TKIs in the treatment of Ph+ALL,Ph+;;ALL,Ph Chromosome-Positive Acute Lymphoblastic Leukemia
312846,Treatment - Surgery And Radiotherapy: Reconstruction,Aesthetic Incisions And Early Complications  For Nipple-Sparing Mastectomy Followed By Immediate Breast Reconstruction,,
280079,Incyte: The Evolving landscape in the Treatment of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia,Q&A and panel discussion,Philadelphia Chromosome;;positive;;Acute Lymphoblastic Leukaemia,Ph-positive Acute Lymphoblastic Leukaemia
312847,Treatment - Surgery And Radiotherapy: Reconstruction,Impact Of Neoadjuvant Chemotherapy On The Short- And Long-Term Outcomes In Patients Who Underwent Immediate Breast Reconstruction After Mastectomy,,
411154,Bone and Mineral Metabolism: CKD-MBD Updates,Association Between Sevelamer Use and Risk of Gastrointestinal Bleeding in Patients with Kidney Failure,Gastrointestinal Bleeding,Gastrointestinal Bleeding
165397,"COVID-19 Complications, co-infections, and clinical outcomes",Risk Factors for Mortality in Severe COVID-19 Patients Admitted to the Intensive Care Unit: a Retrospective Single-Center Study in Saudi Arabia,Severe;;COVID-19,Severe COVID-19 Infection
214551,PD14: Bladder Cancer: Epidemiology & Evaluation I,Comparative outcomes of primary and recurrent high grade non-muscle invasive and primary and progressive muscle-invasive bladder cancer after radical cystectomy: results from a retrospective multicenter study,primary;;recurrent;;high grade;;non-muscle invasive;;primary;;progressive;;muscle-invasive bladder cancer,Primary Recurrent High Grade Non-Muscle Invasive Bladder Cancer;;Primary Progressive Muscle Invasive Bladder Cancer
149018,Thrombosis And Vascular Biology - Biology & Translational Research,Studies Of Geographic Variations In Risk Factors Associated With Thrombophilia And Its Possible Impact On Disease Management Planning,Thrombophilia,Thrombophilia 
230944,"Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary",Outcomes of hepatocellular carcinoma in obese patients: Insights from a nationwide database.,hepatocellular carcinoma,Hepatocellular Carcinoma
329249,Cellular Immunotherapies: Basic and Translational: Poster II,Distinguishing Early Infections from CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL,Relapsed/Refractory;;B-NHL,Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
214562,PD15: Kidney Cancer: Epidemiology & Evaluation/Staging/Surveillance I,Long term follow up in patients undergoing renal biopsy - seeding is not anecdotal,Kidney Cancer,Kidney Cancer
263715,Acute lymphoblastic leukemia - Clinical,A Phase Ii Study Of Mini-Hyper-Cvd Plus Venetoclax In Patients With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia,Philadelphia Chromosome;;Negative;;Acute Lymphoblastic Leukemia,Ph-Negative Acute Lymphoblastic Leukemia
263713,Acute lymphoblastic leukemia - Clinical,"Mini-Hyper-Cvd Plus Inotuzumab Ozogamicin, With Or Without Blinatumomab, In Older Adults With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia: Updates From A Phase Ii Trial",Older Adults;;Newly Diagnosed;;B-Cell Acute Lymphoblastic Leukemia,Elderly Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
165408,"COVID-19 Complications, co-infections, and clinical outcomes",Lung cancer and hematologic malignancy ( HM) patients are associated with the highest risk of progressing to severe disease and mortality in cancer patients with COVID-19,Lung cancer;;hematologic malignancy,Lung Cancer;;Hematologic Malignancy
230947,Genitourinary Cancer-Kidney and Bladder,Single-nucleus RNA-sequencing analysis reveals transcriptome differences in TIGIT+ exhausted T-cell associated with poor prognosis in muscle-invasive bladder cancer (MIBC).,muscle-invasive bladder cancer,Muscle-Invasive Bladder Cancer
181796,Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II,Performance of Standard Prognostic Models in Older Adults Receiving Ibrutinib for Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): A Post Hoc Analysis of Alliance A041202 Phase 3 Trial,Older Adults;;Treatment-Naive;;Chronic Lymphocytic Leukemia,Elderly Treatment-Naive Chronic Lymphocytic Leukemia
411176,Diabetic Kidney Disease: Clinical - I,Canagliflozin Treatment Impact on Collagen Type III Turnover Is Associated with a Reduced Mortality Risk in CANVAS,,
394789,Tumour Biology And Pathology,Multi-Omic Spatial Phenotyping Of The Nsclc Tumour Microenvironment For The Development Of A Spatial Score Associated With Immunotherapy Resistance.,Nsclc ,Non-Small Cell Lung Cancer
280115,Acute myeloid leukemia: Germline predisposition gene mutations in AML,ERCC6L2 as novel entity for inherited AML,inherited;;AML,Inherited Acute Myeloid Leukemia
263732,Aggressive Non-Hodgkin lymphoma - Clinical,A Retrospective Review Of Secondary Hemophagocytic Lymphohistiocytosis From A Teaching Hospital In Singapore.,Secondary;;Hemophagocytic Lymphohistiocytosis,Secondary Hemophagocytic Lymphohistiocytosis
230966,Genitourinary Cancer-Kidney and Bladder,A novel approach to assessing the effects of smoking on treatment response rate in muscle-invasive bladder cancer.,muscle-invasive bladder cancer,Muscle-Invasive Bladder Cancer
198200,Neurobiological Mechanisms of Individual and Structural Racism: Novel Pathways for Race-Related Health Disparities,Prefrontal Cortical White Matter Integrity Mediates Associations between Racial Discrimination and Health Outcomes,,
149051,Inherited And Acquired Hemostasis Defects,Novel treatments in hemophilia,hemophilia,Hemophilia
312891,Tumor Cell And Molecular Biology:Microenvironment - Stromal-Epithelial Interactions,Tumour Associated Macrophages In Breast Cancer - Are They Critical Players In Response To Neo Adjuvant Chemotherapy?,Breast Cancer,Breast Cancer
411198,Diabetic Kidney Disease: Clinical - I,Identification and Validation of Neutrophil Extracellular Traps-Associated Genes in Diabetic Kidney Disease: Integration Data from Bulk RNA and Single-Nucleus RNA Sequencing Analyses,Diabetic Kidney Disease,Diabetic Kidney Disease
394817,Tumour Biology And Pathology,Whole Genome Sequencing Of Aya Patients,Tumour ,Tumour 
280134,EHA-ISLH Laboratory Diagnosis Workshop - Session 3: Diagnostics of rare T-cell/NK cell disorders,Diagnosis and classification of T-Large Granular Lymphocyte Leukemia (T-LGL),T-Large Granular Lymphocyte Leukemia,T-Large Granular Lymphocyte Leukemia
198215,Poster Session II (In-Person),Epigenetic Intergenerational Transmission: Mothers' Adverse Childhood Experiences and Dna Methylation,,
411209,Hypertension and CVD: Clinical - I,Assessing Heart Rate Variability in Patients with CKD: Association with Vascular Dysfunction,Vascular Dysfunction;;CKD,Chronic Kidney Disease;;Vascular Dysfunction
296529,Oesophagogastric cancer,The preliminary efficacy and safety of KN026 combined with KN046 treatment in HER2-positive locally advanced unresectable or metastatic gastric/gastroesophageal junction cancer without prior systemic treatment in a phase II study,HER2;;positive;;locally advanced;;unresectable;;metastatic;;gastric;;gastroesophageal junction cancer,HER2-Positive Locally Advanced Unresectable or Metastatic Gastric Cancer;;HER2-Positive Locally Advanced Unresectable or Metastatic Gastroesophageal Junction Cancer
149077,Targeting Low-Risk Mds,Treating low-risk MDS,low-risk;;MDS,Low-Risk Myelodysplastic Syndrome
394839,Urothelial Cancer,Real-World Effectiveness Of Single Agent Enfortumab Vedotin (Ev) In Patients (Pts) With Locally Advanced Or Metastatic Urothelial Carcinoma (Muc) Based On Line Of Therapy And Impact Of Prior Platinum (Plat) Chemotherapy (Chemo) And Pd-1/Pd-L1 Inhibitors (Pd-1/Pd-L1I),Locally Advanced;;Metastatic;;Urothelial Carcinoma,Locally Advanced/Metastatic Urothelial Carcinoma
394844,Urothelial Cancer,Long-Term Survival Upon Anti-Pd-(L)1 Monotherapy In Metastatic Urothelial Cancer (Muc): A Multicenter Retrospective Study,Metastatic;;Urothelial Cancer,Metastatic Urothelial Cancer
296548,"NSCLC, metastatic","A phase 1 study of CKD-702, an EGFR-cMET bispecific antibody, in advanced or metastatic non-small cell lung cancer (NSCLC)",advanced;;metastatic;;non-small cell lung cancer,Advanced or Metastatic Non-Small Cell Lung Cancer
181862,Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster II,Mutations in the Alternative Complement Pathway in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy,Multiple Myeloma;;Thrombotic Microangiopathy,Multiple Myeloma;;Thrombotic Microangiopathy
296551,Gynaecological cancers,High concordance of different molecular assays in the determination of HRD associated GIS in high grade epithelial ovarian cancer,high grade;;epithelial ovarian cancer,High Grade Epithelial Ovarian Cancer
263786,Stem cell transplantation - Clinical,Treatment Of Severe Steroid-Refractory Acute Gvhd With Mesenchymal Stromal Cells: Results Of The Phase Iii Randomized Double-Blind Multi-Center Hovon-113 Trial,Acute;;Gvhd,Acute Graft-Versus-Host Disease
345706,Hope for Rare Cancers: Novel Targeted and Immunotherapy Agents,"First-in-class, first-in-human phase 1 trial of VT3989, an inhibitor of yes-associated protein (YAP)/transcriptional enhancer activator domain (TEAD), in patients (pts) with advanced solid tumors enriched for malignant mesothelioma and other tumors with neurofibromatosis 2 (NF2) mutations",advanced;;solid tumors;;malignant;;mesothelioma;;neurofibromatosis 2,Advanced Solid Tumor;;Malignant Mesothelioma;;Neurofibromatosis Type 2 
394860,Urothelial Cancer,Detection Of Molecular Recurrence In Early-Stage Bladder Cancer Patients Using A Urinary Tumor Dna Assay After Transurethral Resection Of Bladder Tumor (Turbt),Early-Stage;;Bladder Cancer,Early-Stage Bladder Cancer
394862,Urothelial Cancer,Cdkn2A Deletions Are A Mechanism For P16 Inactivation In Urothelial Bladder Carcinomas And Are Associated With An Aggressive Tumor Phenotype,Urothelial Bladder Carcinomas;;Cdkn2A Deletions,CDKN2A-Deleted Urothelial Bladder Carcinoma
312943,Tumor Cell And Molecular Biology: Other,Adiponectin Regulates Stem Cell Activity In Tamoxifen-Resistant Breast Cancer Cells,Breast Cancer,Breast Cancer
198256,Poster Session II (In-Person),Hopelessness is Associated with Reduced Wide-Band Magnetoencephalographic Power in Anterior Medial Temporal Lobes in a Clinical Sample,,
312945,Tumor Cell And Molecular Biology: Other,Marvel D3 And Its Associated Junctional Proteins In Breast Cancer,Breast Cancer,Breast Cancer
231026,"Genitourinary Cancer-Prostate, Testicular, and Penile",The effect of PARP inhibition on androgen receptor localization and activity in castration resistant prostate cancer.,castration resistant prostate cancer,Castration Resistant Prostate Cancer
329328,Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster II,"ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia",Relapsed/Refractory;;Chronic Lymphocytic Leukemia,Relapsed/Refractory Chronic Lymphocytic Leukemia
165490,COVID-19 Epidemiology and screening,Sensitivity and Specificity of the WHO Probable SARS-CoV-2 Case Definition Among Symptomatic Healthcare Personnel,SARS-CoV-2,SARS-CoV-2 Infection
329332,Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster II,Relapse Prophylaxis Post-Haploidentical Bone Marrow Transplantation and Cyclophosphamide (Haplo/Cy) By Infusion of Donor-Derived Expanded/Activated Gd T Cells: A Phase I Trial,,
345720,How to Design a Successful Career Path in Cancer Research: The Dos and Don'ts for Early-Stage Investigators,Chairperson,Cancer,Cancer
181883,Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials: Poster II,Efficacy and Safety of Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment or on Dialysis: Final Analysis of the Phase 2 Dare Study,Relapsed;;Refractory;;Multiple Myeloma,Relapsed/Refractory Multiple Myeloma
394876,Cancer Nursing: Ehealth And Digital Innovations,The Mount Vernon Cancer Center Non Medical Prescriber Gi Oncology Clinic Experience,,
280189,EHA-EuNet-INNOCHRON Guidelines on Chronic neutropenias,Overview of Guidelines,,
263809,Myeloma and other monoclonal gammopathies - Clinical,Treatment Efficacy Of Progression Free Survival For Refractory/Relapsed Multiple Myeloma In Geriatric Patients: A Network Meta-Analysis,Refractory;;Relapsed;;Multiple Myeloma,Refractory/Relapsed Multiple Myeloma
231041,Gynecologic Cancer,"Effects of five prescriptions in Synopsis of Golden Chamber on the malignant phenotype and expression of CA125, CEA, HE4 proteins in human ovarian cancer cells.",ovarian cancer ,Ovarian Cancer 
345732,Cell-of-Origin and Tumor Heterogeneity in Childhood Cancers: A Pediatric Cancer Working Group Town Hall Meeting and Networking Reception,Developmental pathways and spatial architecture of pediatric high-grade glioma,pediatric;;high-grade;;glioma,Pediatric High-Grade Glioma
280200,Global Blood Therapeutics: Optimising care in Sickle Cell Disease - focusing on the long term right from the beginning,Therapies intervening along the Sickle Cell Disease pathophysiological cascade,Sickle Cell Disease,Sickle Cell Disease
394888,Cancer Nursing: Supportive Care,Evaluation Of Financial Toxicity And Associated Factors In Female Patients With Breast Cancer: A Systematic Review And Meta-Analysis,Breast Cancer,Breast Cancer
378511,DDW Clinical Late Breaking Abstract Session,Direct Endoscopic Versus Step-Up Transluminal Interventions In Necrotizing Pancreatitis (Destin): Results Of A Randomized Trial,Pancreatitis,Pancreatitis
231055,"Genitourinary Cancer-Prostate, Testicular, and Penile",The evolving landscape of practice pattern and survival outcomes in the management of localized low-risk prostate cancer.,localized;;low-risk;;prostate cancer,Localized Low-Risk Prostate Cancer
378513,DDW Clinical Late Breaking Abstract Session,Clinical Validation Of A Cell-Free Dna Blood-Based Test For Colorectal Cancer Screening In An Average Risk Population,Colorectal Cancer ,Colorectal Cancer 
149141,European Working Group On Adult All (Ewall),Targeted therapy and immunotherapy in newly diagnosed Ph-negative ALL,newly diagnosed;;Ph;;negative;;ALL,Newly Diagnosed Ph-Negative Acute Lymphocytic Leukemia
149142,European Working Group On Adult All (Ewall),Selecting the best targeted therapy. Role of drug profiling,Adult;;All,Adult Acute Lymphoblastic Leukemia
312981,"Â Epidemiology, Risk, And Prevention: Epidemiology, Risk, And Prevention - Other",Long-Term Heart Failure Risk Of Trastuzumab With Or Without Anthracyclines In Early Stage Breast Cancer: A Seer-Medicare Database Analysis,Early Stage;;Breast Cancer,Early Stage Breast Cancer
214681,PD26: Bladder Cancer: Non-invasive I,Low-grade urothelial carcinoma recurs at a tempo that naturally accelerates from Adagio to Allegro,Low-grade urothelial carcinoma,Low-Grade Urothelial Carcinoma
378521,General Neurology,Investigating the use of focused ultrasound to induce blood-brain barrier opening and increase drug delivery into a murine model of primary high grade glioma tumors,primary;;high grade;;glioma tumors,Primary High Grade Glioma Tumor
214683,PD26: Bladder Cancer: Non-invasive I,Comparison of Intravesical Therapy and Surgery as Treatment Options for Recurrent Bladder Cancer (CISTO): Update on an Ongoing Multicenter Pragmatic Study,Recurrent;;Bladder Cancer,Recurrent Bladder Cancer
231067,Gynecologic Cancer,Interim analysis from a phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer: APGOT-ov4/ OPEB-01.,BRCA non-mutated;;platinum-sensitive;;recurrent;;ovarian cancer,BRCA Non-Mutated Platinum-Sensitive Recurrent Ovarian Cancer
149153,Mechanisms Of Transformation: Insights From Genetic Predisposition Disorders,DDX41 and leukemia predisposition: Where is the link?,Leukemia,Leukemia
345762,Early Detection and Interception of Cancer,Chairperson,Cancer,Cancer
378532,General Neurology,Racial Disparities in Alzheimer's Disease: the association between early life adversity and AD,Alzheimer's Disease,Alzheimer's Disease
214692,PD27: Prostate Cancer: Localized: Surgical Therapy II,"Prostate Volume, Baseline Urinary Symptoms, and Their Association with Post-Treatment Urinary Function in Men Treated for Localized Prostate Cancer",Localized;;Prostate Cancer,Localized Prostate Cancer
329382,Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster I,Final Results of Phase I/II Study of Donor-Derived CAR T Cells Engineered with Sleeping Beauty in Pediatric and Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed Post-HSCT,Pediatric;;Adult;;B-Cell Acute Lymphoblastic Leukemia,Pediatric B-Cell Acute Lymphoblastic Leukemia;;Adult B-Cell Acute Lymphoblastic Leukemia
296615,Oesophagogastric cancer,Predicting benefit from maintenance durvalumab after first-line chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA-based assay,first-line;;oesophagogastric adenocarcinoma ,First-Line Oesophagogastric Adenocarcinoma
263850,Myeloproliferative neoplasms - Biology & Translational Research,Utility Of Kit P.D816 In Myeloid Neoplasm Without Documented Systemic Mastocytosis To Detect Hidden Mast Cells In Bone Marrow,Myeloid Neoplasm;;Systemic Mastocytosis,Myeloid Neoplasm;;Systemic Mastocytosis
296620,Melanoma and other skin tumours,Time to Development of Central Nervous System (CNS) Metastases (mets) With Atezolizumab (A) or Placebo (P) Combined With Vemurafenib (V) + Cobimetinib (C): Updated Results From the Phase 3 IMspire150 Study,Central Nervous System Metastases,Central Nervous System Metastasis
345772,"Late-Breaking Research: Prevention, Early Detection, and Interception",Racial and ethnic disparities associated with the intratumor microbiome in female cancers,cancers,Cancer
345775,"Late-Breaking Research: Prevention, Early Detection, and Interception",Bio-printed 3D cell models and high-content imaging for testing anti-cancer compounds,,
394925,More Intelligent Trial Design,Pragmatic Trials,,
345777,"Late-Breaking Research: Prevention, Early Detection, and Interception",Simultaneous whole-body ultrasound contrast imaging: a novel high throughput preclinical platform for targeted molecular imaging studies,,
313009,Prognostic And Predictive Factors - Prognostic Factors: Other,Trends In Clinical Treatment Of Early Stage Er+Pr- Breast Cancer In The National Cancer Database,Early Stage;;Er+Pr-;;Breast Cancer,Early Stage Er+Pr- Breast Cancer
313012,Prognostic And Predictive Factors - Prognostic Factors: Other,"Racial Disparities Among Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy Therapy And Impact On Pathologic Response: An Urban, Single-Institution Experience",Breast Cancer,Breast Cancer
345782,Proteomics and Biomarker Discovery,What can we learn from phosphoproteomics compared to transcriptomics in DNA damage and other processes?,,
313018,Prognostic And Predictive Factors - Prognostic Factors: Other,Breast Cancer Characteristics In Premenopausal Women By Contraception Method,Breast Cancer,Breast Cancer
280253,EHA Guidelines on Antifungal prophylaxis and therapy in patients with AML treated with new agents,Patient case presentation,AML,Acute Myeloid Leukemia
149183,What Is High-Risk Disease In The Era Of Modern Agents?,Molecular definition,,
198339,Poster Session II (In-Person),Acute Stress Induces Memory Bias and Stronger Preference for Smoking-Associated Places in Smokers,Acute;;Stress,Acute Stress
411332,Home Dialysis - I,Random Forest Can Accurately Predict the Technique Failure of Peritoneal Dialysis-Associated Peritonitis Patients,Peritoneal Dialysis-Associated Peritonitis,Peritoneal Dialysis-Associated Peritonitis
345801,Late-Breaking Research: Immunology 1,Understanding how IL-2 cytokine synergizes with PD-1 therapy during chronic viral infection,chronic;;viral infection,Chronic Viral Infection
165580,"COVID-19 Special populations (e. g. pregnant women, children, immunocompromised, etc)",Delayed Mortality among Solid Organ Transplant Recipients Hospitalized for Covid-19: An International Multicenter Study,Covid-19,COVID-19
329422,Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster II,"Ciltacabtagene Autoleucel (Cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients with Multiple Myeloma (MM) and Early Relapse after Initial Therapy: CARTITUDE-2 Cohort B 18-Month Follow-up",Multiple Myeloma,Multiple Myeloma
263889,"Enzymopathies, membranopathies and other anemias",Erythrocytes' Oxidative Stress And Antioxidant Response In Patients With Hereditary Spherocytosis And B-Thalassemia Minor - A Small Number Case Study,Hereditary Spherocytosis;;B-Thalassemia Minor,Hereditary Spherocytosis;;B-Thalassemia Minor
345810,"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 1",Identifying novel targets for CAR-T therapies from single cell RNA-sequencing data,,
329431,Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster III,Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience,Relapsed;;Refractory;;Multiple Myeloma,Relapsed/Refractory Multiple Myeloma
329434,Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster III,Standard Cytogenetic Risk Stratification Is Not Predictive of CD19 CAR Outcomes and Impact of Disease Burden Varies between Cytogenetic Risk Groups,,
394977,"Mini Oral Session - Breast Cancer, Early Stage",Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial,invasive cancer,Invasive Cancer
165602,"COVID-19 Special populations (e. g. pregnant women, children, immunocompromised, etc)",Uptake and Perceptions of COVID-19 Vaccines among US Pregnant Women,COVID-19,COVID-19 Infection
329442,Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster III,CD19-CAR-T Cells Are Effective and Safe Treatment of Post-Transplant Relapse in Pediatric and Young Adult Patients with B-Lineage ALL: Real-World Data from Germany,Pediatric;;Young Adult;;B-Lineage ALL,Pediatric Young Adult B-Lineage Acute Lymphoblastic Leukemia
296678,Investigational immunotherapy,Phase 1 Study of SAR444245 (SAR'245) as monotherapy (mono) and combined with pembrolizumab (pembro) or cetuximab (cetux) in patients (pts) with advanced solid tumors,advanced;;solid tumor,Advanced Solid Tumor
329443,Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster III,Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel,Cytokine Release Syndromes,Cytokine Release Syndrome
263910,Thrombosis and vascular biology - Biology & Translational Research,Vkorc1 -1639 G/A Gene Polymorphism Can Modulate The Risk Of Venous Thromboembolism In Elderly Patients With Fv Leiden Mutation,Venous Thromboembolism;;Elderly,Elderly Venous Thromboembolism
214761,PD33: Kidney Cancer: Localized: Surgical Therapy II,Incidence and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy,Kidney Cancer,Kidney Cancer
165611,COVID-19 Treatment,Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNF-a antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure,severe;;COVID-19,Severe COVID-19 Infection
296691,"Breast cancer, early stage",Current use of breast cancer multigene signatures in clinical practice among European experts: results from the PROCURE Project,breast cancer,Breast Cancer
182010,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II",Utilizing Organ-Sparing Marrow Irradiation to Condition Patients Prior to Allogeneic Hematopoietic Cell Transplant with High-Risk Hematologic Malignancies: Results of a Pilot Study,High-Risk;;Hematologic Malignancies,High-Risk Hematologic Malignancy
182014,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II",Sequential Therapy with Fitcy Preparative Regimen for Patients with Primary Refractory AML - a Single Center Retrospective Analysis,Primary;;Refractory;;AML,Primary Refractory Acute Myeloid Leukemia
165631,COVID-19 Treatment,Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment,Severe Acute Respiratory Syndrome Coronavirus-2,Severe Acute Respiratory Syndrome Coronavirus-2 Infection
198398,Virtual Poster Session II,"Brain Function during Risky Decision-Making is Associated with Profiles of Hiv Knowledge, Perceived Severity, and Worry",Hiv,Human Immunodeficiency Virus Infection
198402,Virtual Poster Session II,Longitudinal Changes in Neural Activation that Discriminates between Aspects of Reward Processing in Early Adolescence,,
263941,Acute myeloid leukemia - Clinical,Overall Survival With Intensive Chemotherapy (Ic) Vs Non-Ic In Patients (Pts) With Newly Diagnosed (Nd) Aml From The Connect(r) Myeloid Disease Registry Ineligible For Randomized Clinical Trials (Rct),Newly Diagnosed;;Aml,Newly Diagnosed Acute Myeloid Leukemia
214789,PD35: Prostate Cancer: Advanced (including Drug Therapy) II,The impact of older age on the oncological outcomes for high-risk metastatic hormone-sensitive prostate cancer treated with upfront intensive therapy,high-risk;;metastatic;;hormone-sensitive prostate cancer,High-Risk Metastatic Hormone-Sensitive Prostate Cancer
165642,COVID-19 Treatment,Bamlanivimab (BAM) for SARS-CoV-2 Infection: Rates and Risk Factors for Hospitalization after Monoclonal Antibody Administration in a High-Risk Population,SARS-CoV-2 Infection,SARS-CoV-2 Infection
329488,Cell Collection and Processing: Poster I,High-Density Cryopreservation of Off-the-Shelf CAR-NK Cells Facilitates On-demand Treatment Access,,
395025,"Mini Oral Session - Breast Cancer, Early Stage",Long-term residential and workplace exposure to air pollution and breast cancer risk: A case-control study nested in the French E3N cohort from 1990 to 2011,breast cancer,Breast Cancer
411410,Genetic Diseases: Cystic - Therapeutic Investigations and Prognosis,Correction of PKD by Gene Transfer into Pkd1-Null Mouse Model,PKD,Polycystic Kidney Disease
313106,Tumor Cell And Molecular Biology: Animal Models,Self-Renewal Signatures Of Peripheral Blood T Cells Are Associated With Successful Engraftment To Establish A Humanized Mouse Model Of Breast Cancer,Breast Cancer,Breast Cancer
149271,Fresh Perspectives On Enduring Conversations In Relapsed/Refractory Multiple Myeloma (Rrmm),Panel discussion and concluding remarks,Relapsed/Refractory;;Multiple Myeloma,Relapsed/Refractory Multiple Myeloma
182040,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II",Sex Differences in EBV Viremia after Haplo-HSCT Imply Sex Bias during Immune Reconstitution,,
329497,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II",Frequent Early Geriatric Complications after Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Adults Impairs Disability-Free Survival (DiFS),,
198426,Virtual Poster Session II,Increased Frontal and Parietal Resting-State Lower Alpha Power as a Potential Marker of a Compensatory Mechanism Against Negative Symptoms in Clinical High-Risk Individuals for Psychosis,,
165659,COVID-19 Treatment,Risk Factors Associated with 30-Day Mortality in a Large Cohort of Patients who Received Remdesivir and Corticosteroids for Severe COVID-19,Severe;;COVID-19,Severe COVID-19
329500,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II",Tocilizumab for the Management of Cytokine Release Syndrome after Haploidentical Hematopoietic Transplant with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis,GvHD,Graft-Versus Host Disease
329498,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II",Allogeneic Peripheral Blood Stem Cell Transplantation for Bone Marrow Failure Syndromes Using CD34+-Selected Progenitor Cells Co-Infused with a Reduced Number of Non-Mobilized T-Cells,Bone Marrow Failure Syndromes,Bone Marrow Failure Syndrome
345879,Drug Delivery,The application of a PLGA scaffold for the dual delivery of Y15 and metformin for the treatment of platinum resistant ovarian cancer,platinum resistant;;ovarian cancer,Platinum Resistant Ovarian Cancer
182048,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II",The Incidence and Impact of Clostridioides Difficile Infection (CDI) on Outcomes after Allogeneic Hematopoietic Cell Transplant (alloHCT) - a CIBMTR Study,Clostridioides Difficile Infection,Clostridioides Difficile Infection
182051,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II",CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrab/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia,Pediatric;;High Risk;;Acute;;Leukemia,Pediatric High Risk Acute Leukemia
182053,Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster II,Post-Transplant Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia,Acute Lymphoblastic Leukemia,Acute Lymphoblastic Leukemia
182056,Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster II,Clinical Risk Factors and Prognostic Model for Idiopathic Inflammatory Demyelinating Diseases after Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies,Idiopathic Inflammatory Demyelinating Diseases;;Hematological Malignancies,Idiopathic Inflammatory Demyelinating Disease;;Hematological Malignancy
263983,Myeloma and other monoclonal gammopathies - Clinical,Ciltacabtagene Autoleucel In Lenalidomide-Refractory Patients With Progressive Multiple Myeloma After 1-3 Prior Lines Of Therapy: Cartitude-2 Biological Correlative Analyses And Updated Clinical Data,Progressive;;Multiple Myeloma,Progressive Multiple Myeloma
411442,Genetic Diseases: Cystic - Therapeutic Investigations and Prognosis,Prognosis of Polycystic Kidney Disease: FinnGen Study,Polycystic Kidney Disease,Polycystic Kidney Disease
182069,Autologous Transplantation: Clinical and Epidemiological: Poster II,The Intensity of the Induction Regimen Does Not Affect Post-Transplant Survival Among Patients with Newly Diagnosed Mantle Cell Lymphoma,Newly Diagnosed;;Mantle Cell Lymphoma,Newly Diagnosed Mantle Cell Lymphoma
214837,"PD39: Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy",Evaluating Factors That Influence Healthcare Resource Utilization in Transurethral Resection of Prostate,Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia
263993,Myeloma and other monoclonal gammopathies - Clinical,"Camma 3: A Multicenter Phase Ib Trial Evaluating The Safety, Pharmacokinetics, And Activity Of Subcutaneous Cevostamab Monotherapy In Patients With Relapsed Or Refractory Multiple Myeloma",Relapsed;;Refractory;;Multiple Myeloma,Relapsed Or Refractory Multiple Myeloma
378681,Biomarkers of the Future: New Strategies to Predict Sarcoma Outcomes,Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.,high-risk;;soft tissue sarcomas,High-Risk Soft Tissue Sarcoma
182078,Gene Therapies: Poster II,A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results,Severe;;Leukocyte Adhesion Deficiency-I,Severe Leukocyte Adhesion Deficiency-I
313151,Treatment - Advanced Disease Treatment: Advanced Therapy - Targeted,Prognosis And Treatment Landscape Of Her2-Positive Metastatic Breast Cancer (Mbc) Before The Availability Of Tucatinib And Trastuzumab-Deruxtecan: Results From The Austrian Agmt_Mbc-Registry,Her2;;Positive;;Metastatic;;Breast Cancer,Her2-Positive Metastatic Breast Cancer
182082,Gene Therapies: Poster II,Administration of Granulocyte Colony-Stimulating Factor Post-Transplant Impedes Engraftment of CRISPR-Cas9 Edited Long-Term Repopulating Hematopoietic Stem and Progenitor Cells,,
296771,"NSCLC, metastatic",Clinical outcomes in patients (pts) with tumor PD-L1 < 1% with first-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) vs chemo alone for metastatic NSCLC (mNSCLC): results from CheckMate 9LA,metastatic;;NSCLC ,Metastatic Non-Small Cell Lung Cancer
313155,Treatment - Advanced Disease Treatment: Advanced Therapy - Targeted,High Incidence Of Palbociclib Related Neutropenia In Asian Patients Associated With Genetic Polymorphisms,Neutropenia,Neutropenia
345926,Diagnostic and Prognostic Biomarkers 2,Rare neoplastic subpopulation predicts relapse in nasopharyngeal carcinoma,relapse;;nasopharyngeal carcinoma,Relapsed Nasopharyngeal Carcinoma
198471,The Case for Deep Phenotyping in Psychiatric Genetics: Insights from Rare Variants in Neurodevelopment,Gene Dosage Influences Sensitive Periods of Brain Development and Divergent Phenotypes in Reciprocal 22q11.2 Copy Number Variants,,
214859,PD41: Prostate Cancer: Detection & Screening IV,Moving Beyond PSA: Identifying the Optimal Diagnostic Strategy to Assess Prostate Cancer Risk,Prostate Cancer,Prostate Cancer
345931,Diagnostic and Prognostic Biomarkers 2,Longitudinal tracking of circulating rare events in the liquid biopsy of stage III-IV NSCLC patients during treatment,stage III-IV;;NSCLC,Stage III-IV Non-Small Cell Lung Cancer
296782,"NSCLC, early stage",Efficacy and safety of almonertinib in the adjuvant treatment of resectable stage I non-small cell lung cancer(NSCLC) with epidermal growth factor receptor (EGFR)-sensitizing mutations in solid and/or micropapillary components,resectable;;stage I;;non-small cell lung cancer;;epidermal growth factor receptor,Resectable Stage I EGFR-Mutated Non-Small Cell Lung Cancer
198479,"Oral Session 2: Addiction, Alzheimers, Eating Disorders, OCD & Sex Differences",Identifying Genetic Components of Anorexia Nervosa through Pathway Polygenic Risk Scores,Anorexia Nervosa,Anorexia Nervosa
296783,"Thoracic malignancies, other","Adjuvant nivolumab with chemotherapy in pleural mesothelioma aEUR"" the NICITA trial",pleural mesothelioma,Pleural Mesothelioma
395089,Proffered Paper session 2 - Basic Science and Translational research,Igsf8 Is An Innate Immune Checkpoint And Cancer Immunotherapy Target,Cancer,Cancer
345939,Biomarkers of Therapeutic Benefit 2,TERT C228T and KDM6A alterations are potential predictive biomarkers in non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin instillation,non-muscle-invasive bladder cancer,Non-Muscle-Invasive Bladder Cancer
313170,Prognostic And Predictive Factors: Biomarkers Predicting Tx Response: Predictive Biomarkers-Other,Predictors Of Long-Term Durable Response In De Novo Her2 Positive Metastatic Breast Cancer And The Real World Treatment Experience At Two Institutions,De Novo;;Her2;;Positive;;Metastatic;;Breast Cancer,De Novo Her2-Positive Metastatic Breast Cancer
214869,PD42: Bladder Cancer: Invasive IV,Radical vs Partial Cystectomy for Urachal Carcinoma: A Population-Based Analysis,Urachal Carcinoma,Urachal Carcinoma
329558,"Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster I",Differences in Patterns of Infections Among Allogeneic Hematopoietic Cell Transplant Patients Receiving Letermovir Prophylaxis for Cytomegalovirus,,
214871,PD42: Bladder Cancer: Invasive IV,Do Prophylactic Antibiotics Reduce Urinary Tract Infections Following Robot-Assisted Radical Cystectomy? A Randomized Control Trial,Urinary Tract Infections,Urinary Tract Infection
313169,Prognostic And Predictive Factors: Biomarkers Predicting Tx Response: Predictive Biomarkers-Other,Serial Monitoring Of Circulating Tumor Cells And Circulating Tumor Dna In Metastatic Lobular Breast Cancer Identifies Intra-Tumor Heterogeneity And Precision And Immuno-Oncology Biomarkers Of Therapeutic Importance,Metastatic;;Lobular Breast Cancer,Metastatic Lobular Breast Cancer
345942,Biomarkers of Therapeutic Benefit 2,Lipid and immune-based biomarkers associated with clinical response to TPST-1120: A small molecule antagonist of peroxisome-proliferator activated receptor-alpha,,
182100,Emerging Diagnostic Tools and Techniques: Poster II,Mapbatch: Conservative Batch Normalization for Single Cell RNA-Sequencing Data Enables Discovery of Rare Cell Populations in a Multiple Myeloma Cohort,Multiple Myeloma,Multiple Myeloma
395100,Esmo Clinical Practice Guidelines 2,Non-Oncogene-Addicted Metastatic Nsclc Discussion,Metastatic;;Nsclc,Metastatic Non-Small Cell Lung Cancer
231260,Health Services Research and Quality Improvement,Clinical application of precision medicine among oncologists: A case study in RET-targeted therapy.,,
313185,Prognostic And Predictive Factors: Biomarkers Predicting Tx Response: Predictive Biomarkers-Other,Utility Of The 70-Gene Signature And 10 Year Follow Up In Patients With Early-Stage Breast Cancer In A Single Institution Study,Early-Stage;;Breast Cancer,Early-Stage Breast Cancer
231266,Health Services Research and Quality Improvement,Outcomes of malignant pericardial effusion associated with solid cancers based on treatment modality.,malignant;;pericardial effusion;;solid cancers,Malignant Pericardial Effusion;;Solid Cancer
329574,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II",Effect of CMV Reactivation and Letermovir Use on Chronic Gvhd Incidence Following Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide,Chronic;;Gvhd,Chronic Graft-Versus-Host Disease
378731,Knives Out: Surgical Management of Gynecologic Cancers,Final survival analysis of the phase III OVHIPEC-1 trial of hyperthermic intraperitoneal chemotherapy in ovarian cancer after ten year follow-up.,ovarian cancer,Ovarian Cancer 
378732,Knives Out: Surgical Management of Gynecologic Cancers,Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: The CHIPOR randomized phase III trial.,platinum-sensitive;;relapsed;;epithelial ovarian cancer,Platinum-Sensitive Relapsed Epithelial Ovarian Cancer
378734,Knives Out: Surgical Management of Gynecologic Cancers,An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC): A Gynecologic Cancer Intergroup study led by the Canadian Cancer Trials Group (CCTG CX.5-SHAPE).,low-risk;;early-stage;;cervical cancer,Low-Risk Early-Stage Cervical Cancer
165745,Clinical trials,"Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides difficile Infection (CDI) Compared to Placebo, Regardless of Risk Factors for Recurrence",Clostridioides difficile Infection,Clostridioides Difficile Infection
313205,"Â Epidemiology, Risk, And Prevention: Epidemiology - Population Studies",Cumulative Environmental Quality Is Associated With Differential Breast Cancer Incidence  By Summary Stage And Urbanicity,Breast Cancer,Breast Cancer
165758,Diagnostics: Bacteriology/mycobacteriology,"Rapid, Non-invasive Detection Of Cryptic Tularemia Using A Plasma-Based Microbial Cell-Free DNA Next-Generation Sequencing Test",Tularemia,Tularemia
198526,Oral Session 4: Anxiety/Psychosis/PTSD/Suicide,The Neurobiology of Childhood Trauma - Aldosterone and Blood Pressure Changes in a Community Sample,Childhood;;Trauma,Childhood Trauma
296833,CNS tumours,"Stable, controllable, and scalable manufacturing of B7-H3 UCAR-T, an allogeneic CAR-T product for advanced glioma, from healthy donors",advanced;;glioma,Advanced Glioma
329603,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III",Ibrutinib for Steroid Refractory Chronic Graft Vs Host Disease - Real World Experience,Chronic;;Graft-Versus-Host Disease,Chronic Graft-Versus-Host Disease
313220,"Â Epidemiology, Risk, And Prevention: Epidemiology - Population Studies",The Impact Of Sociodemographic Disparities On Overall Survival Of Adolescent And Young Adults (Aya) With Invasive Breast Cancer,Adolescent;;Young Adults;;Invasive Breast Cancer,Adolescent Young Adult Invasive Breast Cancer
296839,Basic Science,Tertiary lymphoid structure predicts major pathological response in resectable non-small cell lung cancer patients with neoadjuvant chemotherapy,resectable;;non-small cell lung cancer,Resectable Non-Small Cell Lung Cancer
345992,Biomarkers of Therapeutic Benefit 3,"Tumor IL1RAP levels and reduction in serum biomarkers correlate with response in PDAC patients treated with nadunolimab, an anti-IL1RAP monoclonal antibody, in combination with gemcitabine and nab-paclitaxel",PDAC,Pancreatic Ductal Adenocarcinoma
345995,Biomarkers of Therapeutic Benefit 3,A multi-institutional prospective biomarker study of durvalumab after concurrent chemoradiation therapy in patients with unresectable stage III non-small cell lung cancer (WJOG11518L/SUBMARINE),unresectable;;stage III;;non-small cell lung cancer,Unresectable Stage III Non-Small Cell Lung Cancer
198543,Poster Session III (In-Person),Making the MOSTest of genetics: The Multivariate Omnibus Statistical Test Boosts Discovery of the Genetic Determinants of the Brain and Its Disorders,Brain;;Disorders,Brain Disorder
198548,Poster Session III (In-Person),Identification of Structural Brain Alterations in Adolescents at Suicide Risk: A Machine Learning Approach,,
395159,Merck Healthcare Kgaa - Putting Patients First: Cultivating Care In Bladder Cancer,Chairman'S Introduction,Bladder Cancer,Bladder Cancer
313244,"Â Psychosocial, Qol, And Educational Aspects - Qol Issues: Psychosocial Aspects",Surgical Outcomes For Reconstruction After Delayed Contralateral Prophylactic Mastectomy,,
329629,Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster II,Complex Restrictive Lung Disease Patterns Affecting Survival and Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant: A Single-Institution Retrospective Analysis,Lung Disease,Lung Disease
378783,"The Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between",Neoadjuvant Therapy in Triple-Negative Breast Cancer: Where We Are and What's Next?,Triple-Negative Breast Cancer,Triple-Negative Breast Cancer
296867,"Breast cancer, early stage",Staging strategies of newly diagnosed triple-negative breast cancer (TNBC): comparison between CT scan and 18F-FDG-PET/CT,newly diagnosed;;triple-negative breast cancer,Newly Diagnosed Triple-Negative Breast Cancer
378794,Gliomas in Adolescents and Young Adults: Which Paradigm Works Best?,Medical Oncology Perspective,Adolescents;;Young Adults;;Gliomas,Adolescent Young Adult Glioma
296875,"Breast cancer, early stage",Serum metabolomics based risk assessment of disease recurrence in elderly patients with early breast cancer (eBC),elderly;;early;;breast cancer,Elderly Early Breast Cancer
329644,Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster III,Efficacy of Azacitidine Post-Transplant Maintenance for FLT3-Negative Acute Myeloid Leukemia and Myelodysplastic Syndrome,FLT3-Negative;;Acute Myeloid Leukemia;;Myelodysplastic Syndrome,FLT3-Negative Acute Myeloid Leukemia;;Myelodysplastic Syndrome
313262,Treatment - Treatment: Other,Implementation Of A Bone Modifying Agent Pathway At Uchicago Medicine For Metastatic Breast Cancer Patients,Metastatic;;Breast Cancer,Metastatic Breast Cancer
346030,Phase III and Pediatric Clinical Trials,Efficacy and safety of sintilimab (anti-PD-1 mAb) for advanced cervical cancer: Results from a Phase II trial,advanced;;cervical cancer,Advanced Cervical Cancer
313261,Treatment - Treatment: Other,Real World Data Of Adjuvant Endocrine Therapy For Breast Cancer In Very Young Women. A Chilean 20-Year Experience,Breast Cancer,Breast Cancer
165813,Enteric infection,Peritoneal Coccidioidomycosis in a Pediatric Patient: An Extremely Rare Presentation and Literature Review,Pediatric;;Peritoneal Coccidioidomycosis ,Pediatric Peritoneal Coccidioidomycosis 
214972,PD51: Penile & Testicular Cancer II,Medium to Long Term Health-Related Quality of Life and Treatment-Related Side-Effects in Patients treated with a single dose of adjuvant Carboplatin for High-risk Seminoma - results from a pilot study,High-risk;;Seminoma,High-Risk Seminoma
378817,Genitourinary Cancer-Kidney and Bladder,Preliminary results from a phase II study comparing sunitinib alone or with stereotactic body radiotherapy (SBRT) for newly diagnosed oligometastatic renal cell carcinoma.,newly diagnosed;;oligometastatic;;renal cell carcinoma,Newly Diagnosed Oligometastatic Renal Cell Carcinoma
329670,Autologous Transplantation: Clinical and Epidemiological: Poster II,Distinct Patterns in the Reconstitutions of Treg and T-Helper Subsets after Autologous Hematopoietic Stem Cell Transplantation in Juvenile-Onset Systemic Sclerosis Patients,Juvenile-Onset;;Systemic Sclerosis ,Juvenile-Onset Systemic Sclerosis 
296903,Oesophagogastric cancer,Prognostic impact of myeloid subsets in nivolumab monotherapy for advanced gastric cancer (WJOG10417GTR study),advanced;;gastric cancer,Advanced Gastric Cancer
329673,Autologous Transplantation: Clinical and Epidemiological: Poster II,Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported Outcomes,Refractory;;Juvenile-Onset;;Systemic Sclerosis,Refractory Juvenile-Onset Systemic Sclerosis
411593,Glomerular Diseases: Clinical and Epidemiologic Studies,Mood Changes Associated with High-Dose Corticosteroids in Adults with Glomerular Disease,Adults;;Glomerular Disease,Adult Glomerular Disease
231376,Health Services Research and Quality Improvement,National claims data analysis of outcomes of hospitalized cancer patients without COVID-19 infection during versus prior to the COVID-19 pandemic.,COVID-19 infection,COVID-19 Infection
149467,The Sherlock Holmes Approach To Differential Diagnosis: Rare And Not-So Rare Diseases Involving Thrombocytopenia,Case 3: It's simple Watson - persistence pays off!,Thrombocytopenia,Thrombocytopenia
313307,Treatment - Treatment: Other,Impact Of The Theralink Clia Protein/Phosphoprotein Assay On Treatment Selection In Routine Clinical Practice: A Prospective Observational Study In Advanced Breast Cancer,Advanced;;Breast Cancer,Advanced Breast Cancer
198621,Poster Session III (In-Person),Evidences for 10 Hz Rtms-Mediated Ltp,,
215006,PD54: Prostate Cancer: Localized: Surgical Therapy III,Revisiting current National Comprehensive Cancer Network (NCCN) high risk prostate cancer stratification: A National Cancer Database analysis,high risk;;prostate cancer,High Risk Prostate Cancer
346081,Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 2,Misclassification of clonal hematopoietic mutations as tumor-derived confound accurate ctDNA-response assessment in patients with metastatic non-small-cell lung cancer: analyses from the phase 3 MYSTIC trial,metastatic;;non-small-cell lung cancer,Metastatic Non-Small-Cell Lung Cancer
296935,Palliative care,Efficacy and safety of palliative procedures for malignant gastric outlet obstruction: a systematic review and network meta analysis,,
329708,Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II,HLA Evolutionary Divergence (HED) Informs the Effect of HLA-B-Loci Mismatch on Relapse and Disease Free Survival after Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY),,
182253,"Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: Poster III",Association between Hospitalised Vaso-Occlusive Crises and Acute/Chronic Complications in Sickle Cell Disease Patients Aged 16 Years and Older Using the French National Health Insurance Database (SNDS),Vaso-Occlusive Crises;;Acute/Chronic;;Sickle Cell Disease;;16 Years and Older ,Vaso-Occlusive Crises;;Adolescent Acute/Chronic Sickle Cell Disease;;Adult Acute/Chronic Sickle Cell Disease
411632,Glomerular Diseases: Clinical and Epidemiologic Studies,The Impact of Late Renal Biopsy on Renal Survival in Patients with Lupus Nephritis,Lupus Nephritis,Lupus Nephritis
395248,Bristol Myers Squibb - The Changing Paradigm Of Melanoma Treatment: A Clinical Update For 2023,Summary And Close,Melanoma,Melanoma
231411,Health Services Research and Quality Improvement,"Implementation of a ""genetic testing station"" in a safety net hospital to optimize access and increase equity.",,
165876,Health Care-Associated Infections: C. difficile,Readmissions of Hospitalized Patients with Clostridioides difficile Infection (CDI) for Recurrent CDI is Common,Clostridioides difficile Infection;;Recurrent,Recurrent Clostridioides Difficile Infection
378873,Genitourinary Cancer-Kidney and Bladder,Phase I/II randomized clinical trial of in-clinic acupuncture prior to BCG in patients with high-risk non-muscle invasive bladder cancer.,high-risk;;non-muscle invasive bladder cancer,High-Risk Non-Muscle Invasive Bladder Cancer
198655,Poster Session III (In-Person),Prefrontal Connections to the Extended Amygdala and Their Role in Early-Life Inhibited Temperament in Adolescent Rhesus Monkeys,,
296961,Prostate cancer,Lutetium-177-Prostate-Specific Membrane Antigen therapy (177Lu-PSMA) in Patients (Pts) with Prior Radium-223 (223Ra): Safety and Effectiveness Outcomes,Prostate cancer,Prostate Cancer
182278,Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III,A Multicompartment Mathematical Model Based on Host Immunity for Dissecting COVID-19 Heterogeneity,Acquired;;Congenital;;Immunodeficiency Disorders,Acquired Immunodeficiency Disorder;;Congenital Immunodeficiency Disorder
231430,Health Services Research and Quality Improvement,Cancer incidence in U.S. adolescent and young adult (AYA) women stratified by race/ethnicity and region.,Cancer;;adolescent and young adult,Adolescent and Young Adult Cancer
182281,Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III,Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections,Sars-Cov-2;;Infections,Sars-Cov-2 Infection
149515,Off-Label And On-Label Clinical Updates From Pivotal To Practice,Introduction,,
231436,Health Services Research and Quality Improvement,Developing and refining a theory of change to improve time to antibiotic administration for febrile pediatric oncology patients in real-world settings.,pediatric;;oncology,Pediatric Cancer
165901,Health Care-Associated Infections: Gram-negatives (MDR-GNR),Outbreak of Multidrug-resistant Pseudomonas aeruginosa in a Tertiary Healthcare System in Detroit,Pseudomonas aeruginosa,Pseudomonas Aeruginosa Infection
329741,Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I,Alternative Bone Marrow Transplantation with Post-Transplant Cyclophosphamide (PTCy) As Initial Therapy for Acquired Severe Aplastic Anemia (SAA),Severe Aplastic Anemia,Severe Aplastic Anemia
231435,Health Services Research and Quality Improvement,Factors influencing the initiation of adjuvant endocrine therapy in patients with Estrogen receptor-positive ductal carcinoma in situ: A single institution experience.,Estrogen receptor-positive;;ductal carcinoma,ER-Positive Ductal Carcinoma 
231442,Health Services Research and Quality Improvement,Testing of newly diagnosed advanced high grade ovarian cancer (OC) patients with the Myriad Genetics MyChoice CDx Plus next generation sequencing-based in vitro diagnostic test emphasizes the need for public insurance coverage of genetic testing: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO).,newly diagnosed;;advanced;;high grade;;ovarian cancer ,Newly Diagnosed Advanced High Grade Ovarian Cancer 
329752,Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I,Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia
395289,"Proffered Paper session - Breast cancer, metastatic","First-In-Human/Phase I Trial Of Hs-20089, A B7-H4 Adc, In Patients With Advanced Solid Tumors",Advanced;;Solid Tumors,Advanced Solid Tumor
346139,Phase II and Phase III Clinical Trials in Progress,"TRIDENT phase 3 study (EF-32): First-line Tumor Treating Fields (TTFields; 200 kHz) therapy concomitant with chemo-radiation, followed by maintenance TTFields/temozolomide in newly diagnosed glioblastoma",newly diagnosed;;glioblastoma,Newly Diagnosed Glioblastoma
329758,Gene Therapies: Poster II,Hematopoietic and Immunological Assessment in Fanconi Anemia after Ex Vivo Lentiviral FANCA Gene Therapy with RP-L102,Fanconi Anemia,Fanconi Anemia
231453,Health Services Research and Quality Improvement,"Not just biology: Comparing social determinants of health in patients diagnosed with late-stage lung, breast, and colon cancer.",late-stage;;lung;;breast;;colon cancer,Late Stage Lung Cancer;;Late Stage Breast Cancer;;Late Stage Colon Cancer
329764,Gene Therapies: Poster II,Increased Potency and Uniformity of Fetal Hemoglobin Induction from Base Editing Compared to Cas9 Nuclease,,
215076,PD59: Kidney Cancer: Advanced (including Drug Therapy) II,Microwave Ablation Combined with Anti-PD-1/CTLA-4 Therapy Induces Anti-Tumor Immune Response to Renal Cell Carcinoma in a Murine Model,Renal Cell Carcinoma,Renal Cell Carcinoma
182313,Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III,"A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia",Acquired Amegakaryocytic Thrombocytopenia,Acquired Amegakaryocytic Thrombocytopenia
395312,First-Line Therapy In Advanced Melanoma: What Is My Preferred Choice?,"My Preferred Choice Is Pd-1 Monotherapy, And These Are The Reasons Why",First-Line;;Advanced;;Melanoma,First-Line Advanced Melanoma
378935,"Genitourinary Cancer-Prostate, Testicular, and Penile",Final results of a pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the homologous recombination DNA repair pathway.,mCRPC,Metastatic Castration-Resistant Prostate Cancer
231482,Health Services Research and Quality Improvement,Impact of weekend effect on neutropenic fever admissions associated with malignancy.,neutropenic fever,Neutropenic Fever
198714,Virtual Poster Session III,Responses to Positive Affect and Unique Connectivity in Individuals at Clinical High-Risk for Psychosis,High-Risk;;Psychosis,High-Risk Psychosis
182330,Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster III,"Immunogenicity, Efficacy and Safety of Rurioctocog Alfa Pegol in Previously Untreated Patients with Severe Hemophilia a: Interim Results from an Open-Label Multicenter Clinical Trial",Severe;;Hemophilia a,Severe Hemophilia A
329790,Gene Therapies: Poster I,"Durability of Factor IX Activity and Bleeding Rate in People with Severe or Moderately Severe Hemophilia B after 5 Years of Follow-up in the Phase 1/2 Study of AMT-060, and after 3 Years of Follow-up in the Phase 2b and 2 Years of Follow-up in the Phase 3 Studies of Etranacogene Dezaparvovec (AMT-061)",Severe;;Moderately Severe;;Hemophilia B,Severe or Moderately Severe Hemophilia B
297023,"Breast cancer, early stage","Breast cancer overdiagnosis in England, 1995-2019",Breast cancer,Breast Cancer
378944,"Genitourinary Cancer-Prostate, Testicular, and Penile",Early changes of PSMA PET signal after initiation of androgen receptor signaling inhibitors in mCRPC: An international multicenter retrospective study.,mCRPC,Metastatic Castration-Resistant Prostate Cancer
329793,Gene Therapies: Poster I,Vector Analysis of Multicentric Lymphoma in a Severe Hemophilia A Dog after AAV Gene Therapy,Severe;;Hemophilia A;;Lymphoma ,Severe Hemophilia A;;Lymphoma 
313411,Local Therapy- Best Breast Practice,How To Reconcile Novel Reconstructive Techniques With The Need To Radiate,,
182340,Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster III,Factor IX Delivery to the Skin Primes Inhibitor Formation and Sensitizes Hemophilia B Mice to Systemic Factor IX Administration,Hemophilia B,Hemophilia B
182343,Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster III,Sustained Improvement in Health-Related Quality of Life in Patients with Hemophilia A with or without Inhibitors Treated with Fitusiran Prophylaxis,Hemophilia A,Hemophilia A
395357,How Do We Manage Patients With Complicated Toxicity To Immunotherapy?,Discussion Led By Chair,,
215136,V04: Lower Tract Reconstruction,A single stage Urethroplasty for Primary penoscrotal adult Hypospadias,adult;;Hypospadias,Adult Hypospadias
215141,V05: Misc. Benign/Transplant/Renovascular,Repair of Entero-Conduit Fistula Using Robot-Assisted Laparoscopy,,
215143,V05: Misc. Benign/Transplant/Renovascular,Robotic-Assisted Laparoscopic Left Renal Vein Transposition for Treatment of Nutcracker Syndrome,Nutcracker Syndrome,Nutcracker Syndrome
149608,Live Q&A Panel Discussion: Inherited And Acquired Hemostasis Defects,Live Q&A Panel Discussion: Inherited and acquired hemostasis defects,,
215147,V05: Misc. Benign/Transplant/Renovascular,Laparoscopic management of xanthogranulomatous pyelonephritis - comparison of two different yet similar cases,xanthogranulomatous pyelonephritis,Xanthogranulomatous Pyelonephritis
215148,V05: Misc. Benign/Transplant/Renovascular,Robotic-assisted Laparoscopic Excision of Retroperitoneal Ganglioneuroma,Retroperitoneal Ganglioneuroma,Retroperitoneal Ganglioneuroma
395383,East Meets West In The Management Of Head And Neck Cancer: Learning From Each Other,Presentation By Expert,Head And Neck Cancer,Head And Neck Cancer
329853,"Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster II",Combined Structural Variant and Mutation Profiling for Comprehensive Characterization of Chromoanagenesis and TP53 Mutations in Myelodysplastic Syndromes with Complex Karyotype,TP53 Mutations;;Myelodysplastic Syndromes;;Complex Karyotype,TP53-Mutated Complex Karyotype Myelodysplastic Syndrome
329855,"Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster II",High-Efficiency Multi-Drug Functional Profiling in a Microfluidic Device Towards Personalized Predictions in Pediatric Leukemia,Pediatric;;Leukemia,Pediatric Leukemia
215171,"V07: Prostate, Penile, Testis & Misc. Oncology I",Varying approaches to the prostate apex to optimize urethral stability and early continence recovery after robotic radical prostatectomy,,
166023,Hepatitis A,Hepatitis A Burden of Disease and Associated Complications in Children and Adults in Mexico: A Retrospective Database Study from 2000-2019,Children;;Adult;;Hepatitis A,Childhood Hepatitis A;;Adult Hepatitis A
297097,Colorectal cancer,Novel potential predictive biomarker to immunotherapy (Io) treatment in metastatic colorectal cancer (mCRC) patients: the role of the VHIO immune gene-expression signature (VIGex),metastatic;;colorectal cancer,Metastatic Colorectal Cancer
231565,"Hematologic Malignancies-Leukemia, Myelodysplastic Syndromes, and Allotransplant","Impact of TKI combination therapy and MRD negativity on outcomes in Philadelphia chromosome-positive ALL: A retrospective, single-center experience.",Philadelphia chromosome;;positive;;ALL,Ph-Positive Acute Lymphoblastic Leukemia
329868,"Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster III",High Throughput Epigenomic Mapping of Hematopoietic Stem and Progenitor Cells Using Low Cell Input Acoustic Enhanced Immunoprecipitation,,
182420,"Clonal Hematopoiesis, Aging and Inflammation: Poster III",Investigating Germline Predisposition to Clonal Hematopoiesis through Perturbation of a Variant-Harboring Enhancer of TET2,,
329878,"Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster I","Detecting the Unusual without Compromising Diagnostic Accuracy - a Prospective WGS/Wts Pilot Study in Acute Leukemias Provided Additional Information for Diagnosis, Prognosis and Treatment",Acute Leukemias,Acute Leukemia
395416,Her2 Positive Gastroesophageal Cancer,Her2 And Beyond: What'S Next?,Her2 Positive;;Gastroesophageal Cancer,HER2 Positive Gastroesophageal Cancer
198813,Clinical Management,Case Report of Myotonia Permanens with SNEL (Severe Neonatal Episodic Laryngospasm) Onset,Severe Neonatal Episodic Laryngospasm,Severe Neonatal Episodic Laryngospasm
215198,V10: Adrenal & Renal Oncology I,Robotic partial nephrectomy with reversible selective artery endoluminal balloon occlusion on a kidney graft,Adrenal & Renal Oncology,Adrenal Cancer;;Renal Cancer
215200,V10: Adrenal & Renal Oncology I,Minimally-invasive partial nephrectomy employing 4K visualization system with OPAL 1 near-Infrared and indocyanine green technology,,
297129,Oesophagogastric cancer,Outcomes and Tolerability of Neoadjuvant Chemoradiation in elderly patients with Oesophageal Cancer: An Irish Cancer Centre Retrospective Analysis:,Oesophageal Cancer,Esophageal Cancer
182442,Disordered Gene Expression and Epigenetics in Hematologic Malignancies: Basic: Poster III,Metabolic Profiling Reveals Cellular Reprogramming of Acute Myeloid Leukemia By Omipalisib through Serine Synthesis Pathway,Acute Myeloid Leukemia,Acute Myeloid Leukemia
297133,Prostate cancer,FDG-positive/PSMA-negative PET lesion prevalence in metastatic castration resistant prostate cancer and its correlation with lines of systemic therapy: results from the prospective 3TMPO imaging study,metastatic;;castration resistant prostate cancer,Metastatic Castration Resistant Prostate Cancer
231599,"Hematologic Malignancies-Leukemia, Myelodysplastic Syndromes, and Allotransplant",Efficacy and safety of high-intensity versus reduced-intensity induction in Philadelphia chromosome-positive all ineligible for HSCT.,Philadelphia chromosome-positive;;all,Ph Chromosome-Positive Acute Lymphoblastic Leukemia
329914,Health Services and Quality-Non-Malignant Conditions: Poster II,Perceptions and Barriers Related to Outpatient Management of Low-Risk PE Patients: A Community Center Experience,Low-Risk;;PE,Low-Risk Pulmonary Embolism
215227,V12: Sexual Dysfunction/Infertility/Andrology,Surgical Technique for Concurrent Penile Plication and Excision with Grafting for Severe Peyronie's Disease,Severe;;Peyronie's Disease,Severe Peyronie's Disease
379074,Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology,Bevacizumab exposure and tumor response in patients with platinum resistant epithelial ovarian cancer.,platinum resistant;;epithelial ovarian cancer,Platinum Resistant Epithelial Ovarian Cancer
231623,"Hematologic Malignancies-Leukemia, Myelodysplastic Syndromes, and Allotransplant","Analysis of real-world outcomes of IKZFmut in Philadelphia chromosome-positive ALL: A retrospective, single-institution experience.",Philadelphia chromosome;;positive;;ALL,Ph-Positive Acute Lymphoblastic Leukemia
215238,V13: Adrenal & Renal Oncology II,Open Right Partial Nephrectomy with Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma,Renal Cell Carcinoma,Renal Cell Carcinoma
182476,Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III,Synergistic Combination Activity of the Novel GSPT1 Degrader CC-90009 in Acute Myeloid Leukemia Models,Acute Myeloid Leukemia,Acute Myeloid Leukemia
166093,Clinical studies of fungal infections,Incidence of Invasive Fungal Infections in Previously Untreated Patients with Acute Myeloid Leukemia Receiving Venetoclax and Azacitadine,Previously Untreated;;Acute Myeloid Leukemia,Previously Untreated Acute Myeloid Leukemia
297167,"NSCLC, metastatic",Previous viral infections assessed by pan-virus phage immunoprecipitation sequencing (PhIP-Seq) predict response to Immune-checkpoint blockers (ICBs) in Non-small cell lung cancer (NSCLC),Non-small cell lung cancer,Non-Small Cell Lung Cancer
411858,Transplantation: Clinical - I,Hypercalcemia of Humoral Malignancy After Kidney Transplant,Hypercalcemia,Hypercalcemia
329945,Health Services and Quality-Non-Malignant Conditions: Poster I,Retrospective Assessment of Total Cost of Care in Non-Dialysis Dependent Chronic Kidney Disease Patients Receiving Parenteral Iron Therapy for Iron Deficiency Anemia,Chronic Kidney Disease;;Anemia,Chronic Kidney Disease;;Anemia
198874,Clinical Trials,"Immunogenicity of cipaglucosidase alfa/miglustat versus alglucosidase alfa/placebo in late-onset Pompe disease: a Phase III, randomized study (PROPEL)",late-onset;;Pompe disease,Late-Onset Pompe Disease
297179,"NSCLC, early stage",PET derived parameters for response assessment in neoadjuvant atezolizumab - a secondary analysis of PRINCEPS phase 2 trial.,NSCLC;;early stage,Early Stage Non-Small Cell Lung Cancer
297181,"Head and neck cancer, excluding thyroid",Phase 2 Trial of Retifanlimab (anti-PD-1) in Combination With INCAGN02385 (anti-LAG-3) and INCAGN02390 (anti-TIM-3) as First-Line Treatment in Patients With PD-L1-Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck,First-Line;;PD-L1;;Positive;;Recurrent;;Metastatic;;Squamous Cell Carcinoma of the Head and Neck,First-Line PD-L1-Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
346330,"Cell Cycle Progression, Checkpoint, and Telomeres",Fibroblast growth factor receptor-1 is a novel therapeutic target in mantle cell Lymphoma,mantle cell Lymphoma,Mantle Cell Lymphoma
313569,"The Forces That Shape Us: Interactions of Early Experience, Sex, and Puberty on The Development of Circuitry and Behavior","The Forces that Shape us: Interactions of Early experience, sex, and Puberty on the Development of Circuitry and Behavior",,
182504,Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III,Recurrent Germline Variant in the Cohesin Complex Gene RAD21 Predisposes Children to Lymphoblastic Leukemia and Lymphoma,Children;;Lymphoblastic Leukemia;;Lymphoma,Childhood Lymphoblastic Leukemia;;Childhood Lymphoma
166120,Studies of correlates of protection (or biomarkers) against microbial infection and disease in patients or experimental models,Predicting RSV Efficacy for MK-1654 in Temperate and Tropical Climates using MBMA and Clinical Trial Simulation to Account for Seasonal Differences in RSV Force-of-Infection,RSV,Respiratory Syncytial Virus Infection
182509,Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III,Long-Term Follow-up of the Combination of Low-Intensity Chemotherapy Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed-Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia,Relapsed;;Refractory;;Philadelphia Chromosome;;Negative;;B-Cell Acute Lymphoblastic Leukemia,Relapsed-Refractory Ph-Negative B-Cell Acute Lymphoblastic Leukemia
379120,Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology,Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.,breast cancer,Breast Cancer
182517,Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III,Immune and Epigenetic Landscape of TP53-mutated Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS),TP53;;mutated;;Acute Myeloid Leukemia;;Higher-Risk;;Myelodysplastic Syndromes,TP53-Mutated Acute Myeloid Leukemia;;High-Risk Myelodysplastic Syndrome
198904,Pre-Clinical Research,"Onset of LAMA2-congenital muscular dystrophy in the mouse involves cell cycle deregulation, oxidative stress and DNA damage",LAMA2-congenital muscular dystrophy,LAMA2-congenital muscular dystrophy
297208,"Breast cancer, early stage",Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with TP,Breast cancer;;early stage,Early Stage Breast Cancer
411902,Transplantation: Donation and Access,Higher Dialysis Facility Patient-to-Nurse Staffing Ratio Is Associated with Lower Hazard of Kidney Transplantation Among Adolescents and Young Adults,,
182529,Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III,"A Retrospective Observational Real-World Study of the Characteristics, Genomic Analysis, Treatment Patterns and Outcomes of Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) in the United States",Newly Diagnosed;;Acute Myeloid Leukemia,Newly Diagnosed Acute Myeloid Leukemia
149762,Abbvie: Product Theater On Venclyxto/Venetoclax,Patient Case Study: R/R High-risk Patient,,
231684,Hematologic Malignancies-Lymphoma and Chronic Lymphocytic Leukemia,Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated lymphoma administered highly active antiretroviral therapy: Central and Western China AIDS Lymphoma League 001 study (cw-CALL 001).,human immunodeficiency virus;;associated;;lymphoma,HIV-Associated Lymphoma
297223,Prostate cancer,Intermediate Clinical Endpoints (ICE) as Potential Surrogates for Overall Survival (OS) in men with Metastatic Hormone Sensitive Prostate Cancer (mHSPC),Metastatic;;Hormone Sensitive Prostate Cancer,Metastatic Hormone Sensitive Prostate Cancer
297224,"Breast cancer, early stage",Prospective study to evaluate pathological complete response after neoadjuvant therapy in breast cancer: are we ready to avoid surgery?,breast cancer,Breast Cancer
215306,Metabolic Instruction of Immunity,Multiomic analyses reveal the central role of the pentose phosphate pathway in resident thymic macrophages to cope with efferocytosis-associated stress,,
215307,Metabolic Instruction of Immunity,BPI overexpression suppresses Treg differentiation and induces exosome-mediated inflammation in systemic lupus erythematosus,systemic lupus erythematosus,Systemic Lupus Erythematosus
313613,Minority Stress and Its Mechanisms: From Systemic and Proximal Social Context to Mental Health Disparities in Sexual and Gender Minority Youth,Adolescents' Sexual Orientation and Behavioral and Neural Reactivity to Peer Acceptance and Rejection: The Moderating Role of Family Support,,
411924,"Health Maintenance, Nutrition, Metabolism - I",High-Salt and Low-Salt Diets Can Modulate Kidney Immune Cells and Endothelial Cells,,
411927,"Health Maintenance, Nutrition, Metabolism - I",Diet and the Discrepancy Between Cystatin C- and Creatinine-Based eGFR in Middle-Aged and Older Community-Dwelling Japanese Adults,,
182557,"Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III",A Phase 1a/b Dose Escalation Study of the MYC Repressor Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS,Relapsed;;Refractory;;AML;;High-Risk;;MDS,Relapsed/Refractory Acute Myeloid Leukemia;;High-Risk Myelodysplastic Syndrome
379167,Developmental Therapeutics-Immunotherapy,Selective recognition of over-expressed self-antigens in solid tumors using calibrated CAR-T therapy.,solid tumor,Solid Tumor
346411,Novel Antitumor Agents 4,A novel reversible inhibitor of XPO1 with potent efficacy in multiple preclinical mouse models,,
182577,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III",Age-Related Clonal Hematopoiesis Is a Precursor for Adult Acute Lymphoblastic Leukemia,Adult;;Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia
297267,"Breast cancer, early stage",Density lowering effect of ovarian function suppression in premenopausal breast cancer patients who had no density change with one year of tamoxifen treatment (DELFINO study),breast cancer,Breast Cancer
330033,Health Services and Quality-Myeloid Malignancies: Poster III,A Quality Improvement Initiative to Improve Implementation of Guideline-Concordant Hereditary Myeloid Malignancy Syndrome Evaluation,Myeloid Malignancy,Myeloid Malignancy
182581,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III",Implication of ICOSLG on Relapse in Infant T(4;11) Acute Lymphoblastic Leukemia,Relapse;;Infant;;T(4;11);;Acute Lymphoblastic Leukemia,Relapsed Infant T(4;11) Acute Lymphoblastic Leukemia
395574,Yo Masterclass: Tackling New Challenges Facing Young Investigators,Discussion,,
166196,PK/PD studies,Validation of an allometrically scaled body weight equation to predict vancomycin clearance and guide 24-hour vancomycin AUC dosing in obese patients,,
182578,"Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III",Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 Trial,Philadelphia Chromosome-Positive;;Acute Lymphoblastic Leukemia,Ph Chromosome-Positive Acute Lymphoblastic Leukemia
182595,Lymphomas: Translational-Molecular and Genetic: Poster III,A Molecular Classifier Increased the Accuracy of Lymphoma Diagnosis By Expert Pathologists in the Diffuse Large B-Cell Lymphoma Gained Trial from the Lysa,Diffuse Large B-Cell Lymphoma,Diffuse Large B-Cell Lymphoma
231749,Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers,Intratumor heterogeneity analysis in lung adenocarcinoma by single-cell RNA sequencing and construction of a prognostic gene signature.,lung adenocarcinoma,Lung Adenocarcinoma
182599,Lymphomas: Translational-Molecular and Genetic: Poster III,Whole-Exome Sequencing in Multiplex Families to Identify Novel AYA Classical Hodgkin Lymphoma Predisposition Genes,AYA;;Classical Hodgkin Lymphoma,Adolescent and Young Adult Classical Hodgkin Lymphoma
330056,Outcomes Research-Non-Malignant Conditions: Poster II,Pediatric Age at Hematopoietic Stem Cell Transplant: Associations with Non-Malignant Genetic Disease and Race,Non-Malignant;;Genetic Disease,Non-Malignant Genetic Disease
231753,Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers,Long-term survival in small-cell lung cancer patients: Extension of the SMALLBRAIN study.,small-cell lung cancer,Small-Cell Lung Cancer
182608,Lymphomas: Translational-Molecular and Genetic: Poster III,Establishment of Patient-Derived Organoid Culture Platform of Mantle Cell Lymphoma,Mantle Cell Lymphoma,Mantle Cell Lymphoma
346449,Tumor Heterogeneity and Clonal Evolution,Multiregional sampling of high grade glioma identifies regional biologic signatures,high grade;;glioma,High Grade Glioma
297296,"NSCLC, metastatic",Trustworthy Artificial Intelligence Models using Real World and circulating genomics data for the prediction of Immunotherapy efficacy in Non-Small Cell Lung Cancer patients,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer
395602,Mini Oral Session 1 - Non-Metastatic Nsclc And Other Thoracic Malignancies,Invited Discussant 1262Mo And 1263Mo,Non-Metastatic;;Nsclc;;Thoracic Malignancies,Non-Metastatic Non-Small Cell Lung Cancer;;Thoracic Malignancy
182617,Lymphomas: Translational-Non-Genetic: Poster III,Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients >=65 Years Receiving Bendamustine-Rituximab,Mantle Cell Lymphoma;;>=65 Years,Elderly Mantle Cell Lymphoma
330074,Outcomes Research-Non-Malignant Conditions: Poster II,Patient and Health Care Professional Perspectives on Quality of Life and Unmet Needs of People with Chronic Neutropenia: A Survey-Based Assessment,Chronic;;Neutropenia,Chronic Neutropenia
379227,Developmental Therapeutics-Immunotherapy,Deciphering primary and acquired immunotherapy resistance with whole genome and transcriptome analysis (WGTA).,,
166238,Pediatric Antimicrobial stewardship (inpatient/outpatient pediatric focused),The Effect of Penicillin Allergy Labels on Antibiotic Prescribing for Children Diagnosed with Upper Respiratory Tract Infections in two Primary Care Networks,Children;;Upper Respiratory Tract Infection,Childhood Upper Respiratory Tract Infection
330082,Outcomes Research-Non-Malignant Conditions: Poster III,Causes of Death in Patients with Sickle Cell Disease from a Large Population-Based Cohort,Sickle Cell Disease,Sickle Cell Disease
231779,Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers,Driver mutations and air pollution in advanced non-small cell lung cancer (NSCLC) at two reference hospitals in Mexico City.,advanced;;non-small cell lung cancer,Advanced Non-Small Cell Lung Cancer
395621,How Does Digitalisation Help Personalised Care Throughout The Patient Journey?,Patients At The Centre Of The New Digital Solutions: Healthday And Personalised Care,,
313701,Functionalizing Common Variants in Schizophrenia,Genetic Regulation of Caudate Nucleus Transcriptome in Schizophrenia,Schizophrenia,Schizophrenia
166251,Pediatric Bacterial studies (natural history and therapuetic),Duration of antibiotic therapy in the treatment of bacterial meningitis in young infants: a systematic review and narrative synthesis,bacterial meningitis;;young infants,Infant Bacterial Meningitis
231790,Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers,Co-occurring mutations in the DDR pathway and tumor-associated genes for predicting immunotherapeutic efficacy in non-small cell lung cancer patients.,non-small cell lung cancer,Non-Small Cell Lung Cancer
231795,Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers,Treatment patterns and outcomes associated with small cell lung cancer by platinum sensitivity status in a U.S. Medicare population.,small cell lung cancer,Small Cell Lung Cancer
412025,"AI, Digital Health, Data Science - II",Interpretable Machine Learning-Based Individual Analysis of AKI in Immune Checkpoint Inhibitor Therapy,AKI,Acute Kidney Injury
166280,Pediatric Vaccines,Vaccinate Lurie (VaLu) a QI project to improve pediatric pre-transplant immunization rates,,
379279,Developmental Therapeutics-Immunotherapy,A comprehensive pan-cancer analysis of PD-L1 expression using clone E1L3N in Chinese patients with cancer.,cancer,Cancer
182680,Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III,Nilotinib and Dasatinib Evoked Distinct Immune Effects during Tfr Phase of Each Discontinuation Trial,Myeloproliferative Syndromes;;Chronic Myeloid Leukemia,Myeloproliferative Syndrome;;Chronic Myeloid Leukemia
231833,Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers,First-in-human study of pelcitoclax (APG-1252) in combination with paclitaxel in patients (pts) with relapsed/refractory small-cell lung cancer (R/R SCLC).,relapsed;;refractory;;small-cell lung cancer,Relapsed/Refractory Small-Cell Lung Cancer
215450,Molecular Mechanisms of Cytokine Function,Distinct super-enhancer elements differentially control Il2ra gene expression in a cell-type specific fashion,,
330143,Outcomes Research-Lymphoid Malignancies: Poster II,Real-World Outcomes in Relapsed/Refractory DLBCL Patients Who Received Polatuzumab Vedotin PLUS Bendamustine and Rituximab or Tafasitamab Plus Lenalidomide By Line of Therapy,Relapsed;;Refractory;;DLBCL,Relapsed/Refractory Diffuse Large B-Cell Lymphoma
199072,Regulatory Science and Policy / Science and Health Policy,A framework for extrapolating evidence for molecularly targeted therapies from common to rare cancers - bridging the gap,cancers,Cancer
182689,Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III,The Impact of Somatic Mutations upon the Response to Combination Therapy with Ruxolitinib and Interferon in MPN Patients,MPN,Myeloproliferative Neoplasm
412065,Educational Research,Success of Virtual Patient Simulation at Improving Management of CKD-Associated Pruritus,CKD;;Associated;;Pruritus,Chronic Kidney Disease-Associated Pruritus
379296,Developmental Therapeutics-Immunotherapy,A phase II study of durvalumab re-treatment +/- prednisone in patients who discontinued prior checkpoint therapy due to immune related toxicity (CCTG IND.238A).,,
231854,Lung Cancer-Non-Small Cell Metastatic,Short-term efficacy of furmonertinib in treatment of NSCLC patients with EGFR exon20 insertion.,NSCLC ,Non-Small Cell Lung Cancer
313775,"Prazosin for Neuropsychiatric Disorders Beyond PTSD: Efficacy Signals for Alcohol Use Disorder, for Chronic Posttraumatic Headache, and for Disruptive Agitation in Alheimer's Disease",Randomized Controlled Trial of Prazosin for Prophylaxis of Posttraumatic Headaches,,
379314,ASCO Plenary Series: Rapid Abstract Updates,Updates on Abstract 398868: First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).,newly diagnosed;;Philadelphia chromosome-positive;;acute lymphoblastic leukemia,Newly Diagnosed Ph Chromosome-Positive Acute Lymphoblastic Leukemia
182713,Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III,Minimal Toxicity Seen When Pembrolizumab Is Added to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease: Early Results from an Ongoing Phase II Trial (ECOG-ACRIN EA9171),Chronic Myeloid Leukemia,Chronic Myeloid Leukemia
379322,Rare Gynecologic Cancers: A Case of Gestational Trophoblastic Neoplasia,Moderator,Gestational Trophoblastic Neoplasia,Gestational Trophoblastic Neoplasia
330175,Outcomes Research-Lymphoid Malignancies: Poster III,Examination of Disparities in Access to Chimeric Antigen Receptor (CAR) T Cell Therapies in Medicare Patients (Pts) with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Who Had Failed at Least 2 Prior Lines of Therapy (LOT),Relapsed;;Refractory;;Diffuse Large B-Cell Lymphoma,Relapsed or Refractory Diffuse Large B-Cell Lymphoma
231873,Lung Cancer-Non-Small Cell Metastatic,"Relationship between IFN-a, IL-1B, IL-5, IL-6 and effectiveness of the first-line with camrelizumab combined with chemotherapy in non small cell lung cancer.",first-line;;non small cell lung cancer,First-Line Non-Small Cell Lung Cancer
215493,Molecular and Cellular Control of Humoral Immunity,The plasma cell proteome initiates early in B cell activation in advance of Blimp-1,,
297416,Translational research (agnostic),Selection of PD-L1 escape variants in microsatellite stable metastatic colorectal cancer on avelumab treatment,microsatellite stable;;metastatic;;colorectal cancer,Microsatellite Stable Metastatic Colorectal Cancer
215499,Pathogenesis of SARS-CoV-2 Infection,SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation,SARS-CoV-2 Infection,SARS-CoV-2 Infection
199117,A Multilevel Outreach Framework to Increase Representation of African Americans and Latinx Populations in Genomic Research,A multilevel outreach framework to increase representation of African Americans and Latinx populations in genomic research,,
297422,SCLC,Atezolizumab (ATZ) plus Carboplatin (Cb) and Etoposide (eto) in patients with untreated extensive-stage small-cell lung cancer (ES-SCLC): results from the Interim Analysis of MAURIS trial,untreated;;extensive-stage;;small-cell lung cancer,Untreated Extensive-Stage Small-Cell Lung Cancer
215507,Tissue Immunity at Barrier Sites,Bystander CD8 T cell memory responses partially protect mice against lethal vaginal HSV-2 challenge,,
346582,Gene Regulation in Hormonal and Pediatric Cancers,An expression study of circadian clock-associated transcription factors and nuclear receptors in mouse prostate gland and tumor,tumor,Tumor
346583,Gene Regulation in Hormonal and Pediatric Cancers,PDEF restricts prostate cancer cellular plasticity in part by modulating YAP1/TAZ-TEAD transcriptional network,prostate cancer,Prostate Cancer
182742,Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III,"A 3-Part, Phase 2 Study of Bezuclastinib (CGT9486), an Oral, Selective, and Potent KIT D816V Inhibitor, in Adult Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)",Adult;;Nonadvanced Systemic Mastocytosis,Adult Nonadvanced Systemic Mastocytosis
379360,Hematologic Malignancies-Plasma Cell Dyscrasia,"A phase 3, open-label, randomized study to evaluate the efficacy and safety of single-agent belantamab mafodotin (belamaf) compared to pomalidomide plus low-dose dexamethasone (Pd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): DREAMM-3.",relapsed;;refractory;;multiple myeloma,Relapsed/Refractory Multiple Myeloma
231919,Lung Cancer-Non-Small Cell Metastatic,Anti-neoplastic drugs for malignant pleural effusion in non-small cell lung cancer: A meta-analysis.,non-small cell lung cancer,Non-Small Cell Lung Cancer
215538,Immunoregulation-Infection and Immunity,Immune determinants of cardiometabolic risk in pre-existing type-2 diabetes (T2D) severe COVID-19 patients,type-2 diabetes;;severe;;COVID-19,Type-2 Diabetes;;Severe COVID-19
379384,Health Services Research and Quality Improvement,"Talk, test, and take one click to curb prostate cancer mortality.",prostate cancer,Prostate Cancer
346617,Biomarker Discovery,Persistent mutation burden drives sustained anti-tumor immune responses in human cancers,cancers,Cancer
330237,Outcomes Research-Lymphoid Malignancies: Poster I,Architecture and Early Construction of a Multi-Modal Oncology Registry for Follicular Lymphoma,Follicular Lymphoma,Follicular Lymphoma
297480,"NSCLC, metastatic",Genomic characterization of first line advanced or metastatic non-small cell lung cancer (aNSCLC) patients (pts) subgroups associated with good/bad prognosis,first line;;advanced;;metastatic;;non-small cell lung cancer,First Line Advanced or Metastatic Non-Small Cell Lung Cancer
231947,Lung Cancer-Non-Small Cell Metastatic,Limited benefit from the addition of immunotherapy to chemotherapy in TKI-refractory EGFR-mutant lung adenocarcinoma.,TKI-refractory;;EGFR-mutant;;lung adenocarcinoma,TKI-Refractory EGFR-Mutated Lung Adenocarcinoma
313869,Oral Session 4 - Research,Questions & Answers,,
412174,"CKD Mechanisms: Progression, Fibrosis, and Beyond",Alveolar Type II Cell-Specific Mitofusins Modulate Kidney Fibrosis and Associated Lung Injury,Kidney Fibrosis;;Lung Injury,Kidney Fibrosis;;Lung Injury
231951,Lung Cancer-Non-Small Cell Metastatic,"Neoadjuvant Toripalimab plus chemotherapy in patients with stage IIB-IIIB NSCLC: A single-center, prospective, single-arm, phase 2 trial (Renaissance Study).",Stage IIB-IIIB;;NSCLC,Stage IIB-IIIB Non-Small Cell Lung Cancer
166420,Respiratory infections - bacterial,In Vitro Activity of Lefamulin against Staphylococcus aureus isolated from the Lower Respiratory Tract of Children with Cystic Fibrosis,Cystic Fibrosis,Cystic Fibrosis
313875,Oral Session 5 - New Instrumentation,Effect of Fractional CO2 Laser Vs Sham Treatment on Symptom Severity of Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial,,
231957,Lung Cancer-Non-Small Cell Metastatic,Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers.,HER2;;amplified;;non-small cell lung cancers,HER2-Amplified Non-Small Cell Lung Cancer
395795,Mini oral session - Gynaecological cancers,Raludotatug deruxtecan (R-DXd; DS-6000) monotherapy in patients with previously treated ovarian cancer (OVC): Subgroup analysis of a first-in-human phase I study,previously treated;;ovarian cancer,Previously Treated Ovarian Cancer
166429,Respiratory infections - viral,Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF),Older Adults;;Respiratory Syncytial Virus Infection,Elderly Respiratory Syncytial Virus Infection
231968,Lung Cancer-Non-Small Cell Metastatic,The feasibility of weekly paclitaxel in improving performance status(PS) of advanced non-small cell lung cancer (NSCLC) patients with poor performance status: A single-arm phase two trial.,advanced;;non-small cell lung cancer,Advanced Non-Small Cell Lung Cancer 
182823,Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III,Venetoclax Consolidation in Patients with High-Risk CLL Who Have Been on Ibrutinib More Than a Year Achieves a High Rate of Undetectable Minimal Residual Disease,High-Risk;;CLL,High-Risk Chronic Lymphocytic Leukemia
379442,Health Services Research and Quality Improvement,Integrating the 31-gene expression profile test into clinical decision-making to guide risk-aligned care decisions for patients with stage I-III cutaneous melanoma: NCI-SEER Analysis.,stage I-III;;cutaneous melanoma,Stage I-III Cutaneous Melanoma
297537,"NSCLC, metastatic",Taxanes plus immunotherapy might be a potential option for HER2-altered NSCLC beyond first-line progression: a retrospective real-world study,HER2-altered NSCLC,HER2-Altered Non-Small Cell Lung Cancer
166466,Skin and soft tissue,"Deep neck infections: Bacteriology and antimicrobial susceptibilities, Akron children's experience",children's;;Deep neck infections,Childhood Deep Neck Infection
412232,COVID-19 - II,Ferroptosis of Kidney After SARS-CoV-2 Infection,SARS-CoV-2 Infection,SARS-CoV-2 Infection
166480,Studies of treatment and prevention of viral infections,Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-),High Risk;;Cytomegalovirus infection,High Risk Cytomegalovirus Infection
199248,Pediatric Oncology: Clinical Investigation,A population-based assessment of cancer risk in children with recurrent multiple congenital anomalies,children;;recurrent;;multiple;;congenital anomalies,Childhood Recurrent Multiple Congenital Anomalies
232024,Melanoma/Skin Cancers,"Toxicity and outcomes of BRAF and MEK inhibitor ""ramp-up"" dosing strategies for patients with melanoma: A real-world institutional experience.",Melanoma,Melanoma
166489,Tuberculosis and other Mycobacterial Infections,Nontuberculous Mycobacterial Infections of the Upper Extremity,Mycobacterial Infections,Mycobacterial Infection
182876,Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster III,Lenalidomide Compared to Ixazomib Maintenance in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis,Newly Diagnosed;;Multiple Myeloma,Newly Diagnosed Multiple Myeloma
412259,"AKI: Outcomes, RRT",Impact of Using Blood Warmer During Continuous Kidney Replacement Therapy on Hemodynamic Instability,,
346727,Metastatic and Premetastatic Microenvironments,Hypoxic extracellular vesicles induce a pro-metastatic phenotype in neuroblastoma: from the delivery of miR-210-3p to the preconditioning of a metastatic niche,neuroblastoma,Neuroblastoma
412268,"AKI: Outcomes, RRT",Calcium Balance in Slow Extended Dialysis: Effect of Regional Citrate vs. Other Anticoagulation Strategies in a Randomized Trial,AKI,Acute Kidney Injury
379504,Care Delivery and Regulatory Policy,Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation.,symptomatic;;cancer ,Symptomatic Cancer 
182897,Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster III,Loss of Spleen Visualization on Whole-Body Diffusion-Weighted Imaging in Patients with Multiple Myeloma Is Associated with Poor Prognosis and High Tumor Burden,Multiple Myeloma,Multiple Myeloma
182896,Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster III,Early Versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma,Multiple Myeloma,Multiple Myeloma
346736,Metastatic and Premetastatic Microenvironments,Aging increases malignant peritoneal mesothelioma metastasis,Aging;;malignant;;peritoneal;;mesothelioma metastasis,Elderly Metastatic Malignant Peritoneal Mesothelioma
232058,Melanoma/Skin Cancers,Effectiveness of immunotherapy versus BRAF/MEK inhibitors in treatment-naive BRAF-mutant advanced melanoma: A single institution retrospective analysis.,treatment-naive;;BRAF;;mutant;;advanced;;melanoma,Treatment-Naive BRAF-Mutant Advanced Melanoma
346754,Cancer Disparities 2,Outcomes of patients treated with neoadjuvant chemotherapy for breast cancer at a safety net hospital,breast cancer,Breast Cancer 
166534,UTIs,"Treatment Patterns, Healthcare Resource Use, and Associated Costs in Females with Uncomplicated Urinary Tract Infection in the United States",Urinary Tract Infection,Urinary Tract Infection
395918,Controversies In Early Stage Triple Negative Breast Cancer,Optimal Neo-Adjuvant Therapy In Tnbc: Does One Size Fit All?,Tnbc,Triple-Negative Breast Cancer
232079,Melanoma/Skin Cancers,The RNA signature of immune-related genes and distinct spatial distribution of immune cells are closely associated with the treatment outcomes in the malignant melanoma patients receiving immune checkpoint inhibitors.,malignant;;melanoma,Malignant Melanoma
330385,Bone Marrow Failure Syndromes: Diagnostic Principles in 2022,Role of Genetic Evaluation in the Diagnosis of Bone Marrow Failure Syndrome,Bone Marrow Failure Syndrome,Bone Marrow Failure Syndrome
379539,Central Nervous System Tumors,Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade glioma patients: OLA-TMZ-RTE-01.,unresectable;;high grade;;glioma,Unresectable High Grade Glioma
395927,Controversies In Early Stage Triple Negative Breast Cancer,Discussion,Early Stage;;Triple Negative Breast Cancer,Early Stage Triple Negative Breast Cancer
395936,Bladder Preservation Strategies,Radiotherapy In Bladder Preservation,,
232099,Pediatric Oncology,Addition of chemo-immunotherapy to standard induction chemotherapy for high-risk neuroblastoma.,high-risk;;neuroblastoma,High-Risk Neuroblastoma
330405,Childhood Red Cell Disorders: Embracing Technology to Improve How We Manage Challenging Anemias,Dissecting Heterogeneity in Diamond-Blackfan Anemia: Insight from Single Cell Studies and Clinical Findings,Diamond-Blackfan Anemia,Diamond-Blackfan Anemia
215718,Tumor Microenvironment (TME) I,Inhibition of DNMTs and RNA editing increases immunogenic transposable element RNA to reduce tumor burden and prolong survival in a murine ovarian cancer model,ovarian cancer,Ovarian Cancer
412332,AKI: Mechanisms - II,Lats2 Ablation Exacerbates Severe Ischemia/Reperfusion-Induced Renal Maladaptive Repair Through the Upregulation of p53,,
330414,Clonal Hematopoiesis and Inflammation in Patients with Germline Predisposition Syndromes,"Exome Sequencing of 628,388 Individuals Identifies Common and Rare Variant Associations with Clonal Hematopoiesis Phenotypes",,
346802,Informing Future Precision Medicine Trials for Pancreatic Cancer,Chairperson, Pancreatic Cancer, Pancreatic Cancer
346806,Informing Future Precision Medicine Trials for Pancreatic Cancer,The cellular heterogeneity of pancreatic cancer drives local and systemic immune responses and leads to opportunities for patient stratification and trial design,pancreatic cancer,Pancreatic Cancer
232118,"Prevention, Risk Reduction, and Hereditary Cancer","Mammography screening is associated with more favorable breast cancer tumor characteristics and better overall survival: Case-only analysis of 3,739 Asian breast cancer patients.",breast cancer,Breast Cancer
182969,Cellular Immunotherapies: Clinical: Poster III,Decreased Chimeric Antigen Receptor T-Cell Efficacy with Severe or Prolonged Post-Infusion Cytopenias,Severe;;Cytopenia,Severe Cytopenia
182970,Cellular Immunotherapies: Clinical: Poster III,Analysis of Factors Associated with Conversion to CR in Patients with Large B-Cell Lymphoma Achieving Day 30 PR after CAR T-Cell Therapy,Large B-Cell Lymphoma,Large B-Cell Lymphoma
232126,"Prevention, Risk Reduction, and Hereditary Cancer",Trends in incidence and mortality in kidney cancer patients over the last 25 years in Reggio Emilia Province of the North Italy.,kidney cancer,Kidney Cancer
232129,"Prevention, Risk Reduction, and Hereditary Cancer","Step up to health, Nigeria! utilizing information from abuja's world cancer day walks for equity-based cancer prevention interventions.",cancer,Cancer
232139,Professional Development and Education Advances,Is a 'cancer check-up' near for high-risk adults? clinician attitudes and perspectives on multicancer early detection tests.,high-risk;;adults;;cancer ,High-Risk Adult Cancer 
183002,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III",Association of Donor and Recipient Interleukin-1 Gene Single Nucleotide Polymorphisms with Outcome after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood,Acute;;Chronic;;GVHD,Acute Graft-Versus-Host Disease;;Chronic Graft-Versus-Host Disease
183004,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III",Use of Belimumab for Prophylaxis of Chronic Graft-Versus-Host Disease,Chronic;;Graft-Versus-Host Disease,Chronic Graft-Versus-Host Disease
183006,"Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus Combination (CAST) Is Safe and Seems Highly Effective in Preventing Graft-Versus-Host Disease Following Haploidentical Peripheral Blood Stem Cell Transplantation",Graft-Versus-Host Disease,Graft-Versus-Host Disease
346847,Metastasis Promoting and Suppressing Genes,The effect of circulating CXCL10 on osteosarcoma metastasis using orthotopic xenograft mouse models,osteosarcoma metastasis,Osteosarcoma Metastasis
314080,Advanced Anatomy - Accessing The Pelvic Sidewall,The Pelvic Sidewall and the Endometriosis-Surgeon,,
166627,"What is the optimal 2nd line treatment for metastatic somatostatin-receptor positive, liver-dominant midgut NET?",Polling 1 (led by chair),2nd line;;metastatic;;somatostatin-receptor;;positive;;liver-dominant midgut NET,Second-Line Metastatic Somatostatin-Receptor Positive Liver-Dominant Midgut Neuroendocrine Tumor
330471,Gene Editing in Immunotherapy,Moderator Introduction,,
199413,Biological Therapeutic Agents,Aggregation of HER2 receptors on the tumor cell surface induced by a novel anti-HER2 bispecific antibody led to enhanced tumor cell growth inhibition,tumor,Tumor
346871,"Tumor Cell Interactions with Fibroblasts, Neuronal Cells, and Immune Cells",PAUF stimulates monocytes and induces their differentiation into tumor-associated macrophages,tumor,Tumor
215808,Neonatal Mucosal Immunity,Maternally derived epidermal growth factor mediates protection in neonates from opportunistic intestinal pathogens,,
232196,Sarcoma,Complete pathological response after neoadjuvant treatment in soft tissue sarcoma: A single-institution experience.,soft tissue sarcoma,Soft Tissue Sarcoma
199435,Adoptive Cell Therapy 2,Allogenic HER2-CAR T cells overcome intrinsic trastuzumab resistance in vitro and in vivo in a preclinical model of breast cancer,breast cancer,Breast Cancer
232210,Sarcoma,In vitro evidence that combination treatment with anti-PD-1 and anti-CD47 immunotherapy may not be efficient in human soft tissue sarcoma.,soft tissue sarcoma,Soft Tissue Sarcoma
379667,Melanoma/Skin Cancers,KEYVIBE-010: Adjuvant coformulated vibostolimab with pembrolizumab versus adjuvant pembrolizumab in patients with high-risk stage II-IV melanoma.,high-risk;;stage II-IV;;melanoma,High-Risk Stage II-IV Melanoma
199452,Antibodies and Immune Therapies,Amplifying STING activation by cyclic dinucleotide-manganese particles for systemic cancer immunotherapy,systemic;;cancer,Systemic Cancer
330526,Long Term Outcomes of Thrombotic Microangiopathy,Pregnancy in Women with a History of Thrombotic Microangiopathy,Thrombotic Microangiopathy,Thrombotic Microangiopathy
183072,Gene Therapies: Poster III,Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering for Cell Therapy Development,,
215852,Cytokine and Chemokine Control of Cellular Immunity,"Collaboration of therapeutic, systemic IL12p40 with locally released IL12p35 focuses immunity to the tumor microenvironment",,
215870,Adaptive Immunity in Inflammation,Leveraging genetic correlation across immune-mediated disease to gain insights into underpowered studies of rare conditions,,
199489,Late-Breaking Research: Molecular/Cellular Biology and Genetics 2,Analysis of KRAS wildtype pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma,KRAS wildtype;;pancreatic ductal adenocarcinoma;;cholangiocarcinoma,Cholangiocarcinoma;;KRAS Wildtype Pancreatic Ductal Adenocarcinoma
379717,"Prevention, Risk Reduction, and Hereditary Cancer",Cardiorespiratory fitness and BMI in youth and site-specific cancer mortality in men: A population-based cohort study with register linkage.,cancer,Cancer
199499,Cancer Genomics 3,Analytical performance of a novel next generation sequencing assay for myeloid MRD,Cancer ,Cancer 
379731,"Prevention, Risk Reduction, and Hereditary Cancer","Racial disparities in germline testing among men with pancreas, breast and metastatic prostate cancers in two health systems.",pancreas;;breast;;metastatic;;prostate cancers,Pancreatic Cancer;;Breast Cancer;;Metastatic Prostate Cancer
166744,"Mini oral session - Gastrointestinal tumours, non-colorectal","IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)",intermediate stage;;hepatocellular carcinoma,Intermediate Stage Hepatocellular Carcinoma
183137,Health Services Research-Myeloid Malignancies: Poster III,Healthcare Resource Utilization and Costs of Medicare Fee for Service Beneficiaries Newly Diagnosed with Moderate to Severe Non-Advanced Systemic Mastocytosis,Newly Diagnosed;;Moderate to Severe;;Non-Advanced Systemic Mastocytosis,Newly Diagnosed Moderate-Severe Non-Advanced Systemic Mastocytosis
379748,"Prevention, Risk Reduction, and Hereditary Cancer",The impact of extending CRC screening to the older population: Results from CRC-AIM microsimulation model.,older;;CRC,Elderly Colorectal Cancer
199526,Adoptive Cell Therapy 2,Anti-myeloid poly-pharmacy allows FGFR4-targeted chimeric antigen receptors to effectively treat an orthotopic model of rhabdomyosarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma
183143,Outcomes Research-Non-Malignant Conditions: Poster III,"Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis",Pediatric;;Sickle Cell Disease,Pediatric Sickle Cell Disease
183147,Outcomes Research-Non-Malignant Conditions: Poster III,Adherence Trajectories of Extended Direct-Acting Oral Anticoagulants and Risk of Recurrent Venous Thromboembolism and Major Bleeding: A Retrospective Cohort Study,Recurrent;;Venous Thromboembolism ,Recurrent Venous Thromboembolism
183148,Outcomes Research-Non-Malignant Conditions: Poster III,Disability Associated with Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation,Chronic;;Graft-Versus-Host Disease,Chronic Graft-Versus-Host Disease
183150,Outcomes Research-Non-Malignant Conditions: Poster III,"Understanding the Association between Red Blood Cell Transfusion Dependency and Humanistic, Psychosocial, and Psychological Burden in Patients with b-Thalassemia from the Patients' Perspective",b-Thalassemia,B-Thalassemia
330609,Novel Genomic Blood Cancer Entities - Part 1,Feasibility and Clinical Utility of an Rnaseq-Workflow for Subtype Classification and Genomic Characterization of Pediatric B-Lymphoblastic Leukemia (B-ALL),Pediatric;;B-Lymphoblastic Leukemia ,Pediatric B-Lymphoblastic Leukemia 
215923,HSCs and Myelopoiesis,"IL-18R signaling impairs hematopoietic recovery after severe, shock-like infection",severe;;shock-like infection,Severe Shock-Like Infection
379764,"Prevention, Risk Reduction, and Hereditary Cancer",Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?,breast cancer,Breast Cancer
379768,"Prevention, Risk Reduction, and Hereditary Cancer",Comprehensive analysis of patients with cancer with a positive CHEK2 test: Are we getting closer to a genotype/phenotype correlation?,cancer ,Cancer 
330620,PICKUP Study: Pneumonia in the ImmunoCompromised - Use of the Karius Test(r) for the Detection of Undiagnosed Pathogens,PICKUP Study: Pneumonia in the ImmunoCompromised - Use of the Karius Test(r) for the Detection of Undiagnosed Pathogens,Pneumonia,Pneumonia
199551,Preclinical Immunotherapy,Antitumor activity of liposomal formulation of eribulin combined with anti-PD-1,,
199553,Biological Therapeutic Agents,Antitumor and mechanism of selective serotonin reuptake inhibitor fluoxetine on muscle invasive bladder cancer,muscle invasive bladder cancer,Muscle Invasive Bladder Cancer
166786,"Proffered Paper session - Breast cancer, metastatic",Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer (ABC) treated with endocrine therapy (ET) +- ribociclib (RIB),hormone receptor;;positive;;human epidermal growth factor;;receptor;;2;;negative;;advanced ;;breast cancer,HR-Positive HER2-Negative Advanced Breast Cancer
379779,"Prevention, Risk Reduction, and Hereditary Cancer",Evaluating interventions to increase the uptake of NCCN genetic counseling recommendations.,Hereditary;;Cancer,Hereditary Cancer
183174,Outcomes Research-Lymphoid Malignancies: Poster III,Real-World Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First-Line (1L) Therapy in the United States (US),First-Line;;Chronic Lymphocytic Leukemia,First-Line Chronic Lymphocytic Leukemia
379783,"Prevention, Risk Reduction, and Hereditary Cancer",Healthcare utilization among individuals diagnosed with Lynch syndrome through a universal germline genetic testing program.,Lynch syndrome,Lynch Syndrome
379782,"Prevention, Risk Reduction, and Hereditary Cancer",Clinical utility of reporting research genetic predisposition testing results to Total Cancer Care participants.,Cancer ,Cancer 
379786,"Prevention, Risk Reduction, and Hereditary Cancer",A comprehensive analysis of clinical characterization in 149 Chinese patients with Lynch syndrome.,Lynch syndrome,Lynch Syndrome
412560,"Hemodialysis: Quality of Life, Symptoms, Palliative Care",The Utilization of Gabapentin and Pregabalin for the Treatment of CKD-Associated Pruritus and Other Indications in Manitoba,CKD;;Pruritus,Chronic Kidney Disease;;Pruritus
330643,Promoting Minorities in Hematology Oral Presentations St. Charles Ballroom - Malignant Hematology,The RNA Binding Protein Syncrip Is Required for Leukemia Stem Cell Self-Renewal,Leukemia,Leukemia
379795,"Prevention, Risk Reduction, and Hereditary Cancer",Utility of multi-gene panel-based germline analysis following genomic profiling and cascade testing in advanced solid tumors: An initial report of the BRANCH study.,advanced;;solid tumors,Advanced Solid Tumor
379803,"Prevention, Risk Reduction, and Hereditary Cancer",Impact of risk-reducing mastectomy on quality of life of women with Li-Fraumeni syndrome.,Li-Fraumeni syndrome,Li-Fraumeni Syndrome
396217,Exact Sciences - Shifting the Paradigm in Cancer Screening: Multi-cancer Early Detection (MCED) Testing,Meeting the Unmet Needs in Cancer Screening,Cancer,Cancer
183228,Outcomes Research-Myeloid Malignancies: Poster III,Impact of Post-Remission Maintenance Therapy (MT) on Outcomes in Patients (pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) in Real-World Practice,Newly Diagnosed;;Acute Myeloid Leukemia,Newly Diagnosed Acute Myeloid Leukemia
232396,Breast Cancer-Metastatic,"A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial.",unresectable;;hormone receptor-positive;;HER2-negative;;metastatic;;breast cancer,Unresectable HR-Positive HER2-Negative Metastatic Breast Cancer
